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SUMMARY
Failure to  d iffe re n tia te  may represent an in tr in s ic  genetic defect 
or an aberration in  the regulation o f gene expression. An element 
o f th is  deficiency may arise from an a lte ra tion  in  heterologous 
ce ll in teractions resu lting  from modifications in  ce ll contact, 
ex trace llu la r m atrix, or soluble transmissible agents.
A549 c e lls , derived from an alveolar type I I  pneumocyte tumour were 
selected to  study regulation and re-expression o f the 
d iffe ren tia ted  phenotype because:
1. They possess spec ific  markers fo r d iffe re n tia tio n
2. Previous work had indicated stromal dependence fo r the 
d iffe re n tia tio n  o f the normal pneumocyte
3. The system is  regulated by a well characterised inducer, 
hydrocorti sone
4. The ce lls  grow well in  cu lture and have previously 
been well characterised by others
As others had shown previously tha t the d iffe re n tia tio n  o f normal 
type I I  pneumocytes is  regulated by glucocorticoid via i t s  
interactions with stromal fib rob la s ts , the ro le  o f human foetal 
lung fib rob lasts  (M0G-LF113) on the in, v it ro  and 1_n vivo response 
of A549 was investigated.
XA549 ce lls  showed an increase in  pulmonary surfactant synthesis 
with an enhanced response to g lucocorticoid when cultured in  a 
f i l t e r  well as opposed to on a conventional p la s tic  substrate. The 
addition o f foetal lung fib rob las ts  e ither in  coculture in  the 
f i l t e r  w e ll, or separated by the f i l t e r  well membrane, with A549 on 
the f i l t e r  and M0G-LF113 growing on the dish below, fu rthe r 
enhanced pulmonary surfactant synthesis, with greatest stim ulation 
observed under t ra n s f i l te r  conditions in  the presence o f 
g lucocortico id.
Glucocorticoid treated M0G-LF113 conditioned medium was also 
capable o f enhancing pulmonary surfactant synthesis, although to  a 
lesser extent than the t ra n s f i l te r  experiments. Electron microscopy 
studies showed ce lls  treated with conditioned medium had a greater 
incidence o f m ulti lamellar bodies, the in tra c e llu la r  storage s ites  
fo r  surfactant. This medium had no e ffe c t on the growth o f e ither 
A549 or M0G-LF113 i n v i t r o , although i t  was found to  be mitogenic 
to  Swiss 3T3 fib rob la s ts .
I t  was possible to  p u rify  p a r t ia lly  a fa c to r, (or a mixture o f 
fa c to rs ), designated MOG-FDF/IV, from the conditioned medium, and 
treatment of A549 with MOG-FDF/IV stimulated pulmonary surfactant 
synthesis some tw e lve-fo ld .
MOG-FDF/IV had no e ffe c t on A549 ce ll growth in  monolayer, but 
reduced clonogenicity in  suspension. Plasminogen activa to r a c t iv ity  
was reduced in  treated cu ltures, and there was an increase in  to ta l 
ce llu la r  and secreted glycosaminog!yeans.
In tra-peritoneal administration o f MOG-FDF/IV to  nude mice bearing 
A549 xenografts markedly reduced the growth o f the tumour. This was 
accompanied by an a lte ra tion  in  the tumour h isto logy, with 
extensive tissue reorganisation and the formation o f g landu la r-like  
structures.
Preliminary observations with xenografts o f three other tumours 
suggest tha t the carc inosta tic  e ffe c t o f MOG-FDF/IV may be 
spec ific , a t least to  lung.
F ina lly , since an a lte ra tion  in  phenotypic expression may change 
the s e n s itiv ity  to  cytotoxic drugs, the e ffe c t o f induction o f 
d iffe re n tia tio n  on s e n s itiv ity  to  Adriamycin was tested. 
Pretreatment o f A549 with MOG-FDF/IV had no e ffe c t on the 
chemosensitivity o f the c e lls . This was true even when A549 ce lls  
were cultured under conditions conducive to  maximum pulmonary 
surfactant synthesis.
PREFACE
THESIS LAYOUT
This thesis is  divided in to  self-contained chapters, each with i ts  
own in troduction, resu lts  section and discussion. Chapter 1 
outlines the main top ic  o f the thes is . The main methodology used 
is  described in  Chapter 2. Chapter 3 characterises the p rinc ip le  
ce ll lines used in  th is  study, as well as th e ir  response to 
s te ro id . The consequences o f fibroblast-A549 in teractions are 
described in  Chapter 4, while Chapter 5 describes the pa rtia l 
p u rifica tio n  o f fib ro b la s t conditioned medium. Chapter 6 looks at 
other phenotypic markers in  A549, and there is  a b r ie f section on 
chemosensitivity and d iffe re n tia tio n . Chapter 7 looks a t studies 
i_n vi vo, while in  Chapter 8, a general discussion, the 
im plications o f the resu lts  and suggestions fo r fu ture studies are 
discussed.
CHAPTER ONE 
GENERAL INTRODUCTION
21.1 BIOLOGICAL BASIS OF CANCER
Normally, there is  a well contro lled balance between ce ll d iv is io n , 
ce ll d iffe re n tia tio n  and senescence, but th is  delicate balance is  
disrupted in  neoplastic tissues. The onset o f malignancy is  due, at 
least in  part, to  some kind o f block in  the d iffe re n tia tio n  
pathway, since many malignant ce lls  show signs of abnormal or 
incomplete d iffe re n tia tio n . The development o f a less well 
d iffe ren tia ted  ce ll in  a given population is  sometimes referred to  
as "d e d iffe re n tia tio n ". In many ways, th is  term is  a misnomer, 
since i t  implies th a t a ce ll actua lly  progresses backwards along 
the d iffe re n tia tio n  pathway, as a re su lt o f carcinogenic in s u lt.  
This has not been c lea rly  established and is  conceptually more 
d i f f ic u l t  to  explain, A more l ik e ly  scenario is  tha t an anaplastic 
malignant ce ll arises from the progeny o f a tissue stem c e ll ,  (one 
which is  s t i l l  capable o f self-renewal and which has not yet become 
fu l ly  d iffe re n tia te d ), which fo r some reason has been blocked or 
diverted in  the process o f becoming a fu l ly  d iffe re n tia ted  c e l l . By 
removing th is  block, perhaps by the in tervention o f pharmacological 
or b io logical agents, i t  may be possible to  allow the ce lls  to 
proceed towards terminal d iffe re n tia tio n .
31.2 DIFFERENTIATION
But what exactly is  d iffe re n tia tion ?  L ite ra lly ,  i t  has 3 meanings; 
to  develop varia tion  in , to  specialise or to  acquire a d is t in c t 
character. S c ie n tif ic a lly ,  d iffe re n tia tio n  can be described as a 
series of recognisable steps leading to  s tru c tu ra lly  and
functiona lly  mature ce lls  which generally lack the capacity fo r 
fu rthe r p ro life ra tio n .
In the adult, there are 2 main pathways o f d iffe re n tia tio n
(Freshney, 1985). In s e lf renewing tissues such as the skin or the 
haematopoietic system, a small population o f to tip o te n t or
p iu ripotent undifferentia ted stem ce lls  give r ise  to  committed 
precursor ce lls  which progress towards terminal d iffe re n tia t io n . 
These ce lls  lose the capacity to  divide as they reach the terminal 
stages, u ltim ate ly giving r ise  to  fu l ly  d iffe re n tia te d  mature ce lls  
which do not normally d iv ide . A lte rn a tive ly , a d iffe re n tia te d  ce ll 
such as a fib ro b la s t may ded iffe ren tia te  (but s t i l l  re ta in  lineage 
f id e l i t y ) ,  in  response to a local reduction in  ce ll density or
growth factor in tervention, thereby losing some o f i t  is  
d iffe ren tia ted  properties and re-enter the ce ll cycle where i t  
divides to  give new progeny. When the correct ce ll density is  
achieved, ce ll p ro life ra tio n  ceases and d iffe re n tia tio n  is  
reinduced.
41.3 FAILURES IN NEOPLASIA
As already stated above, the crucia l difference between neoplastic 
ce lls  and normal ce lls  is  an apparent lack of normal 
d iffe re n tia tio n  due to a blockade in  the normal pathway towards 
d iffe re n tia tio n . What then, are the p rinc ip le  causes fo r  such a 
fa ilu re  in  response mechanisms ? The differences between normal and 
transformed ce lls  can usually be described in  terms o f the loss or 
repression o f spec ific  endogenous genes and the the incorrect 
expression o f others. This resu lts  in  an absence o f d iffe re n tia te d  
ce ll products and the acquisition o f properties commonly associated 
with tumour growth and spread.
There are probably four p rinc ip le  reasons fo r the fa ilu re  of 
neoplastic ce lls  to  proceed towards terminal d iffe re n tia t io n . (1) 
genomic a lte ra tions , (2) overexpression or am plifica tion  o f 
normally "s ile n t"  oncogenes, (3) loss or m odification o f a receptor 
or associated signal transduction, and (4) a lte ra tio n  in  the 
supporting matrix or stroma. Each o f these points w il l  be discussed 
in  greater deta il below.
1.3.1 Genomic alterations
Many agents have the potential to  cause neoplastic change, and 
th e ir  probable mode o f action is  to  cause DNA damage, re su lting  in 
chromosome aberrations, deletions or mutations. Carcinogenic
5chemicals and irra d ia tio n  have long been known to be mutagenic 
under certa in conditions, and one long-standing theory is  tha t 
cancer is  caused by one or more genetic mutations. These can take 
two forms. F irs t ly ,  by incorrect in teractions w ith in  the DNA. This 
can be caused by e ithe r a misrepair o f damaged DNA, or base 
mispairing by d ire c t covalent bonding o f the carcinogen w ith with 
purine or pyrimidine bases in  the DNA molecule. A second type of 
DNA damage is  a fram eshift mutation, whereby the addition and/or 
deletion of base pairs is  such tha t the "reading frame" o f the 
t r ip le t  base code is  pushed out o f synchrony.
Growth-suppressor genes have also been implicated in  neoplastic 
transformation. Inheritance o f mutated or deleted suppressor genes 
may confer su sce p tib ility  to  cancer. Under normal circumstances 
these genes can suppress ce ll transformation, but i f  they undergo 
deletion or become functiona lly  a ltered, a tumour can arise (Klein 
and Klein, 1985). The most thoroughly analysed example o f such a 
gene is  the Rb gene, the gene responsible fo r  retinoblastoma, where 
both a lle les  are lo s t in  retinoblastoma tumour ce lls  (Weinberg, 
1988).
1.3 .2 Oncogenes
Other genomic a lte ra tions such as oncogene activa tion  have also 
been implicated in  the development of neoplasia. Many d iffe re n t 
types o f human and animal tumours have been shown to contain
6overexpressed or amplified oncogenes, and i t  has been suggested 
tha t these may be responsible fo r neoplastic transformation. 
Oncogenes are not unique to  transformed c e lls , indeed they are 
present in  a quiescent form in  most normal ce lls  where they are 
known as proto-oncogenes (Hunter, 1984). A study by Yokata et 
(1986), using both normal and neoplastic human tissues, showed tha t 
oncogene activa tion  appeared to  corre late with tumour development. 
In the case o f the H-ras oncogene, activa tion  is  associated with a 
single base mutation resu lting  in  an altered and chron ica lly  active 
6-protein product (Reddy e t al ,^ 1982; Tabin e t a^, 1982).
Am plification o f the c e llu la r myc, myb or H-ras oncogenes were 
found in  more than one th ird  of human so lid  tumours studied. 
Apparent a l le l ic  deletions in  H-ras and myb were correlated with 
tumour progression and metastasis, w h ils t am plifica tion o f myc 
occurred in  advanced tumours or in  aggresive primary tumours. Of 
more than seventy normal tissues studied, none expressed 
a lte ra tions in  c e llu la r  oncogenes (Yokata e t al ,^ 1986).
Therefore c e llu la r  oncogenes appear to  be c r it ic a l elements in  
neoplastic transformation in  mammalian c e lls , such th a t in  a 
transformed c e ll,  oncogenes encode proteins which function 
abnormally, inappropriately or at the wrong concentration. This 
resu lts  in  a circumvention o f the normal ce ll control mechanisms, 
which regulate ce ll d iv is ion  and d iffe re n tia tio n .
71.3.3 Receptors and growth factors
Regulatory changes in  e ithe r growth facto r production or in  
receptor expression are also l ik e ly  contributors fo r  the onset of 
neoplasia. I f  there was an a lte ra tion  in  the ce ll surface receptor, 
i t  is  not d i f f ic u l t  to  imagine the consequences o f th is , 
p a rticu la r ly  i f  the receptor was fo r a growth regulatory fa c to r. 
Over-expression o f a PDGF-like peptide has been asociated with 
expression of the svs oncogene (D o o litt le  e t aT_, 1983; W aterfield 
e t a l , 1983), and the erb-B oncogene codes fo r a truncated EGF- 
receptor which is  constantly active (Downward et al ,^ 1984). 
Neoplastic ce lls  also tend to  have a reduced capacity fo r growth 
regulatory factors which are essential fo r normal homeostatic 
con tro l, often showing autocrine control o f growth, and th is  can 
give them a growth supremacy over th e ir  normal counterparts (Moses 
and Robinson, 1982).
1.3.4 A lte ra tion  o f the stroma
I t  is  well known tha t tumour ce lls  secrete mitogenic peptides, o f
which one of the actions is  to  induce a transform ation-like
reaction in  fib rob las ts  (Todaro and De Larco, 1978). This may a lte r
the capacity o f the tumour-associated stroma to  act as an
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e p ith e lia l inducer. Therefore by recombining tumour ce lls  with 
foetal stroma from the correct s ite  and the correct phenotypic 
status, the tumour ce lls  may then receive the correct inductive
signal from the stroma, thus regaining th e ir  a b il i ty  to  respond. 
The significance and ro le  o f c e ll-c e ll and cell-strom al 
in teractions is  well established in  the normal foeta l development 
programme, and th is  concept w il l  be discussed in greater de ta il 
below.
1.4 REVERSIBILITY OF NEOPLASTIC CHANGE
Malignant transformation gives r ise  to  an altered pattern o f 
d iffe re n tia tio n , resu lting  in  a clone of ce lls  w ith unlim ited 
p ro life ra tiv e  capacities. However, a malignant tumour is  not 
usually composed exclusively o f und ifferentia ted stem c e lls , but 
can re ta in  abortive representations o f the mature stem ce lls  or 
structures o rd in a rily  found in  non-neoplastic tissues (Reiss e t a l , 
1986). These morphological characteris tics suggest th a t under the 
correct conditions, at least some tumour ce lls  s t i l l  re ta in  the 
a b il i ty  to  give r ise  to  d iffe ren tia ted  progeny in  the tissue of 
o r ig in .
The idea tha t a tumour is  but a caricature o f normal tissue has 
been illu s tra te d  well in  studies by Pierce and Wallace (1971). 
Their model system was a squamous ce ll carcinoma, which contains 
squamous e p ith e lia l "pearls", the presence o f which are regarded to 
be excellent replicas o f squamous d iffe re n tia tio n . When animals 
bearing such tumours were injected with 3H-thymidine, there was no 
label in  the pearls two hours a fte r in je c tio n . However, the label
9was found in  many undifferentia ted c e lls . By 96 hours, labelled 
ce lls  began to  appear in  the pearls, supporting the conclusion tha t 
previously und ifferentia ted ce lls  had migrated in to  the pearls. On 
autoradiographic examination under EM, i t  transpired tha t they had 
undergone d iffe re n tia tio n  in to  squamous e p ith e lia l c e lls . When the 
pearls were dissected out and transplanted in to  rec ip ien t mice, 
they never produced tumours, and under the conditions o f the 
experiment, equivalent amounts o f undifferentia ted tissue produced 
tumours in  at least one th ird  o f a ll cases (Pierce and Wallace, 
1971).
This has been substantiated by Illmensee and Mintz (1975; 1976), 
who dramatically demonstrated tha t single murine embryonic 
carcinoma ce lls  in jected in to  early stage mouse embryos ( ie  
blastocysts), gave r ise  to mature tissues which formed an in tegra l 
part o f normal chimeric mice which arose from the embryos.
A more recent study by Pierce e t Q  (1987) followed the fa te  of 
3H-thymidine labelled embryonic carcinoma ce lls  which were in jected 
in to  mouse blastocysts. Autoradiography revealed th a t the cancer- 
derived ce lls  had d iffe ren tia ted  in  accordance w ith th e ir  
lo ca lisa tio n .
Therefore, under the correct inducing conditions, i t  appears tha t 
neoplastic ce lls  s t i l l  re ta in  the capacity to  form d iffe re n tia te d  
c e lls .
10
1.5 DIFFERENTIATION AND ORGANOGENESIS
C ellu lar d iffe re n tia tio n  is  a necessary component o f organogenesis 
in  developing organ systems. Heterologous ce ll in teractions between 
ce lls  o f e p ith e lia l and mesenchymal o rig in  play a central ro le  in  
coordinating the d iffe re n tia tio n  o f a large number o f d iffe re n t 
organ systems, and i t  is  well established tha t normal e p ith e lia l 
d iffe re n tia tio n  requires mesenchymal support during organogenesis 
(Auerbach and Grobstein, 1958; Cooper, 1965; Wessells, 1970). There 
are four main parameters which regulate d iffe re n tia tio n :
1. matrix in teractions
2. c e ll-c e ll in teractions
3. p o la rity  and ce ll shape
4. soluble factors (Freshney, 1985).
1.5.1 Matrix interactions
The d iffe ren tia ted  state is  maintained by the ex trace llu la r matrix 
(ECM), a dense supporting scaffo ld which separates tissue 
compartments, mediates ce ll attachment and influences tissue 
architecture (Kleinman e t al., 1981). The ECM can be regarded as a 
macromolecular f i l t e r ,  which plays a ro le  in  d iffe re n tia tio n  and 
mitogenesis (Kleinman et al ,^ 1981; L io tta , 1986). Malignant change 
can be perceived as a defect in  d iffe re n tia tio n , whereby the ce lls  
in  some way escape from the normal matrix con tro l. The ECM i t s e l f  
tends to become altered in  neoplasia (Hynes, 1976) and th is  may
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influence tumour d iffe re n tia tio n , p ro life ra tio n  and invasion 
(L io tta  et al_, 1983; L io tta , 1986). The loss o f appropriate c e ll-  
ce ll in te ractions, whether due to  deletion o f certa in glycopeptides 
on the ce ll surface (Hynes, 1976; Sherbert e t al_, 1982), a lte ra tio n  
in  the s ia la tion  o f ce ll surface proteins (Van Beck e t a^, 1973), 
or to the p ro teo ly tic  a c t iv ity  o f the tumour (Unkeless e t al ,^ 
1974), or induced in the stroma by the tumour (Gross e t a^, 1983), 
may re su lt in  the tumour ce ll being deprived o f the correct 
inductive signals from the stroma.
To maintain the d iffe ren tia ted  sta te , there is  a continuous 
feedback o f information between in te racting  ce lls  and the 
ex trace llu la r matrix (ECM), such tha t both matrix and transmembrane 
macromolecules (collagen, lam inin, in teg rins , cadherins, 
proteoglycans) and soluble factors (growth and d iffe re n tia tin g  
factors e.g. TGF-beta) can mediate these epithelial-mesenchymal 
in teractions (Schor and Schor, 1987 -  see also Figure 1).
Many investigators have shown tha t growth and d iffe re n tia tio n  o f 
normal ce lls  can be enhanced by cu ltu ring  the ce lls  on ECM coated 
material e.g. laminin is  important fo r e p ith e lia l ce ll growth and 
d iffe re n tia tio n  (Kleinman et al_, 1981), while the presence of 
fib ronectin  is  necessary fo r the adhesion and spreading of 
fib rob lasts  (Thom et al_, 1979). The ECM component, fib ron e c tin , 
has been shown to  be permissive fo r EGF in it ia te d  DNA synthesis in  
ra t hepatocytes (Sawada e t al^, 1986), who suggested th a t ECM 
components could modify hepatocyte DNA synthesis by means o f post-
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EGF-receptor mechanisms. Freshly isolated ra t type I I  pneumocytes 
showed increased ce ll p ro life ra tio n  and d iffe re n tia tio n  when 
cultured on an ECM which was r ich  in  fib ronec tin . This stimulated 
production o f th e ir  own ECM, compared to  the equivalent ce lls  
cultured on p la s tic  (Rannel s e t al_, 1987).
Studies by Bissell (1988) using mammary e p ith e lia l ce lls  growing on 
ECM material have shown tha t the ECM can regulate protein synthesis 
and milk secretion. Both these observations are consistent with a 
model o f "dynamic re c ip ro c ity ", proposed by Bissell e t al_ in  1982, 
whereby the ECM can influence gene expression via transmembrane 
proteins attached to the actin  myofilaments, which have connections 
with the ce ll nucleus. A lterations in  gene transcrip tion  can, in  
tu rn , influence the composition o f the m atrix. This e ffe c t has been 
ve rifie d  and extended by several other groups. Blum and Wicha 
(1987) showed tha t the expression o f the genes responsible fo r m ilk 
proteins required an in ta c t cytoskeleton, since long-term treatment 
(24 hours) with cytochalasin B, a cytoskeletal in h ib ito r ,  inh ib ited  
the synthesis o f m ilk proteins, while short term treatment (1 
hour), enhanced the secretion o f alpha-casein and tra n s fe rr in .
Li e t al_ (1987) emphasised the ro le  o f the ECM in  receiving and 
in tegrating structura l and functional signals, since cultures o f 
mammary epithelium growing on reconstituted Engelbreth-Holm-Swarm 
(EHS) tumour matrix (which is  mainly lam in in), permitted more than 
90% of the ce lls  to  produce beta-casein, as well as stim ulating 
duct formation. Components o f the ECM, glycosaminoglyeans and
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proteoglycans, have been shown to  be important regulators in  the 
synthesis and s ta b ilty  o f tissue spec ific  mRNA’ s and in  the 
expression o f gap junction proteins in  cultures o f normal
hepatocytes (F u jita  e t al_, 1987).
However, i t  is  not clear to  what extent transformed ce lls  require 
or respond to the ECM, since they frequently show reduced adhesion 
to substrates in  v it ro  and are more l ik e ly  to  have anchorage 
independent growth (Macpherson and Montaigner, 1964). There are
several p o s s ib ilit ie s  why transformed ce lls  tend to  lack the 
requirement fo r the ECM. I t  may be th a t they lack the appropriate 
ce ll surface receptor to bind to  the ECM, or the production o f 
p ro teo ly tic  enzymes by tumour ce lls  may simply digest away the ECM. 
Also, a neoplastic ce ll produces i t s  own autocrine growth facto rs, 
which may override signals from the ECM, causing a reduced
dependence on the ECM. Neoplastic c e lls , therefore, tend to  be less
dependent on the ECM fo r growth. Nevertheless, a recent study by 
Daneker et aj[ (1989), using a panel o f colon carcinoma ce ll lin e s , 
has demonstrated tha t the a b il i ty  o f these ce lls  to  in te ra c t with 
the ECM depended on the degree of d iffe re n tia tio n  o f the c e lls , 
with poorly d iffe ren tia ted  ce lls  generally adhering and spreading 
s ig n ific a n tly  better than moderately well d iffe ren tia ted  lin e s , 
fu rthe r supporting the ro le  o f the ECM in  structuring development.
14
1.5 .2 C ell-cell communication
Another prerequisite fo r c e llu la r d iffe re n tia tio n  is  c e ll-c e ll 
communication. Cells can communicate in  3 ways. F irs t ly ,  they can 
share the products of metabolism by means of gap junctions. Gap 
junctions mediate communication between ce lls  by allowing inorganic 
ions and other water soluble molecules to  pass d ire c tly  from, the
cytoplasm o f one ce ll type to  the other, thereby coupling the ce lls
both metabolically and e le c tr ic a lly .  This usually occurs between 
lik e  c e lls , allowing an even d is tr ib u tio n  o f second messengers e.g. 
cAMP, although i t  can occur, a lb e it less frequently, between
disparate ce lls  e.g. across basement membranes (Finbow and P itts ,
1981; P itts  e ta l^ , 1988).
Secondly, and especially during organogenesis, there may be a 
contact in te raction  between opposed ce ll surfaces. This may involve 
in teractions between ce ll surface molecules or the ECM, and may be 
influenced by hormones, p a rt ic u la r ily  hydrocortisone (Simon- 
Assmann e t al_, 1988).
The th ird  form of c e llu la r  communication may involve transfe r o f a 
d iffu s ib le  facto r between in te racting  ce lls  in  a paracrine fashion. 
This may be dependent on the ECM, since in  the stromal induction o f 
haematopoietic c e lls , the matrix has been shown to bind growth 
factors (Roberts e t a l , 1988).
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A fu rthe r regulatory aspect o f ce ll d iffe re n tia tio n  to  be 
considered is  c e ll-c e ll in teractions between heterotypic ce ll 
populations, which are necessary fo r organogenesis in  developing 
organisms. The concept o f organogenesis has been discussed 
previously. To what extent these in teractions pers is t a fte r 
embryonic development is  not c lear, but in  the skin at leas t, i t  
has been suggested tha t dermal fib rob lasts  are necessary fo r 
complete maturation o f keratinised squames and co rn ified  envelope 
formation (Fusenig, 1986;1989).
The biochemical id e n tity  o f the s igna lling  molecules which are 
believed to  mediate epithelial-mesenchymal in teractions have been 
the subject o f intensive investiga tion , since the in i t ia l  
speculation by Grobstein in  1975 th a t matrix macromolecules may be 
involved. Adult bladder epithelium was induced to d iffe re n tia te  
in to  glandular epithelium a fte r recombination with urogenital sinus 
mesenchyme (Cunha e t al_, 1983), suggesting these ce lls  could re ta in  
a certain responsiveness to  embryonic mesenchymal induction. A 
s im ila r study by Neubauer et al ,^ (1983) showed tha t e p ith e lia l 
cy tod iffe ren tia tion  was associated with expression o f prostate 
specific  antigens and androgen receptors, suggesting th a t the 
inductive influence o f the urogenital sinus mesenchyme had 
reprogrammed both the morphological and functional characte ris tics 
o f the epithelium. This event appears to  be tissue sp e c ific , since 
only urogenital sinus mesenchyme stimulates p rosta tic  bud 
formation, with heterotypic mesenchyme fa il in g  to  do so, and 
hormone dependent, as pretreatment o f the mesenchyme with androgens
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enhanced prosta tic  bud formation (Laznitski and Mizuno, 1979). In 
the same way, e p ith e lia l ce lls  from BALB/c te s ticu la r feminisation 
mutant (tfm ) mice, which lack nuclear androgen-binding s ite s , when 
combined with w ild-type stromal ce lls  (which are androgen-receptor 
p o s itive ), resu lts  in  p rosta tic  development, suggesting tha t 
stromal ce lls  have a d irec t ro le  in  androgen-mediated 
d iffe re n tia tio n  in  the prostate (Cunha, 1984). Normal ep ith e lia , 
however, do not respond to tfm stroma. .
The loss of appropriate c e ll-c e ll in te ractions, whether due to  a 
deletion o f a glycopeptide on the ce ll surface (Hynes, 1976; Vaheri 
and Mosher, 1978; Sherbert e t al_, 1982), or induced by the tumour 
stroma (Gross e t al ,^ 1983) may re su lt in  tumours receiving the 
wrong inductive signals from the stroma. Eventually th is  breakdown 
in  communication could lead to  a loss o f d iffe ren tia ted  function 
and u ltim ate ly neoplasia.
1.5 .3 Polarity
In ep ith e lia l c e lls , the expression o f complete d iffe re n tia tio n  
requires the development o f p o la rity  w ith in  the ce ll (S a ttle r et 
al ,^ 1978; Chambard e t al ,^ 1982). P o la rity  involves correct c e llu la r  
orienta tion in  space. Chambard e t al  ^ (1981) have shown the 
importance o f collagen gels on the orienta tion  o f p o la r ity  o f 
ep ithe lia l thyro id  ce lls  in  cu ltu re . Cells cultured on the surface 
o f the gel formed a monolayer with the apical pole in  contact with
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the cu lture medium and the basal membrane attached to  the the 
substratum. Cells embedded w ith in  the gel matrix organised w ith in  8 
days in to  fo l l ic le s ,  with the basal pole in  contact with the 
collagen and the apical pole orientated towards the in te r io r  o f the 
fo l l ic u la r  lumen. The same group in  1983, th is  time using thyroid 
ce lls  growing in  a f i l t e r  well assembly, showed the basal surface 
generated receptors fo r thyro id stim ulating hormone and secreted 
triio d o ty ro s in e , while the apical surface released thyrog lobu lin . 
From these observations, i t  seems lik e ly  tha t a ce ll which is  
correctly  polarised w il l  be capable o f regulating gene expression. 
This, in  fa c t, has been demonstrated by Ben-Ze’ ev e t jrt (1988), 
who showed tha t hepatocytes cultured on dried ra t t a i l  collagen had 
a fla ttened morphology and expressed high levels o f cytoskeletal 
mRNA's but low levels o f l iv e r  spec ific  mRNA's. Conversely, ce lls  
growing on a hydrated gel matrix formed spherical aggregates with a 
low cytoskeletal mRNA and a high l iv e r  specific  mRNA, thus 
conforming more closely to  the gene expression seen in  the whole 
animal. The relevance of p o la rity  to  epithelium d iffe re n tia tio n  in 
lung w ill be discussed in  a la te r  chapter.
1.5 .4 Soluble factors
Fibroblasts are the principal ce ll type in  the mesenchymal 
matrices. Despite th e ir  widespread d is tr ib u tio n  and re la tiv e  ease 
o f culture in  v i t r o , they s t i l l  remain a poorly defined group of 
c e lls , commonly id e n tifie d  on the basis of such non-specific
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a ttribu tes  as a spindle shaped morphology, the presence o f vimentin 
intermediate filaments and the synthesis o f in te r s t i t ia l  collagens 
and fib ronectin . Nevertheless, they have been shown to  be 
responsible fo r the synthesis and secretion of a number o f soluble 
factors which influence neighbouring e p ith e lia l sheets in a 
paracrine fashion (Stoker and Pennyman, 1986), notably PD6F or a 
PDGF-like molecule (Bowen-Pope e t aj_, 1984; N im ianet al_, 1984).
The ro le  o f soluble factors as d iffe re n tia tin g  agents w ill be 
discussed below.
1.6 COMMONLY USED DIFFERENTIATING AGENTS
Over the past several years, c e lls , both normal and transformed 
have been shown to  be capable o f undergoing d iffe re n tia tio n  in  
response to  many phenotypic inducers. Commonly used inducers can be 
divided in to  2 main categories:
1. Non-physiological inducers
2. Physiological inducers
1.6.1 Non-physiological inducers
Non-physiological inducers such as planar polar solvents e.g. 
dimethylsulphoxide (DMSO) and N-methlyformamide (NMF) have been
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used fo r a number o f years, and have proved e ffec tive  
d iffe re n tia tin g  agents fo r many ce ll types, both normal and 
transformed (Spremulli and Dexter, 1986; Reiss e t a^, 1986; Marks 
e t a l , 1987), DMSO has been reported to  stimulate d iffe re n tia tio n  
in  a human amelanotic melanoma, measured by a decrease in 
p ro life ra tio n  and an increase in  melanisation (Siracky e t al_, 
1985). Dexter and colleagues (1982), showed a growth in h ib it io n  in 
2 human colon cancer xenografts fo llow ing treatment with 
di methyl formamide (DMF) and i t s l  analogue NMF. I t  has been 
suggested tha t in  the induction o f d iffe re n tia tio n  by polar 
solvents in  the HL-60 leukaemic ce ll l in e , the potency o f a 
potential d iffe re n tia tin g  agent can be predicted on the basis o f 
i t s  molecular size (Langdon and Hickman, 1987).
Other non-physiological inducers which have been used successfully 
to  induce d iffe re n tia tio n  include sodium butyrate, a 4 carbon fa tty  
acid (Reiss e t al_, 1986). Sodium butyrate has been shown to  induce 
morphological ce ll p o la rity  in  clones o f the colonic c e ll lin e  HT- 
29, as well as the formation o f domes and the secretion o f mucus 
(Augeron and Laboisse, 1984). A study by Chung e t al  ^ (1985), using 
colorectal ce ll lin e s , showed tha t sodium butyrate was capable of 
increasing the amount o f brush border membrane associated enzymes, 
p a r t ic u la r ily  a lka line phophatase, which is  a marker o f 
d iffe re n tia tio n  in  colonic c e lls .
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1.6,2 Physiological Inducers
Physiological inducers include substances such as growth regulatory 
factors and hormones. Haematopoietic regulatory proteins 
(cytokines) e.g. G-CSF and GM-CSF have been found to  enhance 
p ro life ra tio n  and d iffe re n tia tio n  o f granulocyte-macrophage 
precursors and induce d iffe re n tia tio n  in  cultured leukaemic ce lls  
(Reiss e t al_, 1986; Begley e t a l, 1987). Staying with the
haematopoietic system, in te rfe ron ,(IF N ), hailed as the cancer 
wonder drug in  the early e igh ties, has proved to  be a useful
d iffe re n tia tin g  agent fo r some leukaemias, p a r t ic u la r ily  the rare 
hairy ce ll leukaemia, where alpha-IFN is  highly e ffec tive  (Quesada 
e t al_, 1984; Sigaux e t aj_, 1987). S im ila r ily , tumour necrosis 
facto r (TNF) is  also e ffec tive  towards leukaemic ce lls  (Sugarman
et al ,^ 1985). In the same way, Geissler e t al  ^ (1989) have recently
demonstrated tha t cytokines such as recombinant human TNF-alpha 
and gamma-IFN have can induce d iffe re n tia tio n  i_n v it ro  in  b last 
ce lls  derived from patients suffering from acute myeloid leukaemia.
Retinoic acid, a vitamin A analogue (Lotan, 1980; Bloch, 1984) is  
another physiological inducer, although i t  has been used in  tumour 
studies a t non-physiological concentrations. Retinoids, especially 
re tin o l acetate, have been shown to  reduce the growth and invasive 
capacity of A549 c e lls , accompanied by a s ig n ifica n t decrease in  
type IV collagenase a c t iv ity  (Fazely et al^, 1988). S im ila r ily , 
re tino ids can induce transglutaminase expression in  HL-60 c e lls , an 
enzyme associated with the induction of a group o f re tin o id
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regulated genes which are linked to  c e llu la r d iffe re n tia tio n  
(Davies e t al., 1988).
Hormones, p a rt ic u la r ily  stero ids, have been reported to  be 
d iffe re n tia tio n  inducers in  a number o f c e lls . The g lucocortico id , 
dexamethasone, has been p a rt ic u la r ily  well studied, and has been 
found to in h ib it  both ce ll growth and DNA synthesis in  glioma 
(Guner e t a]., 1977; Mackie e t al_, 1988), lung carcinoma ce ll lin e s , 
(Oones e t al., 1978; McLean e t a]., 1986) and in  breast (Osborne et 
crt., 1979). In the same way, a ra t fibrosarcoma ce ll l in e  cultured 
in  the presence o f glucocorticoids became fla ttened in  shape, lo s t 
b ip o la r ity , extended in  size and showed arrest o f growth at 
confluence (Steffen et al., 1988). Other e ffects o f glucocorticoids 
w il l  be discussed more fu l ly  in  a la te r  chapter.
Whilst the mode o f action o f many o f the non-physiological inducers 
is  unclear, the action o f stero id hormones is  f a i r ly  well 
documented. Steroids d iffuse passively through the plasma membrane 
and translocate to  the nucleus. There they bind to  empty receptors 
where in teraction  with the chromatin is  mediated by a nuclear 
receptor complex (Alberts et al., 1989).
1.7 MODELS FOR DIFFERENTIATION
Haemopoietic tumours have proved good models fo r the induction o f 
d iffe re n tia tio n  by pharmacological and b io logical agents fo r  two
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reasons. F irs t o f a l l ,  they are comparatively easy ce lls  to  culture 
and secondly (and most im portantly), th e ir  d iffe re n tia tio n  pathways 
are fa ir ly  well characterised, making i t  easy to  see at which stage 
o f the d iffe re n tia tio n  pathway the blockage is  occuring. For 
example, tumours such as the murine Friend erythroleukaemic ce ll 
lin e  has been shown to  undergo terminal d iffe re n tia tio n  in  response 
to  DMSO (Friend e t al_, 1971), and the human promyelocytic ce ll 
lin e , HL-60, has been reported to  d iffe re n tia te  te rm ina lly  in  
response to  agents such as purine and pyrimidine analogues (Bodner 
e t a]., 1981) and polar organic solvents such as NMF (Langdon and 
Hickman, 1987).
1.8 NORMAL LUNG DEVELOPMENT
1.8.1 Epithelial-mesenchymal Interactions
As with many developing organs, the appearance o f structure 
(organogenesis) in  the embryonic lung is  strongly dependent on b i­
d irectiona l in teractions between epithelium and mesenchyme 
(Taderera, 1967; Smith and Fletcher, 1979). The in i t ia l  lung bud 
develops from the ventral surface o f the endodermal foregut and 
gives r ise  to  the epithelium o f the resp ira tory tra c t .  As i t  grows 
and branches repeatedly, i t  is  surrounded by a loose mesenchyme, 
which w ill u ltim ate ly  give r is e  to  the pulmonary in te rs tit iu m , 
smooth muscle, ca rtilage  and endothelium. The branching pattern o f 
the endoderm is  strongly influenced by the surrounding mesenchyme,
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since organ explants o f ’ the lung bud (endoderm and mesoderm) 
continue to  branch vn v i t r o , but i f  the mesenchyme is  removed, 
branching ceases (Wessels, 1970), This e ffe c t on the mesenchyme is  
organ specific  and also region spec ific  as bronchial mesenchyme 
w il l  induce the la te ra l tracheal epithelium, which does not 
normally bud, to  do so, and, conversely, paratracheal mesenchyme 
w il l  in h ib it  budding o f the more peripheral airway epithelium 
(Wessels, 1970). Thus the mesenchyme is  responsible fo r  conferring 
s p e c if ic ity .
1.8 .2 Cytodifferentiation of type I I  ce lls
Stages o f human foetal lung development are divided in to  three main 
stages:
1. glandular (5-16 weeks)
2. canalicular (17-24 weeks)
3. saccular (25 weeks onwards)
During the glandular phase of embryonic lung development, the walls 
o f the lung primordium are lined with und ifferentia ted columnar 
e p ith e lia l c e lls . In la te  glandular and early canalicu lar phase, 
these undifferentia ted ce lls  s ta r t to  d iffe re n tia te  in to  
prospective respira tory (alveolar) epithelium (Cutz e t a^, 1982). 
This begins with the formation o f acinar tubules, which are lined 
with cuboidal epithelium, composed o f ce lls  expressing phenotypic
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features o f type I I  ce lls  (Post and van Golde, 1988). The alveolar 
respiratory system develops fu rthe r by budding o f the acinar 
tubules, which leads to  the development o f p rim itive  saccules 
(a lve o li)  (Cutz e t al^ 1982). This resu lts  in  a rapid p ro life ra tio n  
o f the type I I  c e lls , with an increase in  size and number of 
cytoplasmic multi lamellar bodies, the in tra c e llu la r  storage s ites 
fo r pulmonary surfactant (Post and van Golde, 1988). The ro le  of 
pulmonary surfactant w ill be discussed in  greater de ta il in  Chapter
3.
1.9 LUNG CANCER
Lung cancer is  one o f the leading causes o f death from malignant 
disease and i t ' s  incidence is  increasing alarmingly throughout the 
world. The main causative agent fo r lung cancer is  inhaled tobacco 
smoke, and, not su rpris ing ly , c igarette  smokers show at leas t a 25- 
fo ld  increase in  the incidence o f lung cancer. Although a strong 
positive  corre la tion between, inhaled tobacco smoke and the r is k  of 
developing lung cancer has been established, other carcinogenic 
substances tha t cause lung cancer have also been id e n tif ie d . These 
include atmospheric po llu tion , chemical products and indus tria l 
hazards such as asbestos.
Lung cancer can be divided in to  2 main categories. Non small ce ll 
lung cancer (NSCLC) accounts fo r approximately 75% o f a ll lung 
carcinomas, with small ce ll lung cancer (SCLC) making up the
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remaining 25%. However, these 2 types d if fe r  in  many respects and 
th is  is  summarised in  Table 1.
TABLE 1 PROPERTIES OF LUNG CANCER CELL LINES
PROPERTY NSCLC SCLC
MORPHOLOGY E pithe lio id  Floating aggregates
SUBSTRATE ADHESION Present Absent
POPULATION DOUBLING Short Long
CLONING EFFICIENCY High Low
*APUD CELL PROPERTIES Absent Present
POLYPEPTIDE HORMONE
SECRETION Occasional Frequent
CREATINE KINASE LEVELS Low High
(BB ISOSYME)
*APUD (amine precursors uptake and decarboxylation) ce ll properties 
re fe r to  neuroendocrine properties associated with SCLC ce ll lines 
and include secretion o f 4 biochemical markers; L-DOPA 
decarboxylase (DDC), bombesin, neurone spec ific  enolase and the BB 
enzyme o f creatine kinase, CK-BB (Pearse, 1968).
Previously, i t  was thought tha t SCLC and NSCLC were o f d iffe re n t 
o rig ins , the ce ll o f o rig in  in  SCLC being the Kulchitsky 
neuroendocrine c e ll ,  while the more, heterogeneous NSCLC had 
e p ith e lia l o rig ins . However, i t  has recently been proposed tha t a 
common stem ce ll may ex is t fo r a ll types o f lung cancer (Carney, 
1987). Mixed NSCLC/SCLC tumours occur in  up to  40% o f patients with 
SCLC at autopsy, suggesting tha t one ce ll type e.g. SCLC may
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undergo d iffe re n tia tio n  to  another e.g. adenocarcinoma (Carney, 
1987).
NSCLC represents a heterogeneous population o f tumours with 
d is t in c t but overlapping h is to log ic  appearances, c lin ic a l course 
and b io logical behaviour. For th is  reason, NSCLC is  fu rthe r 
subdivided in to :
(a) squamous carcinoma 35%
(b) adenocarcinoma/alveolar carcinoma 25%
(c) large ce ll carcinoma 15%
Unlike SCLC, which is  generally responsive to  chemotherapy on 
in i t ia l  presentation (although i t  frequently relapses and becomes 
more re s is ta n t), NSCLC is  normally res is tan t from the outset, and, 
other than by surgical excision, is  very d i f f ic u l t  to  tre a t 
successfully.
There is ,  therefore,a pressing need fo r new regimes o f therapy in  
the treatment o f so lid  tumours, since these tumours are generally 
evasive to  conventional cytotoxic techniques, i f  not from the 
outset, then a fte r acquiring drug resistance.
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1.10 RATIONALE FOR THE PRESENT WORK
The ra tiona le  behind th is  study was based on observations made by 
Smith in  1979. Smith was able to  demonstrate tha t foeta l lung 
fib rob lasts  could produce, in  response to  g lucocortico ids, a 
fa c to r, fib ro b la s t pneumocyte facto r (FPF), which accelerated lung 
maturation in  foetal ra ts . This was measured by the phospholipid 
p ro file s  in  treated and untreated animals. When foetal ra ts  were 
in jected on day 17 o f gestation with 1ug of FPF, there was 
evidence, on day 20, o f accelerated lung maturation. A la te r  study 
(Smith and Sabry, 1983) looked at the effects o f co rtiso l and 
triiodothyron ine (T3), on 20 day foeta l ra t  lung cu ltu res. They 
proposed tha t g lucocorticoid was inducing FPF production in  
fib rob las ts  which in  turn induced cAMP (a second messenger) in  
e p ith e lia , resu lting  in  enhanced production o f saturated 
phoshatidylcholine. The glucocorticoid and T3 were having a 
synergistic e ffe c t on the expression o f d iffe ren tia ted  e p ith e lia l 
functions. In cultured type I I  c e lls , FPF was shown to  stimulate 
the production o f surfactant lip id s  in  foetal ra t lung (Post and 
Smith, 1984).
The essential ro le  o f FPF on pulmonary surfactant production by 
alveolar type I I  ce lls  was demonstrated by Post e t al  ^ (1984), who 
developed a monoclonal antibody against FPF which blocked the 
stimulatory e ffe c t o f FPF in  type I I  c e lls . S im ila r ily , when 
embryonic chicks were injected on day 15 o f incubation w ith the 
monoclonal, they showed biochemical evidence of delayed lung
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maturation, as compared to contro ls. This confirmed tha t in  normal 
lung development, the production o f a fu l ly  mature type I I  ce ll is  
mediated by glucocorticoids which act on fib rob las ts  rather than on 
lung epithelium d ire c tly , causing the production o f FPF, which in  
turn stimulates pulmonary surfactant production, an ind ica to r of 
lung m aturity.
I f  th is  is  the case in  normal lung development, can such a system 
be applied to  neoplastic cells? A fte r a l l ,  tumours often assume a 
quasi-foetal phenotype, expressing foetal markers such as 
carcinoembryonic antigen, and might be expected to  re-express 
d iffe ren tia ted  functions i f  given the correct embryonic 
physiological s tim u la tion (s).
Fibroblasts have been implicated previously in  the control o f ce ll 
p ro life ra tio n  and d iffe re n tia tio n  o f e p ith e lia l tumours. Human 
fib rob lasts  have been shown to  cause degenerative changes in  KB 
carcinoma c e lls , and th is  e ffe c t was enhanced by in terfe ron 
(Imanishi e t al ,^ 1983). This event was believed to be mediated by 
factors produced by the fib rob las ts , because the supernatant from 
fib rob la s t cultures caused the same degenerative changes in  KB 
ce lls  as the coculture with fib rob las ts  d id . Another study has 
shown tha t medium conditioned by normal human fib rob las ts  could 
cause growth in h ib it io n  and stimulate d iffe re n tia tio n  in  human 
sa livary adenocarcinoma ce lls  (Shirasuna e t al ,^ 1988). Again th is  
was mediated by soluble facto rs. The ro le  o f fib rob las ts  in  
e p ithe lia l d iffe re n tia tio n  w ill be discussed in  greater de ta il in
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Chapter 4, but i t  is  clear tha t th e ir  involvement in  e p ith e lia l 
d iffe re n tia tio n  extends to  malignant epithelium.
As discussed previously above, normal e p ith e lia l d iffe re n tia tio n  
requires the support o f the mesenchyme during organogenesis 
(Auerbach and Grobstein, 1958; Taderera, 1967). The importance of 
the mesodermal!y derived component o f prostate and lung has been 
demonstrated by Cunha et Q  (1983), and Post e t al_ (1984), and i t  
has also been shown tha t in te raction  with the correct temporal 
phase at the correct s ite  can in h ib it  the tumourigenic potentia l o f 
melanoma and neuroblastoma (Podesta e t a^, 1984). By recreating the 
correct c e llu la r  environment, i t  may be possible to  to  increease 
the d iffe re n tia tio n  and repress malignancy o f lung carcinoma.
1.11 MODEL SYSTEM
The present study examines the importance o f fib rob lasts  fo r  the vn 
v it ro  and i_n vivo d iffe re n tia tio n  of alveolar carcinoma c e lls , 
A549, and th e ir  response to  g lucocorticoids.
Reiss et (1986) outlined 3 optimum c r ite r ia  which should be
considered when devising experimental models to  te s t the potential 
o f d iffe re n tia tio n  inducing agents. F irs t ly ,  mature ce lls  should be 
able to  be distinguished from the tumour ce ll phenotype by 
biochemical and morphological markers. With many e p ith e lia l c e lls , 
th is  is  often a problem, since they do not possess well
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characterised d iffe re n tia tio n  markers, w h ils t in  others, they are 
easily measured, e.g. melanin production in  melanocytes and 
melanoma. While the precise d iffe re n tia tio n  pathway is  not well 
established, in  the ce ll lin e  selected fo r  the bulk o f th is  study, 
A549, biochemical and morphological markers do e x is t. These include 
synthesis and secretion o f pulmonary surfactant and the presence o f 
m ulti lamellar bodies in  the ce ll cytoplasm (Lieber e t aj_, 1976; 
Smith, 1977; Shapiro e t al^, 1978, McLean e t al ,^ 1986). Secondly, 
the ce lls  should have the potential to  be cloned in  v it ro  and th e ir  
tumourigenic capacity should be able to  be measured in  v ivo . These 
ce lls  have a good p la ting e ffic iency h i v i t r o , and grow well as 
xenografts. F in a lly , every vn v it ro  model should have an jm vivo 
counterpart with measurable parameters o f maturation. A549, 
although o r ig in a lly  derived from a human tumour, may be 
successfully grown as xenografts in  nude mice, allowing such 
determinations to  be made.
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CHAPTER TWO
MATERIALS AND METHODS
This chapter w il l  deal with the main methodology employed in  th is  
thes is . Specific de ta ils  w il l  be dealt with separately w ith in  the 
relevant Chapters.
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2.1 GENERAL CELL CULTURE METHODS
2.1.1 Maintenance of cell lines
The orig ins and characteris tics o f the p rinc ip le  ce ll lines used is  
shown in Table 2.
A ll ce ll lines used grew as monolayers and were maintained in 
e ither Nunclon 80cm2 or Falcon 75cm2 flasks in  a 1:1 mixture o f 
Hams F10: DMEM (NBLjFlow) containing 2mM glutamine (Gibco) and 0- 
10% foetal c a lf serum (FCS) as indicated in  the te x t.  Sodium 
bicarbonate (Gibco) was added in  equilibrium  with 2% C02 or 5% C02 
giving 8mM and 23mM respectively. Cells were passaged weekly, a fte r 
tryp s in isa tion , with a seeding concentration o f 103 or 104 
ce lls /m l. B r ie fly , the medium was aspirated and replaced with 
phosphate buffered saline (PBS) containing 1mM EDTA fo r 30 seconds. 
This was removed and replaced with 0.25% tryps in  (Gibco) fo r a 
fu rthe r 30 seconds. Following removal o f tryps in , the monolayer was 
incubated at 37°C fo r 10-15 minutes u n til the ce lls  had detached, 
and then dispersed in to  a single ce ll suspension.
Medium used fo r most o f the experiments described in  Chapter Four 
contained a mixture of pen ic illin /s trep tom ycin  a t 100 un its /m l. 
Otherwise, -all cultures were maintained free o f a n tib io tic s .
TABLE 2: ORIGINS AND CHARACTERISTICS OF THE MAIN CELL LINES USED
CELL LINE SOURCE ORIGIN CELL TYPE PATHOLOGY
A549a ATTC,
Maryland
Human
lung
Type I I
alveolar*
e p ith e lia l
Alveolar 
carcinoma
M0G-LF113 Medical
Oncology
Glasgow
1st
trim ester
human
foetal
lung
Fibroblast Normal
WIL Haddow
Labs.
Sutton
Human
lung
EpitheH$l Adenocarci noma
A2780b NCI
Bethesda *
Human
ovary
E p ithe lia l Adenocarcinoma
MOG-LT-34 Medical 
Oncology 
Glasgow
Human
lung
Epi th e !i al Adenocarcinoma
NCI-H69V NCI
Betheseda
Human
lung
Small ce ll 
lung
Derivative o f 
NCI H69
carci noma
aG ia rd e ta ]>, 1972; Lieber e t a l , 1976 
bTsuruo e t a^, 1986; Van der B lick e t a l , 1988
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2.1 .2  Cell freezing
To reduce the chances o f genetic d r i f t ,  a ll ce ll lines were 
replaced from frozen stocks every 3 months. Frozen stocks were 
maintained in  liq u id  nitrogen. Cells fo r freezing were trypsinised 
and suspended in  cu lture  medium at a concentration o f a t least 
10^/ml, and 10% DMSO (BDH) was added as a preservative and the 
suspension a liquotted in to  1ml v ia ls  (Nunclon). They were frozen 
with a cooling rate o f approximately 1°C/minute to -70°C and 
retained at -70^C overnight before being transferred to  liq u id  
nitrogen.
Cells were thawed by rapid warming of the v ia l in  a covered 
container with water at around 35°C, and then transferred to 
s te r i le  25cm2 flasks (Nunclon), and d ilu ted 1:20 by the slow 
addition o f fresh cu lture medium.
2.1 .3 Mycoplasma testing
Cultures were checked fo r the presence o f mycoplasma every month. 
Cells were fixed with 25% g lacia l acetic acid in  methanol and 
incubated with the fluorescent DNA sta in Hoescht 33258 fo r 15 
minutes at room temperature (Chen, 1977). Cultures which contained 
extranuclear DNA in  a characte ris tic  punctate or filamentous 
pattern were ind ica tive  o f mycoplasma in fec tion . A ll experiments 
were carried out on ce lls  which were free o f mycoplasma.
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2.1 .4  Aseptic technique
A ll aseptic manipulations were carried out in a class I I
m icrobiological safety cabinet with ve rtica l a ir  flow . A ll 
glassware was dry heat s te r ilis e d  at 160®C fo r a minimum o f one 
hour and heat stable solutions autoclaved p rio r to use. Heat la b ile  
solutions were e ithe r purchased s te r i le  or f i lte re d  through 0.2um 
s te r ile  f i l t e r s  (Mi H i pore).
2.1 .5 Cell counting
Cell counts were performed using a Coulter counter, model ZB-j
(Coulter Electronics, Luton, Beds.) previously calibrated fo r  these
ce ll lin e s . The ce ll suspension was d ilu ted  1:50 in  PBS and 0.5ml
o f the d ilu ted suspension drawn through the o r if ic e  tube (100um) 
on the counter. As the ce lls  pass through the o r if ic e ,  they change 
the resistance to the e le c trica l current flowing through the 
o r if ic e  by an amount proportional to ce ll volume. This generates a 
pulse which is  amplified and counted. The f in a l ce ll count on the 
readout was m u ltip lied  by 100 to  give the cells/m l in  the o rig ina l 
suspension.
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2.1 .6 Growth curves
Growth curves were performed using A549 and LF113 and terminal ce ll 
densities and population doubling times determined from the data. 
Cells were seeded at a concentration o f 104 ce lls/m l (2x103
cells/cm2) fo r A549 and 5x104/ml (1x104/cm2) fo r LF113. The ce lls
were allowed to  attach overnight, then the medium was removed and
replaced with fresh cu lture  medium with or without the pa rticu la r 
variable under study. T rip lica te  samples were counted every 2 days, 
and the ce lls  fed as necessary depending on the pH o f the spent 
medium.
2.2 PREPARATION OF FOETAL MOUSE LUNG
(Adapted from Douglas and Teel, 1976)
19 day mouse foetuses were aseptica lly  removed from timed-pregnant 
AKR females, freed o f attending membranes and decapitated. The
lungs were dissected out under aseptic conditions and washed in  
ch ille d  Hams F10 cu lture  medium, then chopped in to  1mm3 pieces with 
crossed scalpel blades. The pieces were transferred to  a universal 
container (S te r ilin )  which contained 10ml o f 0.25% tryp s in , and 
le f t  overnight at room temperature to  allow the ce lls  to  
dissociate. The tryps in  was aspirated and 15ml o f F10 medium added 
to  the c e lls , which were then f i l te re d  through nylon bo lting  c lo th  
to  remove ce ll clumps. The ce ll suspension was centrifuged at 260 x 
g fo r 5 minutes then the p e lle t was resuspended in  Hams F10:DMEM
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containing 10% FCS. A fte r another centrifugation step, the p e lle t 
was incubated with the supernatant fo r one hour at 37°C, since i t  
is  believed th is  allows synthesis o f matrix macromolecules which 
are essential fo r ce ll reaggregation (Douglas and Teel, 1976). The 
p e lle t was resuspended in  fresh F10:DMEM containing 10% FCS, 100 
units/ml o f p e n ic ill in  and 100ug/ml o f kanamycin, and 1 ml aliquots 
were transferred to 25cm2 flasks. The number o f viable c e lls , 
estimated by trypan blue exclusion was always greater than 95%, and 
the ce ll concentration always exceeded 106 cells/m l
2.3 CHROMOSOME ANALYSIS
Cells in  exponential growth were incubated in  the presence of 
colcemid fo r 4 hours at 37^C to  arrest d iv id ing ce lls  in  metaphase. 
Following incubation, the medium was removed and replaced with- 5ml 
of hypotonic buffer (0.04M KC1/0.025M NaCitrate). A fte r 20 minutes 
at 37^C, the metaphase ce lls  were collected by gently p ipe tting  the 
buffer over the monolayer. The metaphase ce lls  were then 
transferred to  p la s tic  te s t tubes (S te r il in )  and 5ml o f ice cold, 
fresh ly  prepared acetic acid/ethanol f ix a tiv e  (1 part g lacia l 
acetic acid/3 parts ethanol) was added dropwise with constant 
mixing. The tubes were centrifuged at 2000g fo r 2 minutes at 4°C 
(IEC-centra), and the supernatants discarded. The f ix in g  process 
was repeated twice more. The fin a l pe lle ts  were resuspended in  
approximately 10Oul o f f ix a tiv e  and a few ul dropped onto a glass 
s lid e . The preparations were a ir  dried and stained with Giemsa
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(BDH). Chromosomes were counted by eye or photographed under o il 
immersion using a Polyvar microscope equipped with an automatic 
camera.
2.4 PROTEIN DETERMINATION
A ll protein measurements were carried out using the Bradford 
protein assay (BioRad), which is  based on the d iffe re n tia l colour 
change o f a dye, Coomassie Blue, in  acid ic so lu tion, in  response to 
various concentrations o f protein (Bradford, 1976). When binding to 
the dye occurs, the absorbance maximum fo r an acid ic solution o f 
Coomassie B r i l l ia n t  Blue G-250 s h ifts  from 465-595nm. Depending on 
the amounts o f protein present, the assay was performed using 
e ithe r standard assay or microassay conditions. Protein was 
so lub ilised in  100mM NaOH. When using standard assay conditions, 
(20-140ug/ml of p ro te in ), 100ul a liquots were dispensed in to  te s t 
tubes and 5ml o f Bradford reagent, d ilu ted  1:4 with d is t i l le d  water 
was added and the tubes vortexed. Colour was allowed to develop fo r 
up to  1 hour. Absorbance was measured on a G ilfo rd  250 
spectrophotometer at 595nm.
For the microassay, (less than 20ug o f p ro te in ), 200ul a liquots o f 
so lub ilised protein were mixed with 50ul o f undiluted Bradford 
reagent in  m ic ro titre  plates (Flow Laboratories) and the plates 
read on a m ic ro titra tio n  plate reader 600nm (BioRad ELISA, model 
2550).
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Using bovine serum albumin (BSA) standards (Sigma) o f known 
concentrations (0-1000ug/ml), a standard curve was performed each 
time, and from th is  the protein content o f the unknown solution was 
determined.
2.5 MEASUREMENT OF PULMONARY SURFACTANT
2.5.1 Secreted pulmonary surfactant
Pulmonary surfactant was measured using a m odification of the 
technique of Smith (1977). Cells were plated out in  e ithe r 25cm  ^
flasks or in  f i l t e r  wells at a ce ll density o f 5 x 104 per ml 
(flasks) or 8 x 104 per ml ( f i l t e r  w e lls ), and allowed to  achieve 
confluence. At confluence, the medium was aspirated and the ce lls  
washed twice with serum free medium, then incubated fo r the 
appropriate times with the compound under investiga tion . The ce lls  
were labelled with 0.1uCi/ml (76Ci/mmol) o f [methyl-^H] choline 
chloride (Amersham) fo r 24 hours. A fte r the la b e llin g  period, the 
medium was removed and the ce lls  washed 3 times with serum free 
medium. A 3ml portion o f serum free medium containing 1.0mM 
isoproterenol (Sigma) was added to the ce lls  plus 20ul o f L-3 
phosphatidylcholine, 1,2 -d i[1 -^4C] palmitoyl (117mCi/mmol; 
approximately 2000cpm; Amersham) fo r 15 minutes at room 
temperature. The ^C-DPPC acts as an internal standard fo r 
calcu lating subsequent recoveries. This medium was collected and 
mixed with 9ml o f a 2:1 mixture o f chloroform:methanol (BDH) and
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1.0mg o f DL-alpha-phosphatidylcholine dipalm itoyl (Sigma) and the 
sample vortexed. The two resu lting  layers were allowed to 
p a rt it io n , and the top aqueous phase removed by suction. The 
organic phase was dried under a stream o f nitrogen or in  a vortex 
evaporator (Buchler), then reacted with 0.5ml o f a 6.2mg/ml 
solution of osmium te troxide (Sigma) fo r 15 minutes at room 
temperature. The tubes were allowed to  stand at room temperature 
fo r a fu rther 30 minutes to  ensure the reaction had reached 
completion, then the samples evaporated as before.
The remaining ce ll monolayer was dissolved in  100mM NaOH and 
assayed fo r protein content (see section 2 .4).
2.5 .2 Cell associated pulmonary surfactant
Cell associated surfactant was measured as fo llow s. Cells were 
incubated with or without 0.25uM dexamethasone fo r 48 hours then 
labelled w ith 0.1uCi/ml 3H-methyl choline chloride (Amersham; see 
2.5.1) fo r 24 hours. Following the la b e llin g  period, the medium was 
removed and the ce lls  fixed with 5ml o f methanol (BDH)• These ce lls  
were scraped from the flasks and transferred to  glass tubes and the 
lip id s  extracted with 5ml of 100mM KC1 (BDH) and 10ml o f chloroform 
(BDH). 1.0mg o f dipalm itoylphosphatidylcholine, a "cold" ca rrie r 
was added, along with approximately 2000cpm o f ^4C- 
dipal mi toy!phosphatidyl choline, an in ternal standard fo r 
ca lcu lating recoveries. The tubes were vortexed and the aqueous and 
organic layers allowed to separate. A fte r removing the top aqueous
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phase, the lower organic phase was dried under nitrogen, or in  a 
vortex evaporator. The remaining protocol was identica l to tha t 
described in  section 2.5.1.
In both cases, disaturated phosphatidylcholine (DPPC) was pu rified  
by column chromatography according to  the method o f Mason e t a^ 
(1976). Columns were prepared by plugging a 145mm glass Pasteur 
p ipette with 0.08g of glass wool, then layering 0.8g of neutral 
alumina on top (BioRad). Samples were redissolved in  0.5ml o f a 
20:1 (v/v) mixture o f chloroform:methanol and applied to  the 
columns (which were pre-equilibrated w ith chi oroform:methanol) .  To 
elute neutral l ip id s ,  15ml o f the 20:1 chloroform:methanol mixture 
was run through. The bound DPPC, which is  ac id ic , was eluted with 
8ml o f a 70:30:2 (v/v) solution o f chloroformimethanol:7M ammonia. 
Eluted DPPC was collected in  s c in t i l la t io n  v ia ls  and evaporated to 
dryness, then 10ml o f s c in t i l la n t  (Ecoscint) added.
Samples were counted on a double channel s c in t i l la t io n  counter 
(Beckman or Packard), and the resu lts  calculated by the channels 
ra tio  method using the follow ing formula.
1. channel 1 = 3H 
channel 2 = 3H + ^C
14C = channel 2 -  channel 1
2. % sp illove r from 14C in to  3H = channel 2 -  channel 1/channel 2 = 
X%
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3. Total 3H count (cpm):
(channel 2 -  channel 1) x X = Y
Total 3H count = channel 2 -  Y
4. To correct fo r recovery,
cpm channel 2 -  cpm channel 1/cpm 14C added x 100 = Z = % 
recovery
5. 3H-choline (surfactant),
Total 3H cpm x 1/Z x 100 = R (surfactant)
6. Expressed as pulmonary surfactant/mg o f protein or 
pulmonary surfactant/106 c e lls .
2.6 PREPARATION OF CONDITIONED MEDIUM
Bulk quantities o f conditioned medium were prepared by Dr Gierish 
Shah, Glaxo Group Research, Greenford, Middx, according to  the 
f o l1owi ng protocol.
Foetal lung fib rob las ts  were grown to  confluence in  e ithe r 175cm2 
flasks (Nunclon) or 850cm2 ro lle r  bo ttles (Corning). The medium was 
aspirated and the ce ll monolayers washed twice w ith serum free 
cu lture medium, then incubated with serum free medium containing 
25uM dexamethasone (dexamethasone sodium phosphate; Merck Sharp and 
Dohme) fo r a fu rthe r 24 hours. At the end of the incubation period, 
the ce ll monolayers were washed twice with serum free medium, then
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incubated with serum free medium fo r 6 hours at 37°C. The medium 
was collected, centrifuged at 1000g to  remove ce ll debris, and 
e ithe r used immediately or stored at -70°C u n til required.
2.7 HIGH PERFORMANCE LIQUID CHROMATOGRAPHY (HPLC) OF CONDITIONED 
MEDIUM TO DETECT DEXAMETHASONE
HPLC analysis o f both conditioned medium and extracted LF113 ce lls
*•
was performed, using a m odification o f the technique o f Derendorf 
e t a l (1986), to  measure dexamethasone leve ls .
Samples o f conditioned medium were collected s ix  hours a fte r 
dexamethasone removal. In addition, in ta c t ce lls  were scraped from 
the flasks at various predetermined time points and resuspended in  
a small volume o f PBS (1-2ml) . To release ce ll contents, the ce lls  
were disrupted using a blender (U ltra  Turrax) fo r 2 minutes. Both 
conditioned medium and ce ll extracts were mixed with 30ul o f 
in ternal standard (20mg/l 6-alpha-methylprednisolone (Sigma) in 
methanol (BDH)) and extracted twice at pH 1.0 by shaking fo r 15 
minutes with 3ml portions o f ethyl acetate (dames Burrough), then 
centrifuged at 5000rpm fo r 5 minutes (Oouan). The samples were 
dried in  a vortex evaporator (Buchler), then resuspended in  50ul o f 
mobile phase. The mobile phase consisted o f acetonitrile-0.05M  
phosphate bu ffe r, pH 2.0, 30:70 v /v , both HPLC grade. For the 
assay, the fo llow ing instruments were used: a high pressure pump 
(A ltex, model 110A) equipped with a "Promis" autosampler w ith a 
variable in jec tion  volume (Milton Roy), a 10um u-Bondapak C18 
column 24cmx4mm internal diameter (Phase Sep) and a U.V. detector
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(Altex H itachi) set at 230nm. A ll in tegration was performed on a 
OCL 6000 chromatography data system (Oones Chromatography). The 
flow rate was 2ml/minute and the in je c tion  volume was 30ul.
2.8 PROTEIN PURIFICATION FROM CONDITIONED MEDIUM
2.8.1 Ammonium sulphate precipitation
Aliquots o f conditioned medium were cooled to  4°C on ice and 20% of 
(NH4)2S04 (w / v ) added. The medium was le f t  fo r 30 minutes on ice 
with constant s t ir r in g .  Following incubation, the medium was 
centrifuged in  a Sorvall fo r 20 minutes at 10 000 x g. The 
supernatant was retained and precip ita ted to  40% with (NH4)2S04 as 
above. Further fractions were collected a t 60 and 80% (w/v) using 
the same protocol. The precip ita tes were resuspended in  a small 
volume o f ice-cold PBS (no more than 2ml) and dialysed extensively 
overnight in  Sigma d ia lys is  tubing against PBS at 4°C. The dialysed 
samples were e ither used immediately or stored at -70°C u n til 
required.
2.8 .2  Isoelectric focusing (IEF)
IEF is  a re la tiv e ly  gentle non-denaturing and high resolution 
technique whereby mixtures of proteins in  so lution can be 
separated, usually without loss o f b io log ica l a c t iv it ie s .  IEF in
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free solution has the added advantage tha t the separated proteins 
can be recovered easily once they are focused -  they do not need 
to  be eluted from a so lid  gel m atrix. Separation o f proteins by IEF 
is  based on the fa c t tha t a ll proteins have a pH dependent net 
charge. This is  determined by both the amino acid sequence o f the 
protein and the pH o f the environment. When a protein is  
electrophoresed through an established pH gradient, i t  w il l  migrate 
u n til i t  reaches the point a t which the net charge is  zero; at th is  
point w il l stop migrating and is  said to  be focused.
Conditioned medium was dialysed against Tris-HCl, pH 7.4 overnight 
at 4°C. Before focusing began, the dialysed solution was mixed with 
1% ampholyte solution to  establish a pH gradient (BioRad; pH range 
3-10). The sample was loaded in to  the focusing chamber o f a Rotofor 
Cell (BioRad) linked to  a rec ircu la tin g  water bath a t 4°C and 
allowed to  run fo r 4-6 hours at 12W constant power u n til the 
voltage reached plateau. At the end o f the run, a ll 20 samples were 
harvested simultaneously under vacuum and assayed d ire c tly .
2.8 .3 Large scale purification of conditioned medium by ion 
exchange chromatography
A glass column, 8cm X 25cm and f i t te d  with a sc in tre  was packed 
with 200ml of S-Sepharose (Pharmacia), a cation exchanger, to  give 
a gel bed of approximately 5cm. A f i l t e r  paper disc was placed on 
top of the gel bed to  allow a more even flow o f liq u id  through the
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column. The column was linked to  a UV absorbance monitor set at 
280nm (Uvicord; LKB) and a chart recorder. The column was
equilibrated with 50mM MES (2-CN-morpholinolethanesulphonic acid), 
pH 6.0 at 4°C overnight. Aliquots from a 20 l i t r e  batch of
conditioned medium were d ilu ted  1:4 with equ ilib ra tion  buffer ju s t 
p r io r to loading and the d ilu ted  medium allowed to  run under
grav ity  at 4°C fo r 4 days. Flow ra te  was between 10 and
20ml/minute. At the end o f the run, proteins were eluted from the
column using 1M NaCl in  50mM MES, pH 6.0
2 .8 .4  Gel f i l t ra t io n  using fast protein liqu id  chromatography 
(FPLC)
200ul o f protein solution was loaded onto a Superose 12 gel 
f i l t r a t io n  column linked to a fu l ly  automated FPLC system 
(Pharmacia). The run took 40 minutes, a fte r which the samples were
collected every 2 minutes in  1ml a liquots in  PBS.
2.9 POLYACRYLAMIDE GEL ELECTROPHORESIS
SDS-PAGE was performed routine ly  a fte r each p u rific a tio n  stage 
under denaturing conditions according to  Laemmli (1970) as fo llow s. 
A 12.5% running gel was prepared by mixing 10ml o f 1.5M Tris-HCl 
pH8.8 containing 0.4% SDS with 12.5ml 1.07% b is , 40% acrylamide 
(Sigma/BDH), 17.2ml of d is t i l le d  water and 12ul o f N,N,N! ,N! -
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tetramethyl-ethylenediamine (TEMED; Sigma). This solution was 
degassed fo r 5 minutes, then 300ul o f a 10% solution o f ammonium 
persulphate (BDH) added. The gel was cast between 2 clean glass 
plates and allowed to photopolymerise. The in terface between the 
running and the stacking gels was made level by the addition o f a 
few drops o f water saturated n-butanol -  th is  was poured o f f  before 
the- addition o f the stacking gel.
The stacking gel was prepared by mixing 2.5ml o f Tris-HCl pH 6.8 
containing 0.4% SDS with 1.0ml o f bis/acrylamide (1.07%/40%), 
6.42ml of d is t i l le d  water and 10ul o f TEMED. A fter degassing, 75ul 
o f a 10% solution o f ammonium persulphate was added and the gel 
applied on top o f the preformed running gel.
Protein samples were d ilu ted  with appropriate amounts o f sample 
bu ffe r. This consisted o f 1.25ml o f 1M Tris-HCl pH 6.8, 0.1ml of 
glycerol (BDH), 2ml o f 10% SDS (Sigma), 0.1ml o f beta- 
mercaptoethanol (Gibco) and 0.55ml o f d is t i l le d  water. Samples plus 
buffer were boiled fo r 4 minutes to  denature the proteins and 
applied to  the gel in  50ul a liquots with a Hamilton syringe. 
Running buffer consisted o f 0.25M Tris/1.92M glycine, d ilu ted  1:10 
before use with the addition o f 10ml o f 10% SDS per l i t r e .
SDS-PAGE was performed using e ithe r a BioRad or a BRL system at 50V 
(constant voltage) overnight.
2.10 GEL STAINING
All gels were s ilv e r  stained, since s ilv e r  staining techniques are
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generally 100-fold more sensitive than Coomassie Blue and can
detect nanogram quantities o f pro te in . The gels were fixed in 30% 
ethanol:10% acetic acid, v /v , (Games Burroughs; BDH) fo r  one hour 
at room temperature, then stained using e ither an Amersham or Sigma 
s ilv e r  sta in k i t  according to  the manufacturers ins truc tions .
2.11 IMMUNOBLOTTING OF PROTEINS (WESTERN BLOTTING)
To t ry  to  id e n tify  fu rthe r the p a r t ia lly  p u rified  peptide, a series 
of western b lots were carried out using a panel o f antibodies to  
growth facto rs. Western b lo ttin g  depends on the transfe r of 
proteins from polyacrylamide gels to  n itroce llu lose  membranes using 
an e le c tr ic  current. The bound protein can be detected using 
various probes, the most common being double antibody techniques. 
Immediately a fte r electrophoresis, gels were soaked in  degassed
transfer buffer fo r 30 minutes. This contained 20mM Tris  bu ffe r, 
150mM glycine (both Sigma) made up in  20% methanol v /v .
N itrocellu lose and f i l t e r  paper (both BioRad) used to  make up the 
gel sandwich were equilibrated overnight in  the same bu ffe r. 
B lo tting  was carried out fo r up to  4 hours at 150V in  a BioRad 
Trans-Blot according to  the manufacturers ins truc tions . At the end 
of the run, the n itroce llu lose  was soaked fo r 10 minutes in  T ris 
buffered saline (TBS; 500mM NaCl, 20mM Tris-HCl, pH 7 .4 ), then
blocked fo r 1 hour at room temperature with TBS buffer containing 
3% EIA grade ge la tin  (BioRad).
To check fo r successful transfer o f the proteins, the gel was
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stained with Coomassie Blue and transfe r was always a t least 95%. 
For specific  b lo ttin g  d e ta ils , re fe r to  Chapter 5.
2.12 FILTER WELL CULTURES
. 2.12.1 General culture methods
F ilte r  wells (Costar Transwells; 24.5mm) were used fo r  most
coculture experiments. This permitted cu lture  o f a second ce ll type
independently in  the lower chamber, thus allowing c e ll-c e ll
in teractions to  take place without the need fo r c e ll-c e ll contact. 
A diagram of a f i l t e r  well can be seen in  Figure 2. The f i l t e r  
wells used were f i t te d  with a 10um th ick  polycarbonate membrane 
(Nucleopore) with a pore size o f (Mum. Routinely, ce lls  were
seeded at a concentration o f 5 x 104ce lls /m l. The to ta l volume of 
cu lture  medium used was 3.5ml; 2.5ml in  the dish which housed the 
f i l t e r  w e ll, and 1ml ( in  which the c e lls  were suspended) above the 
f i l t e r  membrane.
2.12.2 Preparation of f i l t e r  wells fo r electron microscopy
Electron micrographs were prepared by Mr Graham Ainge and Mr Gohn 
Bowles, Glaxo Group Research, Ware, Herts, using the fo llow ing 
protoco l. A549 ce lls  growing on f i l t e r  wells were fixed fo r a 
minimum of 90 minutes in  4% formaldehyde/2% glutaraldehyde,
FIGURE 2
Diagram of a f i l t e r  well
medium
filter
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followed by a p ostfix  in  1% osmium te troxide  fo r 1 hour. The ce lls  
were dehydrated in  graded alcohols, then washed in  acetone/epoxy 
resin before being embedded in  the res in . U ltra th in  sections were 
cut using a Diatome diamond kn ife , collected on copper grids, and 
then stained with uranyl acetate (15 minutes a t 60°C) and lead 
c itra te  (5 minutes at 20°C) in  an LKB u ltras ta in e r. The stained 
grids were placed in  a Philips CM10 electron microscope and 
photographed on I lfo rd  83x102mm E.M. f ilm .
2.13 CLONING EXPERIMENTS
2.13.1 Monolayer cloning
Cells were d ilu ted  with fresh cu lture  medium to  a concentration o f 
100 cells/m l and 5ml aliquots seeded in to  6cm p e tri dishes 
(Nunclon). These were incubated fo r 10 days at 37°C in  a humid 
incubator with 2% gas phase to  allow the formation o f colonies. 
A fte r incubation, colonies were pre-fixed with a 1:1 mixture o f 5ml 
o f PBS/methanol fo r 10 minutes. This was removed and replaced with 
5ml o f methanol fo r a fu rthe r 10 minutes. The dishes were a ir  dried 
overnight, stained with 0.1% crysta l v io le t (BDH) fo r 10 minutes, 
then rinsed extensively with running tap water u n til the water ran 
c lea r. The fin a l rinse was in  d is t i l le d  water. Colonies greater 
than 0.5mm were counted using an Artex colony counter.
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2.13.2 Suspension cloning
A suspension o f 1000 cells/m l in  cu lture  medium supplemented with 
10% FCS containing 0.3% agar (Gibco) was poured onto a preformed 
layer o f 1% agar in cu lture  medium in  35mm pe tri dishes (Nunclon). 
Thereafter, the ce lls  were cultured fo r 14 days a t 37°C in  a humid 
2% C02 incubator. Colonies were stained with 5mg/ml 3 -[4 ,5 - 
dimethylth ia z o l-2 -y l]-2 ,5-diphenyl tetrazolium  bromide (MTT;Sigma), 
fo r four hours at 37®C in  the dark. MTT is  taken up by liv e  but not 
dead ce lls  (see MTT assay la te r ) .  Colonies containing more than 20 
ce lls  were counted by eye using a binocular dissecting microscope.
2.14 IN VIVO STUDIES
2.14.1 Experimental animals
For most experiments, 6-8 week old male MF1/NuNu/0la/Hsd 
immunodeficient nude mice were used. For experiments using the 
ovarian tumour ce ll l in e , A2780, female BALB/c nude mice were used. 
The athymic nature of these mice is  the re su lt o f a genetic 
mutation and subsequent inbreeding to  produce the homozygous nude 
mouse. Nude mouse production is  achieved by mating heterozygous Nu+ 
females with homozygous NuNu males. A hareem system is  used with 
one male fo r every two females. Nude mice are weaned at 21 days.
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A ll experimental animals were maintained on s te r ile  ra t and mouse 
number 3 d ie t (Special Diet Services) and s te r i le  tap water ad 
1ib itum . They were housed in  transparent MT1 polycarbonate boxes 
w ith in  a laminar flow hood (Bassair) at a temperature o f 27°C and a 
humidity o f 40-60%. A lig h t  cycle o f 12 hours l ig h t ,  12 hour dark 
was used.
2.14.2 Xenograft preparations
Mice received a subcutaneous (s .c .)  in jec tion  o f a t least 106 
cells/m l in  PBS. The animals were le f t  fo r three weeks, a fte r which 
time the ce lls  had formed a tumour. The tumours were removed 
aseptica lly and cut in to  5mm pieces. These pieces were transplanted 
in to  the appropriate hosts under anaesthetic (Hypnorm), and le f t  
fo r a fu rthe r two weeks to  allow them to  become established. At 
th is  point the experiment was started.
2.14.3 Xenograft histology
At the end o f each experiment, xenografts were excised aseptica lly  
and processed fo r l ig h t  microscopy. Each tumour piece was fixed in 
10% formol saline fo r at least 24 hours, then dehydrated through 
graded alcohols. The pieces were then embedded in  wax (Paraplast), 
and 5um sections were cut on a Le itz ro tary microtome, then 
transferred to  a clean glass s lide  (Chance Propper). The sections
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were then rehydrated through graded alcohols and stained with 
haematoxylin and eosin.
2.15 PHOTOGRAPHY
Phase contrast photographs o f l iv e  ce lls  were taken using an 
Olympus OM camera f i t te d  to  an Olympus CK-2 inverted microscope. 
Photographs o f tissue sections were taken using a Reichart-Oung 
Polyvar microscope equipped with an automatic camera using Kodak 
Ektachrome 160 ISO Tungsten or Kodacolour Gold 35mm f ilm  (except 
where stated otherwise). Exposure was set automatically.
2.16 STATISTICAL ANALYSIS OF DATA
All s ta t is t ic a l analysis was performed using the Student's t - te s t  
(unpaired te s t, two ta ile d  analysis) using the follow ing formula:
s c 2 =  [ C x 1 -  ( x 1 ) 2 / n 1 + i x ?2  -  (  x ? ) 2 / n ? 1
N-l + N2 “ 2
Sc (1/Nj + 1/N2) (where t  has (N^  + N2 -  2) degrees of
freedom.
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CHAPTER THREE
GENERAL PROPERTIES OF A549 ALVEOLAR CARCINOMA
AND LF113 FIBROBLASTS IN CULTURE
This chapter w il l  deal with some o f the more general aspects o f the 
ce ll lines used in  the study with p a rticu la r emphasis on th e ir  
response to  stero id and the induction of pulmonary surfactant 
secretion.
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INTRODUCTION
As already discussed in the General Introduction, alveolar type I I  
e p ith e lia l ce lls  undergo rapid p ro life ra tio n  during the saccular 
phase of lung development. In preparation fo r extrauterine l i f e ,  
the foetal lung must produce s u ff ic ie n t quantities o f pulmonary 
surfactant fo r correct post-natal functions.
Pulmonary surfactant is  a phospholipid rich  material which reduces 
surface tension and maintains alveolar s ta b il i ty ,  thereby reducing 
the chances o f alveolar collapse during the expiratory phase 
(Goerke, 1974). I t  is  generally accepted tha t surfactant p u rified  
from bronchoalveolar lavage is  composed o f approximately 90% l ip id ,  
5-10% protein with trace amounts o f carbohydrates (Post and van 
Golde, 1988). Almost 75% o f surfactant is  composed of 
phosphatidylcholine, and disaturated phosphatidylcholine accounts 
fo r approximately 60% of the to ta l surface l ip id  (Goerke, 1974; 
King, 1979). Floros et al_ (1986) have recently isolated cDNA clones 
fo r the 35kDa major protein component o f pulmonary surfactant, and 
southern b lo t analysis has revealed tha t th is  is  encoded on 
chromosome 10 (Bruns et al_, 1987). The composition o f surfactant is  
shown in Table 3.
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TABLE 3 COMPOSITION OF PULMONARY SURFACTANT
DIPALMITOYLPHOSPHATIDYL CHOLINE 60%
MONOENOIC PHOSPHATIDYL CHOLINES 11-20%
PHOSPHATIDYL ETHANOLAMINE 5-10%
PHOSPHATIDYL GLYCEROL < 10%
NEUTRAL LIPIDS 5-13%
Surfactant is  synthesised and secreted by alveolar type I I  ce lls  o f 
the lung, one o f the two e p ith e lia l ce ll types which lin e  the 
alveolar w a ll. The other ce ll type is  the alveolar type I c e l l .  
Type I ce lls  (also known as membraneous pneumocytes), are th in  
squamous ce lls  which cover most o f the alveolar wall and represent 
the s ite  where gaseous exchange takes place. Type I I  ce lls  are 
cuboidal c e lls , located in  the corners o f the a lveo li (hence they 
are sometimes referred to  as ‘ corner1 c e lls ) .  They contain the 
characte ris tic  multi lamellar bodies, concentric osmiophilic rings 
w ith in  which pulmonary surfactant is  stored (Mason e t al ,^ 1977). 
Surfactant is  believed to  be synthesised in  the endoplasmic 
reticulum, then modified by the Golgi cisternae, before being 
transported to  the lamellar bodies fo r storage and secretion (Mason 
e t al_, 1977). Much o f the evidence concerning surfactant has come 
from studies using fe ta l tissue, since one o f the leading causes of
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m orta lity  in  premature human neonates is  respira tory distress 
syndrome, which is  caused by an immaturity in  the mechanisms 
con tro lling  the synthesis and secretion o f surfactant by the type 
I I  ce lls  o f the lung (Snyder e t al ,^ 1981). However i t  now appears 
tha t the onset o f surfactant production and consequent lung 
maturation can be promoted by the administration o f exogeneous 
glucocorticoids. Torday (1980), showed tha t foetal ra b b it lungs 
were dependent on the presence o f co rtiso l fo r d iffe re n tia tio n  and 
pulmonary surfactant secretion. S im ila r ily , dexamethasone has been 
shown to elevate levels o f surfactant in  human foetal lung in  organ 
cu lture  (Odom et a^, 1988), by increasing the numbers o f beta- 
adrenergic receptors, the action o f which stimulated pulmonary 
surfactant secretion (Maniscalco and Shapiro, 1983). In addition, 
Li ley e t al ,^ (1987) showed tha t dexamethasone could induce 
synthesis o f the major surfactant-associated protein, SP 28-36.
Primary cultures o f type I I  e p ith e lia l ce lls  have been reported to  
secrete phospholipids in  response to  exogeneous stim u li other than 
glucocorticoids, including beta-adrenergic agonists (Brown and 
Longmore, 1981), phorbol esters and cytochalasins (Rice e t al ,^ 
1984a,b). Supplementing culture medium with l in o le ic  acid increased 
the phospholipid composition o f A549 (Smith, 1982). However, 
glucocortocoid or glucocorticoid analogues such as dexamethasone 
appear to  be the most widely used substances fo r the acceleration 
o f lung maturation and concomitant secretion o f pulmonary 
surfactant.
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A549, the main ce ll type examined in  th is  study, was in it ia te d  in 
1972 by Giard et al_ from an explant cu lture o f pulmonary 
adenocarcinomatous tissue from a 58 year old Caucasian male. This 
ce ll lin e  displays the morphological features associated with 
pulmonary alveolar type I I  ce lls  i .e  multi lamellar bodies, and 
active ly  synthesises phosphatidylcholine, a large proportion o f 
which is  disaturated (Lieber e t <al_, 1976). A549 is  therefore 
assumed to  be o f type I I  o r ig in .
Production o f pulmonary surfactant in  cultured A549 ce lls  has been 
reported by a number o f groups (Lieber e t <rt, 1976; Smith, 1977; 
Shapiro et al_, 1978; Mason and Williams, 1980). This is  a major 
characte ris tic  o f lung maturity and the principal d iffe ren tia ted  
function o f type I I  pneumocytes.
Dexamethasone (9-alpha-fluoro-16-alpha-methylprednisolone) is  a 
synthetic g lucocorticoid analogue. (For structure see Figure 3). 
Glucocorticoids stimulate gluconeogenesis, the synthesis o f glucose 
from non-carbohydrate precursors. Synthesis o f glucocorticoids 
occurs in the adrenal cortex under the control of 
adrenocorticotrophic hormone (ACTH) which stimulates the conversion 
o f cholesterol to  pregnenolone, the ra te  lim it in g  step in  stero id 
hormone synthesis.
Glucocorticoids have been shown to  have a number o f e ffects both on 
tissues and cultured c e lls . This is  re flected by the fa c t tha t 
receptors fo r g lucocorticoid hormones have been found in  a varie ty
FIGURE 3 STRUCTURE OF DEXAMETHASONE
C1I20H
C«0
OH
0
DEXAMETHASONE.
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of tissues and c e lls , including normal and pathological white 
c e lls , l iv e r ,  placenta, kidney, prostate, lung and colon of most 
vertebrates (Munck and Leung, 1977). However the phenotypic 
response varies from one tissue to  another, and th is  w il l  be 
discussed below. In some tissues, glucocorticoids induce de novo 
synthesis o f a number o f enzymes, whereas in  others, a catabolic 
e ffe c t has been observed. These hormones have been shown to  exert 
an a n ti-p ro !ite ra tiv e  e ffe c t in  many tumour systems (Crabtree e t al 
1978; Cones et a l^  1978; Freshney e t al_, 1980; McLean e t al_, 1986). 
Although the duration and magnitude o f th is  a n ti-p ro !ife ra tiv e  
response has been found to  be both dexamethasone dose- and 
glucocorticoid receptor-dependent (Braunschweiger e t al., 1983), the 
actual levels o f g lucocorticoid receptors in  ce lls  o f a p a rticu la r 
type of cancer do not corre late well with th e ir  overall c lin ic a l 
chemosensitivity.
As well as having important a n ti-p ro !ite ra tiv e  e ffec ts , 
glucocorticoids have also been used as d iffe re n tia tin g  agents in  
many d iffe re n t ce ll cu lture  systems. Dexamethasone has been shown 
to  stimulate d iffe re n tia tio n  in  a mouse myeloid leukemia ce ll lin e  
(Sachs, 1978), as well as in  a breast cancer ce ll l in e , ZR-75 
(Osborne e t al_, 1979) and Steffen e t al_ (1988) showed th a t a cloned 
ra t mammary tumour ce ll lin e  could become more d iffe ren tia ted  with 
less aggressive ijn vivo behaviour and p a r t ia lly  reduced growth 
a fte r treatment with dexamethasone.
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Glucocorticoids have been reported to  modify the ce ll surface o f 
human glioma c e lls . Mackie et al_ (1988), showed tha t stero id 
treated cultures of human glioma ce ll lines expressed elevated 
levels o f heparan sulphate w h ils t hyaluronic acid levels decreased 
in  response to  s te ro id .
The glucocorticoid induction o f the enzyme tyrosine 
aminotransferase (TAT), the f i r s t  enzyme in  the metabolism of 
tyrosine in the homogentisic acid pathway, has been known fo r  many 
years, since Granner et al  ^ (1958) demonstrated tha t dexamethasone 
could stimulate TAT synthesis in  cultured hepatocytes. This 
observation has since been ve rifie d  and extended by Dow e t al_ 
(1983), who showed TAT induction by co rtiso l in  chick embryo mixed 
cu ltures, and Chou et a^ (1988), have shown tha t in  hepatocytes, 
administration o f glucocorticoid could induce a series o f events 
associated with normal hepatocyte maturation, notably induction o f 
albumin, tra n s fe rrin  and TAT, and in h ib itio n  of foetal 
alphafetoprotein secretion.
In human glioma ce ll lin e s , McLean e t al  ^ (1986) have shown tha t 
glucocorticoids could almost completely abolish the a c t iv ity  o f the 
p ro teo ly tic  enzyme, plasminogen activa to r (PA). The same group also 
showed tha t the same was true in  human NSCLC ce ll lin e s , where the 
e ffe c t was found to be time dependent, with the m ajority o f the 
reduction induced by dexamethasone in  the f i r s t  25 hours o f 
cu ltu re . Whether th is  was due to  decreased synthesis o f PA or 
increased synthesis of an in h ib ito r  was not established.
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Glucocorticoids have also been shown to  regulate EGF receptors in 
HeLa-S3 ce lls  (Fanger e t 1983). This e ffe c t was both reversib le  
and ce ll cycle dependent, with a lack o f stero id response in  the
G2/M and early G^ phases. They have also been shown to  stimulate
glutamyl synthetase, a d iffe re n tia tio n  marker in  the embryonic 
re tina  (Moscona and Piddington, 1966), and in  certa in lymphoid ce ll
lin e s , these hormones have a cytocidal e ffe c t (B lew itt e t a l ,
1983).
Perhaps one o f the best documented glucocorticoid actions is  th e ir  
a b il i ty  to  reduce swelling and inflammation. Consequently, th is  
property has been well u t ilis e d  in  the c lin ic a l environment, 
p a rt ic u la r ily  in  the management o f brain tumours.
3.1 CONFIRMATION OF THE IDENTITY OF LF113 AND A549
3.1.1 Chromosome analysis
Both ce ll lines were grown to  mid-log phase in  75cm2 flasks 
(Falcon) and colcemid (Sigma), a t a f in a l concentration o f 0.1 uM 
added d ire c tly  to  the medium to  arrest the ce lls  in  metaphase, 
according to  the Materials and Methods. An average o f 20 typ ica l 
chromosome spreads were counted fo r each ce ll lin e  and th is  
confirmed tha t LF113 had the normal human d ip lo id  chromosome number 
o f 46. A549, as expected, was aneuploid and heteroploid, w ith a
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modal chromosome number of 59, Histograms o f the chromosome spreads 
are shown in  Figure 4.
3.1 .2  Lactate dehydrogenase isoenzymes
Lactate dehydrogenase (LDH) occurs as 5 d is t in c t isoenzymes in  the 
tissues o f a ll vertebrates. Each species has a chac te ris tic  LDH 
pattern when separated by electrophoresis on cellu lose acetate or 
agarose gels. LDH catalyses the same overall reaction:
LDH
LACTATE + NAD+  > PYRUVATE + NADH+ + H+
Confluent cultures o f A549 and LF113 plus one known non human ce ll 
l in e , STO (mouse embryo fib rob las ts ) were scraped from th e ir  flasks 
and resuspended in  a small volume of PBS (<2ml) in  p la s tic  tubes. 
The samples were then frozen and thawed twice to  release c e llu la r  
contents. Cells were frozen rap id ly  in  a mixture o f dry 
ice/methanol and thawed in  a water bath at 37°C. An LDH k i t  (Sigma) 
was used fo r separation and id e n tif ic a tio n  o f LDH isoenzymes, 
B r ie fly , 2x1ul samples were applied to  the wells o f a precast 
agarose gel (Ciba-Corning) and run at 12V/cm fo r 30 minutes in  LDH 
electrophoresis buffer (50mM T ris , 12mM c itra te  and 25mM b a rb ita l) . 
A sample o f human LDH, provided in  the k i t ,  was used as a standard. 
The areas of enzyme a c t iv ity  were then visualised by histochemical 
procedures according to  the reactions shown in  Figure 5.
FIGURE 4
A549 and LF113 chromosome spreads.
a LF113 spread
b A549 spread
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FIGURE 5
Abbrevi a ti ons:
NAD nicotinamide adenine dinucleotide
NADH " " " (reduced form)
PMS phenazine methosulphate 
TNBT te tran i troblue te trazo l i urn
LACTATE + NAD
LDH
PYRUVATE + NADH
NADH + PMS NAD + PMS-H
PMS-H + TNBT PMS + TNBT-FORMAZAN
The TNBT-formazan which is  highly coloured and insoluble, loca lises 
in  the electrophoretic zones o f LDH a c t iv ity .
Photographs o f LDH p ro file s  are shown in  Plate 1 and both A549 and 
LF113 possess a characte ris tic  human p ro f ile .  STO (mouse) has quite 
a d iffe re n t p ro f ile .  This, and the chromosome data, confirm the 
id e n tity  o f the ce ll lin e s .
PLATE 1: LDH GEL OF A549, LF113 AND STO.
Samples were electrophoresed and stained as described in  the 
Materials and Methods.
C = Human LDH standard
Numbers 1-5 re fe r to  the fiv e  LDH bands present in  the sample.
The differences in  in ten s ity  in  the three LF113 samples are due to 
d iffe re n t volumes o f sample loaded.
+
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3.2 EFFECT OF DEXAMETHASONE ON THE GROWTH OF A549 AND LF113.
Growth curves were performed using each ce ll lin e  and terminal ce ll 
densities determined from the data.
Dexamethasone was found to be cy tos ta tic  to  A549 resu lting  in  a 30% 
reduction in  the terminal ce ll density (Figure 6). With LF113, 
however, the re su lt was d iffe re n t (Figure 7). At a concentration of 
0.25uM, dexamethasone appeared to  have a mitogenic e ffe c t on the 
treated cultures o f fib rob las ts . This increased the terminal ce ll 
density by some 12%. These resu lts  are summarised in  Table 4.
TABLE 4 EFFECT OF DEXAMETHASONE (0.25uM) ON TERMINAL CELL DENSITY 
IN A549 AND LF113
CELL LINE
TERMINAL CELL 
DENSITY 
(CELLS/cm2 x 104)
+FCS -FCS
+DX -DX +DX -DX
A549 8.9+0.15, 12+0.2 2.85+0.41 4.7+0.43
LF113 6.1+0.5 5.4+0.4 1.45+0.39 1.7+0.41
FIGURE 6
Semi-logarithmic plot of the e ffec t o f dexamethasone on the 
growth of A549 ce lls  in the presence and absence of serum.
A549 ce lls  growing in  24 well plates were exposed to 
s te ro id , £  FCS as described in  the Materials and Methods, 
and t r ip l ic a te  wells were counted once every two days.
Each data point represents the mean o f three observations ±  
SE of one representative experiment out o f a series o f 
three.
a Cells incubated in  the presence o f serum j± 0.25uM DX
b Cells incubated in  the absence o f serum j±'0.25uM DX
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FIGURE 7
Semi-logarithmic p lot showing the effects of dexamethasone 
on M0G-LF113 in the presence or absence of serum.
Cells growing in  24 well plates were exposed to 
dexamethasone, hh FCS as described in  the Materials and 
Methods, and t r ip l ic a te  wells counted once every 2 days.
Each data point represents the mean o f three observations +_ 
SE
a Cells incubated in  the presence o f serum j +. 0.25uM DX
b Cells incubated in  the absence o f serum j + 0.25uM DX
10»
•o
10
DAYS IN CULTURE
• CONTROL 
o + DX
10s
10
DAYS IN CULTURE
64
3.3 DOSE RESPONSE TO DEXAMETHASONE
3.3.1 Optimum concentration required for maximum cytostasis
Mid log phase cultures o f A549 growing in  25cm2 flasks (Falcon) 
were incubated with dexamethasone (Decadron; Merck, Sharp and 
Dohme) at various concentrations ranging from 0-25uM in  serum free 
cu lture  medium. A fter 6 days in  the presence of s te ro id , the ce lls  
were trypsinised and counted. The resu lts  are shown in  Figure 8.
Dexamethasone at a concentration o f 0.25uM was cy tos ta tic  fo r A549 
without being cytotoxic to  the c e lls .
3.3 .2  Optimum concentration to achieve maximum pulmonary 
surfactant synthesis
A549 was incubated in  6-well plates (Nunclon) with various 
concentrations o f dexamethasone (0-25uM) fo r 48 hours and assayed 
fo r pulmonary surfactant synthesis as described in  the Materials 
and Methods.
As shown in  Figure 9, dexamethasone caused a r ise  in  the production 
o f pulmonary surfactant, resu lting  in  an approximately two-fo ld
FIGURE 8
Dexamethasone dose response curve for maximum cytostasis.
Log phase cultures o f A549 growing in  25cm2. flasks were 
incubated in  the presence o f d iffe re n t concentrations of 
dexamethasone fo r four days. At the end o f the incubation 
period the ce lls  were trypsinised and counted 
e le c tro n ica lly .
Each data point represents the mean o f four individual 
experiments £  SE.
C e ll d e n s ity  a t s t a r t  o f experim ent = 5 x 104/cm2 ;
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FIGURE 9
Dose response of induction o f pulmonary surfactant 
production in A549 cultured on plastic by dexamethasone.
A549 ce lls  growing in  25cm2 flasks were treated with various 
concentrations o f dexamethasone fo r 48 hours and the a b il i ty  
o f the drug to stimulate pulmonary surfactant was measured 
as described in  the te x t.
Each data point represents the mean o f three observations ^  
SE of one representative experiment out o f a series o f 
three.
C e lls  were in  la te  log  phase a t the  s t a r t  o f the  
e xp e rim e n t.
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increase with a concentration o f 0.25uM. Since th is  concentration 
was also found to have a cy tos ta tic  e ffe c t on the ce lls  (section 
3 .3 .1 ), i t  was used fo r a ll subsequent experiments.
3.4 PULMONARY SURFACTANT SPECIFICITY
As mentioned in  the introduction to  th is  Chapter, pulmonary 
surfactant is  composed largely o f disaturated phosphatidylcholine. 
However, th is  phospholipid is  also an integral part o f the ce ll 
membrane so i t  must be determined whether there is  any difference 
between surfactant production between A549 and other ce ll lin e s . In 
addition, ce ll associated surfactant was measured, but in  A549 
only, to  determine s p e c if ic ity  fo r surfactant synthesis and 
release.
3.4.1 Specific ity of pulmonary surfactant synthesis and release
To determine s p e c if ic ity , cell-associated and secreted surfactant 
was measured in  cultures o f A549, as descibed in  the Materials and 
Methods.
A549 control cultures produced a low level o f surfactant in  
cu ltu re , but th is  was stimulated some 50% by the addition o f 
dexamethasone. Induction o f surfactant production can be seen in  
Figure 10 with the greatest e ffe c t seen in  the secreted component.
FIGURE 10
Effect of dexamethasone on ce llu la r and secreted pulmonary 
surfactant production In A549.
Late log phase cultures o f A549 ce lls  growing in  25cm2 
flasks were incubated with 0.25uM dexamethasone fo r 48 
hours, as described in the Materials and Methods and then 
assayed fo r cell-associated and secreted pulmonary 
surfactant.
Each data point represents the mean o f three observations ±  
SE o f one representative experiment out o f a series o f 
three.
C e ll d e n s ity  a t s t a r t  o f experim ent = 5 x 104/cm2
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3.4 .2  Specificity for steroid response
A549 plus 4 other lung carcinoma ce ll lin e s , WIL, H125 (both 
adenocarcinomas), L-DAN (a mixed large cell/squamous carcinoma) and 
SK-MES (a squamous ce ll carcinoma) were seeded in to  6-well plates 
(Nunclon) at a ce ll density o f 2.5x10^ cells/cm^ and grown to  pre­
confluence. The medium was aspirated and the ce lls  washed twice 
with serum free cu lture  medium, then incubated with or without 
0.25uM dexamethasone fo r 48 hours. Cells were assayed fo r secreted 
pulmonary surfactant according to  the protocol described in  the 
Materials and Methods chapter. As is  shown in  Figure 11, WIL, SK- 
MES and H125 showed only very low levels o f surfactant secretion, 
both in control and in stero id treated cu ltures. L-DAN however 
showed a greater secretion, and appeared to  be stimulated by 
dexamethasone, although th is  measurement was not s ig n if ic a n t, the 
highest levels o f pulmonary surfactant were found in  A549.
DISCUSSION
This Chapter set out to  define the characteris tics o f the main ce ll 
lines used in  th is  study, and to  determine th e ir  response to 
stero id .
Dexamethasone was found to have d iffe r in g  e ffects on ce ll 
p ro life ra tio n  and i t s  actions seemed to  be dependent both on ce ll 
density and ce ll type. With the transformed lin e , A549, the
FIGURE 11
Effect of dexamethasone on pulmonary surfactant production 
in A549, L-DAN, SKMES and WIL.
All f iv e  ce ll lines were grown to  la te  log phase in 25cm2 
flasks , then treated with 0.25uM dexamethasone in  serum free 
medium fo r 48 hours. Pulmonary surfactant production was 
determined as described in  the te x t.
Each data point represents the mean o f three observations 
SE of one representative experiment out o f a series o f 
three.
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cy tos ta tic  e ffe c t o f dexamethasone was observed. These resu lts  are 
in  agreement with the observations o f McLean (1986), who showed 
tha t dexamethasone caused a s ig n ifica n t reduction in  the growth 
rates af a number o f NSCLC ce ll lines in  a dose dependent manner, 
with an accompanying increase in  the p la ting  e ffic ie n cy . In 1978, 
Oones e t al_ reported s im ila r cy tos ta tic  e ffects on A549, although 
with a d iffe re n t steroid concentration (0.04uM as opposed to 
0.25um used in  th is  study). In breast, dexamethasone has also been 
shown to have s im ila r e ffects with a decrease in  growth rates and 
saturation densities in  several ce ll lines (Osborne et al^, 1979; 
Dabre and King, 1987). In glioma, w h ils t glucocorticoids were 
cy tosta tic  at high ce ll densities, they were actua lly mitogenic at 
clonal ce ll densities. In the absence o f serum, nanomolar 
concentrations were mitogenic (McLean e t al^, 1986) in  regular 
monolayer cu ltu re .
The e ffe c t o f dexamethasone on LF113 however, was d iffe re n t. The 
presence of s tero id  was seen to  cause a cy tosta tic  e ffe c t a t low 
ce ll densities, but as the ce lls  approached confluence, the e ffe c t 
was mitogenic. This observation is  perhaps not quite as unusual as 
i t  may f i r s t  appear, since observations by Grove e t al, (1977) have 
shown tha t DNA synthesis and ce ll growth in  the foeta l lung 
fib ro b la s t ce ll lines WI-38 and WI-26, were both stimulated by by 
hydrocortisone.
The p ro life ra tiv e  response o f WI-38 ce lls  to  g lucocortico id has 
recently been found to  be a ttribu ted  to  stim ulatory fac to r(s )
68
present in  the cu lture  medium, suggesting an autocrine response 
(Finlay et al., 1985; Finlay and C ris to fa lo , 1987). The stimulatory 
e ffe c t o f WI-38 conditioned medium was mediated by secondary 
factors present in  the medium conditioned by ce lls  in  the presence 
o f hormone. Preliminary attempts to  characterise the the a c t iv ity  
revealed a low molecular weight, heat stable, dialysable factor 
(Finlay e t al_, 1985). More recently, Finlay and C ris to fa lo  (1987), 
have shown tha t the generation o f stim ulating factors seemed 
dependent on the cu lture conditions, since confluent or low density 
quiescent cultures fa ile d  to  produce media stim ulatory to ce ll 
growth. The facto r was protease res is tan t with a molecular weight 
o f less than 10kDa. The autocrine stim ulation o f the g lucocorticoid 
conditioned medium was a ttribu ted , at least in  part, to  a low 
molecular weight fac to r(s) present in  the medium. Moreover, 
production of the facto r was dependent on the presence o f fresh 
serum containing medium, making i t  d i f f ic u l t  to  determine whether 
the a c tiv ity  was actua lly synthesised by the ce lls  and subsequently 
secreted in to  the medium, or i f  i t  was a serum component which was 
altered to  a more mitogenic form by a ce ll derived product such as 
a growth factor (Finlay and C ris to fa lo , 1987).
Dexamethasone alone was found to  increase both ce ll associated and 
secreted pulmonary surfactant in  A549 in  agreement with 
observations previously reported (Smith, 1977; Shapiro et al_, 1978; 
McLean, 1986). Since in i t ia l  observations by Liggins (1969), tha t 
accelerated foetal lung maturation followed the in je c tio n  o f 
co rtiso l in to  foetal lambs, many authors have suggested th a t there
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is  a ro le  fo r glucocorticoids in  the regulation o f type I I  
pneumocyte d iffe re n tia tio n  and subsequent surfactant synthesis and 
secretion (de Lamos et a^, 1970; Kotas and Avery, 1971; Torday, 
1980). However, these studies have dealt with normal lung, which 
contained mixed ce ll types, so i t  is  d i f f ic u l t  to  say whether or 
not the stero id was having a d ire c t e ffe c t on the type I I  ce lls  or 
acting in d ire c tly  through the mesenchyme (th is  point w il l  be 
discussed in  much greater deta il in  a la te r  chapter). I t  appears 
tha t dexamethasone can act d ire c tly  on A549 c e lls , inducing a more 
d iffe ren tia ted  phenotype.
The fa c t tha t L-DAN was capable o f synthesising and secreting 
pulmonary surfactant a fte r dexamethasone treatment was surpris ing. 
Although L-DAN is  thought to be a mixed large cell/squamous 
carcinoma, i t  is  possible tha t i t  may have some secretory 
properties, or perhaps a small population o f multi potent stem ce lls  
are present. However, disaturated phosphatidylcholine is  present in  
the ce ll membrane and the presence o f dexamethasone may ju s t be 
a lte ring  the membrane phospholipids somewhat, with a resu ltan t 
increase in  phosphatidylcholine. Compared with the other lung lines 
studied, there does seem to  be a degree o f s p e c if ic ity  in  th is  
induction, with greatest s p e c if ic ity  confined to  the secretory 
component in  A549.
I t  was d i f f ic u l t  to  quantify the e ffects  o f the steroid on c e l l-  
associated surfactant, because o f the fa c t tha t pulmonary 
surfactant is  composed mainly o f disaturated phosphatidylcholine,
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which is  also an in tegra l component o f the ce ll membrane. Since the 
assay measured to ta l c e llu la r  surfactant, i t  was impossible to  say 
whether the labelled choline was due e ithe r to  membrane cholines or 
to  surfactant-associated choline, A possible way round th is  would 
have been to iso la te  the multi lam ellar bodies, the in tra c e llu la r  
storage s ites fo r surfactant, from the c e lls , thus giving a more 
accurate estimation o f cell-associated surfactant. This technique 
has been reported by a number o f groups including Snyder et al ,^ 
(1981), Crecelius and Longmore, (1983) and Schalme et a^, (1988), 
and the major advantage is  tha t i t  iso lates membrane 
phosphatidylcholine from surfactant-associated phoshatidylcholine.
To summarise, glucocorticoids have a d ire c t e ffe c t on A549 c e lls , 
causing a cy tos ta tic  e ffe c t as well as stim ulating pulmonary 
surfactant secretion. This suggests tha t these ce lls  possess the 
appropriate glucocorticoid receptors, and in  fa c t, receptor binding 
studies have shown th is  to be the case both in  normal lung 
(Ballard, 1977) and in  A549 ( McLean, 1986). The induction o f 
pulmonary surfactant appears to  be spec ific  fo r A549, since other 
NSCLC ce ll lines studied fa ile d  to  produce any appreciable leve ls . 
The e ffe c t o f glucocorticoids on fib rob las ts  w h ils t cy tos ta tic  at 
low ce ll densities, was mitogenic a t high ce ll densities.
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CHAPTER FOUR
INTERACTION BETWEEN A549 AND FIBROBLASTS
A549 was shown to produce surfactant when stimulated with stero id . 
This is  not a new find ing  and has been reported elsewhere. However, 
the main aim behind th is  work was to  determine i f  fib rob las ts  were 
implicated in  the response o f A549 to  stero id as demonstrated by 
Post e t af[ (1984) in  normal lung. The follow ing chapter w ill 
describe the e ffe c t o f such in teractions as well as optim isation of 
cu lture  conditions.
A ll experiments described in  th is  Chapter were performed my myself 
with the exception o f the EM preparation, which was done by Mr. 
Graham Ainge and Mr. CJohn Bowles, Glaxo Group Research, Ware, 
Herts.
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INTRODUCTION
An important aspect to be considered when dealing with cultured 
c e lls  is  whether or not the establishment o f p o la rity  is  necessary 
fo r expression o f the correct d iffe re n tia te d  functions. Po la rity  
is  a requ is ite  function in  both tissues and.cultured normal c e lls , 
although the extent to  which p o la rity  is  required in  transformed 
ce lls  in  cu lture is  as yet unclear.
In the case o f normal lung, ce lls  seeded onto tissue cu ltu re  grade 
p la s tic  substrates lose th e ir  c ilia te d  and secretory ce ll 
morphology and adopt a squamous ce ll appearance w ith in  72 hours o f 
seeding (Wu e t cf[, 1985). There are 2 possible explanations fo r 
th is .  F irs t ly ,  when a ce ll is  growing on a p la s tic  substrate, there 
is  l i t t l e  chance of the ce ll being able to  become polarised 
co rrec tly , as, depending on how the ce ll adheres to  the p la s tic , 
i t  may find  i t s e l f  inco rrectly  orientated or have the wrong shape 
fo r the correct expression o f d iffe re n tia te d  functions. P o la rity  
has been shown to  be necessary fo r the secretion o f thyroxine by 
thyro id  epithelium in  culture (Chambard e t al ,^ 1983) and i t  has 
also been shown tha t ra t  pheochromocytoma; ce lls  when cultured on 
ce llu lo s ic  f i l t e r s  exh ib it a p o la rity  not seen by the same ce lls  
cultured on a conventional p las tic  substrate (Van Buskirk e t a^, 
1988).
Secondly, and most importantly in  the case o f ce lls  o f lung o r ig in , 
i t  may be necessary to  have the ce lls  growing at or near to  the
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a ir - l iq u id  in terface fo r the correct expression o f d iffe ren tia ted  
features (Van Scott et al_, 1986). Under normal circumstances,
respira tory e p ith e lia l ce lls  are situated a t the a ir - l iq u id
in terface, so to  cu lture  a ce ll o f respira tory o rig in  submerged in 
cu lture  medium does not re la te  to  the tjq vivo environment.
Whitcutt and his colleagues (1988) developed th e ir  own cu lture  
chamber, the Whitcutt chamber, which permitted the maintenance of 
p o la rity  and d iffe re n tia tio n  in  cultured respira tory tra c t 
epithelium. The chamber consisted o f a moveable transparent 
permeable ge la tin  membrane which could be used e ither submerged in  
the culture medium, thereby feeding the ce lls  in  the tra d itio n a l 
immersion method, or raised to  the surface of the cu ltu re  medium, 
which enabled the apical surface o f the ce lls  to  come in  contact 
with a ir  and provide nutrients from the basal surface only. Thus, 
p o la rity  or asymmetrical expression o f c e llu la r  functions appears 
to  be a prerequisite fo r f u l l  expression o f d iffe re n tia te d
function, not only jm vivo but in  v it ro  as w e ll, fo r many
e p ith e lia l ce ll types.
The ce ll lin e  A549, used in  th is  study, is  reputed to  be o f type I I  
o rig in  (Smith, 1977) and although transformed, i t  may be possible 
tha t i t  w il l respond better to  various exogeneous s tim u li when i t  
has the opportunity to  become polarised or be close to  the a ir -  
liq u id  in terface.
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A th ird  important point to  be considered is  the re la tionsh ip  
between tumour ce lls  and ce lls  o f the mesenchyme. The im plications 
o f such a re la tionsh ip  have been discussed at length in  the general 
i ntroducti on.
There are several reports supporting the concept o f stromal - 
associated e ffects in  mammary tissues (McGrath, 1983, Haslam, 
1986). In mice, mammary fib rob las ts  d ire c tly  stimulate the d iv is ion  
o f mammary e p ith e lia l ce lls  (Enami e t al ,^ 1983) w h ils t augmenting 
th e ir  response to  oestrogens (McGrath, 1983). In the developing 
tooth, intimate close-range in teractions between mesenchymal ce ll 
processes, matrix vesicles and the outer surfaces o f the responding 
epithelium appear to  be crucial determinants o f tooth morphogenesis 
(Slavkin e t a^, 1977; Mackenzie, 1984).
Age s p e c ific ity  has been demonstrated by Fukamachi e t a^ (1979), 
who showed tha t iso lated mouse stomach mesenchyme could only
modify embryonic development in  embryos of less than 10.5 days. 
They postulated tha t epithelium from la te r  embryos had the a b il i ty  
to  undergo s e lf-d iffe re n tia tio n .
There are two main types of epithelial-mesenchymal in te ractions. 
F irs t ly ,  ins truc tive  in teractions, whereby the mesenchyme 
influences the epithelium to  d iffe re n tia te  in to  a p a rticu la r 
phenotype, e.g. dental ameloblasts which produce enamel ECM 
constituents. The second type o f in te raction  is  the permissive 
in teraction  which maintains or s tab ilise s  a committed e p ith e lia l
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phenotype e.g. mediators o f production o f pulmonary surfactant by 
type I I  ce lls  (Smith, 1977).
In the female reproductive tra c t, stroma plays a crucia l ro le  in 
the regulation of e p ith e lia l morphogenesis, cy to d iffe re n tia tio n , 
hormone responses and function, where neonatal uterine and vaginal 
stromal ce lls  have been shown to  express normal inductive functions 
when reassociated with the appropriate epithelium and grown in  vivo 
(Cooke e t al_, 1987). More relevant to  th is  study, in  the lung, 
Smith and Fletcher, 1979, showed tha t a factor transferred from 
mesenchymal to  e p ith e lia l ce lls  accelerates lung maturation in  
foeta l rodents.
S im ila r ily , experiments with lung type I I  pneumocytes have shown 
tha t production o f pulmonary surfactant is  dependent on the steroid 
binding to  receptors in  the stroma which then releases a peptide 
which activates the type I I  ce lls  (Post e t al_, 1984 -  see also 
Figure 12).
Normal skin stroma can induce basal ce ll carcinoma to  express a 
more normal phenotype, characterised by growth and d iffe re n tia tio n  
(Cooper and Pinkus, 1977), and j[n v itro  studies with ra t tracheal 
epidermal ce lls  have demonstrated tha t d iffe re n tia tio n  factors 
produced by these ce lls  could in h ib it  the growth o f carcinogen- 
induced e p ith e lia l ce lls  (Terzaghi-Howe and McKeown, 1986).
FIGURE 12
Schematic representation of pulmonary surfactant Induction 
In type I I  pneumocytes by glucocorticoid induced fibroblast 
pneumocyte factor.
PULMONARY
SURFACTANT
TYPE II 
PNEUMDCYTE
STROMAL CELL
GLUCOOORTICOID
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These observations ra ise some in te resting  questions regarding the 
p o s s ib ility  o f stim ulating the d iffe re n tia tio n  o f lung carcinoma 
ce lls  in  v it ro .  Perhaps the tumour-associated stroma is  defective 
in  some way, possibly through in te raction  with the tumour c e lls , or 
production o f tumour ce ll factors which override inductive signals 
from the stroma, such tha t i t  may be incapable o f " in s tru c ting " the 
epithelium. Thus, i f  the tumour ce lls  were cultured, under the 
correct conditions, with normal stroma capable o f supplying the 
correct signal, they may respond. Also, as discussed in  the general 
in troduction, there is  good evidence to  suggest tha t the a c t iv ity  
o f the stroma is  hormone dependent (Lasnitski and Mizuno, 1979; 
Cunha, 1984; Post e t al^, 1984). Taken together, these observations 
suggest tha t given the correct inducing environment, with the 
appropriate hormonal stimulus, i t  may be possible to  a lte r  the 
phenotype o f A549. These questions w il l  be addressed in  th is  
chapter.
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4.1 CULTURE CONDITIONS: FILTER WELL VERSUS PLASTIC
A549 is  reputed to  be of type I I  o r ig in , therefore under in  vivo
conditions, i t  would be situated in  the alveolar wall o f the lung,
close to the a ir - l iq u id  in te rface . I t  may be tha t these ce lls  w ill 
respond better when cultured near the a ir - l iq u id  in terface rather 
than completely submerged, so to  t ry  to  achieve th is  and allow fo r 
the development o f p o la r ity , A549 ce lls  were grown both on a 
conventional p la s tic  substrate or raised from the bottom o f the 
dish by means o f a f i l t e r  w e ll.
A549 was seeded e ithe r in to  6-well plates (Nunclon) or in to  f i l t e r  
wells (Costar) at a ce ll density o f 2.5x104 cells/cm2 and assayed 
fo r secreted pulmonary surfactant as previously described a fte r 
exposure to  0.25uM dexamethasone.
The resu lts  can be seen in  Figure 13 and i t  is  clear from the graph 
th a t ce lls  growing on the f i l t e r  well appeared to  respond bette r to  
stero id , resu lting  in  a 5 -fo ld  increase in  pulmonary surfactant
secretion compared with only a 1 .5 -fo ld  increase when the ce lls
were grown on p la s tic . Since cu ltu ring  the A549 ce lls  in  f i l t e r  
wells seemed to  enhance surfactant secretion, a ll subsequent assays 
involving surfactant measurement were performed under these 
conditions.
FIGURE 13
Effect of culture In f i l t e r  wells on pulmonary surfactant 
production in A549.
A549 were cultured on the base o f the dish or in  f i l t e r  
wells in  the presence and absence o f stero id  (0.25uM 
dexamethasone) and pulmonary surfactant production measured 
as described in  the Materials and Methods.
Each data point represents the mean o f four separate 
experiments ±  SE.
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4.2 EFFECT OF STEROID ON MOUSE FOETAL LUNG CULTURES
I t  has been shown tha t A549 can produce pulmonary surfactant in  
cu ltu re , but i t  was in teresting  to  compare th is  with normal lung. 
Since normal human lung is  d i f f ic u l t  to  obtain, foetal mouse lung 
was used instead.
Cultures o f foetal mouse lung were prepared according to  an 
adaptation o f the method of Douglas and Teele (1976), as described 
in the Materials and Methods and cultured on e ither 6 well plates 
(Nunclon) or in  f i l t e r  wells (Costar). Cells were assayed fo r 
surfactant fo llow ing treatment with or without dexamethasone as 
previously described.
The resu lts  are shown in  Figure 14. Dexamethasone increased 
incorporation o f 3H-choline in to  disaturated phosphatidylcholine by 
approximately 1.5 fo ld , regardless whether the ce ll were growing on 
p la s tic  or on a f i l t e r  w e ll. Overall, the ce lls  cultured on the 
f i l t e r  expressed higher levels o f surfactant than pa ra lle l cultures 
incubated on p la s tic . However, i t  must be remembered th a t these 
cultures not only contained e p ith e lia l c e lls , but fib rob la s ts  as 
w e ll, and th is  point w il l  be discussed la te r .
FIGURE 14
Pulmonary surfactant production by early passage cultures of 
foetal mouse lung and the effec t of dexamethasone.
Cultures o f foetal mouse lungs were prepared and assayed fo r 
pulmonary surfactant production when grown on p las tic  and in 
f i l t e r  wells in  the presence and absence o f steroid as 
described in  the Materials and Methods.
Each data point represents the mean o f three observations _+ 
SE
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4.3 MORPHOLOGICAL INTERACTIONS
A549 ce lls  are fa ir ly  typ ica l e p ith e lia l ce lls  with a fa ir ly  
regular shape and forming a pavement-like appearance in  cu ltu re . 
LF113 have a typ ica l f ib ro b la s t morphology, assuming a spindle 
shape and producing characte ris tic  pa ra lle l arrays o f ce lls  at 
confluence. As the main aim o f th is  work was to  determine the 
e ffe c t o f fib rob las ts  on e p ith e lia l phenotype, the f i r s t  log ica l 
step was to  see how the ce lls  reacted at the morphological level 
when confronted in  coculture.
LF113 were grown to  confluence on glass coverslips with a diameter 
o f 16mm (Chance Propper L td), in  24 well plates (Nunclon), then 
transferred to  non- tissue cu lture  treated pe tri dishes (S te r i l in ) .  
A549 (5x104/cm2) was added to  the dish containing the covers!ip and 
le f t  to  attach overnight. A fte r 24 hours, d is t in c t in teractions 
were observed between the fib rob las ts  and A549 which had plated 
down on top o f the fib rob la s t coverslip , with evidence o f A549 
ce lls  invading the fib ro b la s t monolayer. This resulted in  a 
"p u lling  back" o f the fib rob lasts  to form c ircu la r structures. 
These in teractions persisted fo r up to  10 days in  cu lture  (Plate 
2a,b). In addition, c ircu la r holes appeared in  the A549 monolayer 
which was growing separately from the coverslip , on the non-tissue 
cu lture  p la s tic , with evidence o f chromophilic material in  the 
spaces so formed. This did not occur in  the absence o f fib rob la s ts  
(Plate 2c).
PLATE 2: PHENOTYPIC EFFECT OF COCULTURING A549 AND LF113.
Plate 2a: Structural reorganisation in  A549/LF113 cultured in  d ire c t 
contact.
Plate 2b: E ffect o f a fib ro b la s t coated coverslip on A549 growing on non 
tissue cu lture  grade p la s tic . No d ire c t contact.
Plate 2c: Control cultures o f A549 growing on non-tissue cu lture  grade 
p la s tic .
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Clearly there were in teractions going on between the 2 ce ll types, 
suggesting tha t biochemical estimation o f surfactant p ro d u c tio n  
should be investigated.
4.4 MEASUREMENT OF PULMONARY SURFACTANT USING COCULTURED CELLS
Fibroblasts were seeded on to  a Costar f i l t e r  well membrane and 
grown to  confluence. At confluence, 2.5x104 A549/cm2 were plated on 
top. The ce lls  were cocultured in  th is  fashion fo r 2 days before 
the addition o f 0.25uM dexamethasone in  serum free medium. Parallel 
cultures were also set up as contro ls , and secreted pulmonary 
surfactant was measured as before. The draw back o f th is  type of 
experiment is  in  the d i f f ic u lty  o f expressing pulmonary surfactant 
as specific  a c t iv ity ,  due to  the contribution o f the fib rob las ts  to 
the to ta l c e llu la r  pro te in . In the coculture experiments, when the 
ce lls  were so lub ilised  to  release to ta l prote in, i t  was impossible 
to  determine A549 associated protein separate from LF113 associated 
prote in . So, not only did the measurements account fo r  A549 
associated prote in, but fib rob la s t associated protein as w e ll. In 
an attempt to  get around th is ,  fib ro b la s t cultures alone were 
subjected to  exactly the same experimental conditions as the 
cocultures and the protein values were obtained a fte r the value fo r 
fibroblast-associated protein had been subtracted from the 
coculture values. This assumed, of course, tha t c e lls  cultured 
independently had the same growth rates as ce lls  which were growing 
in  coculture. The resu lts  o f the experiment are shown in  Figure 15.
FIGURE 15
Effect of coculture with M0G-LF113 on pulmonary surfactant 
production in A549.
A549 were cocultured In f i l t e r  wells with M0G-LF113 in 
d ire c t contact in  the presence or absence o f stero id and 
assayed fo r pulmonary surfactant production. The ce lls  were 
cocultured fo r 3 days before the addition o f ste ro id , and 
then cocultured fo r a fu rthe r 48 hours in  the presence o f 
0.25 uM dexamethasone.
Real = observed value, corrected = value obtained a fte r 
accounting fo r fibroblast-associated prote in . For 
explanation, re fe r to  te x t.
Each data point represents the mean o f f iv e  separate 
experiments + SE.
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In both the observed values and the values corrected fo r 
f ib ro b la s t- associated prote in, there was an approximate doubling 
in  surfactant secretion in  the presence o f s te ro id . Relative to  the 
control values in  the previous graph (Figure 13), the addition o f 
fib rob lasts  caused a th ree-fo ld  increase in  pulmonary surfactant in  
the presence o f s te ro id , and a seven-fold stim ulation in  the 
absence o f s te ro id .
4.5 TRANSFILTER COCULTURE
To avoid the contribution o f the fib rob las ts  to  the to ta l ce ll 
p rote in, and, more im portantly, to  te s t whether c e ll-c e ll contact 
was required, the ce lls  had to  be separated in  some way from A549. 
The use o f f i l t e r  wells permitted th is ,  allowing a separate ce ll 
type to  be cultured in  the lower chamber o f the f i l t e r  well holder 
(Figure 16).
Fibroblasts were grown to  confluence on the bottom o f the dish 
which housed the f i l t e r  well and A549 ce lls  plated onto the f i l t e r  
membrane. The ce lls  were grown in  serum free medium with or without 
steroid 3 days, then assayed fo r surfactant secretion as before. 
The specific  a c t iv ity  o f secreted surfactant re la tiv e  to  ce ll 
protein could now be calculated more accurately, and the highest 
levels o f surfactant were recorded (Figure 17), a 5 -fo ld  increase 
in  the absence of stero id and a fu rthe r 4 -fo ld  increase in  the 
presence o f stero id (re la tive  to  control values).
FIGURE 16
Diagram of A549 and LF113 cells  cultured under tra n s filte r  
conditions.
medium
filter
i A 5 4 9
FIGURE 17
Stimulation of pulmonary surfactant production In A459 by 
the addition of M0G-LF113 tra n s filte r .
A549 ce lls  were cultured in  a f i l t e r  well and M0G-LF113 
cultured on the bottom o f the dish, which housed the f i l t e r  
w e ll, in  the presence and absence o f dexamethasone, and 
assayed fo r pulmonary surfactant production as described in 
the te x t.
Each data point represents the mean o f four separate 
experiments + SE.
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4.6 EFFECT OF FIBROBLAST CONDITIONED MEDIUM
4.6.1 Effect on pulmonary surfactant
Conditioned medium was prepared from LF113 cultures exactly as 
described in  the Materials and Methods section. A549 ce lls  were 
grown to  confluence in  f i l t e r  wells and then treated with stero id 
treated conditioned medium, d ilu ted  1:1 with an equal volume o f 
fresh serum free cu lture  medium, fo r e ither 24 or 48 hours, and 
then assayed fo r surfactant as usual. The results  are shown in  
Figure 18.
There was no s ig n ifica n t difference between control and treated 
cultures a fte r 24 hours in  cu lture  in  the presence o f conditioned 
medium, but a fte r 48 hours there was an approximate doubling in 
pulmonary surfactant secretion. The actual levels achieved were 
lower than the t ra n s f i l te r  values (Figure 17). This point w il l  be 
discussed la te r .
The surfactant data is  summarised in  Table 5.
4 .6 .2  Effect on cell growth
To determine the e ffects on ce ll growth, A549, LF113 and Swiss 3T3 
fib rob las ts  were treated with various concentrations o f f ib ro b la s t 
conditioned medium and assayed fo r m itogenicity, as described in  
the Materials and Methods. The resu lts  are shown in  Figures 19 and
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FIGURE 18
Effect of fibroblast conditioned medium on production of 
pulmonary surfactant in A549.
A549 ce lls  growing in  f i l t e r  wells were exposed to 
conditioned medium fo r e ithe r 24 or 48 hours and then 
assayed fo r pulmonary surfactant production as previously 
described.
Each data point represents the mean o f three observations ±
SE of one representative experiment out of a series of
three.
TABLE 5: SUMMARY OF PULMONARY SURFACTANT DATA
EXPERIMENTAL CONDITIONS cpm/mg PROTEIN + SE
+DX -DX
A549 ALONE FILTER 3273.87 345.30 637.14 144.09
LF113 TRANSFILTER 12375.67 1487.92 3222.66 385.83
COCULTURE (rea l) 3818.48 709.60 2079.71 381.84
COCULTURE (corrected) 8670.14 1239.39 4493.41 1036.44
CONDITIONED MEDIUM (24hrs) 3501.17 350.15 3008.01 200.00
CONDITIONED MEDIUM (48hrs) 4350.17 359.12 1950.09 350.11
FOETAL MOUSE ( f i l t e r ) 10062.81 1018.95 8717.43 1812.92
FOETAL MOUSE (plate) 6319.42 904.62 4243.93 122.96
Each value represents the mean o f at least three separate 
experiments £  the standard e rro r. Pulmonary surfactant is  expressed 
as 3H-choline incorporation/mg o f to ta l ce ll prote in.
FIGURE 19
Effect of M0G-LF113 conditioned medium on the growth of MOG- 
LF113 and A549 In v itro .
Both ce ll lines were incubated with 0-1 00 pe rce n t \z o f 
MOG-LF113 conditioned medium fo r 48 hours and the e ffe c t on 
ce ll growth monitored by a modification o f the MTT assay as 
explained in  the Materials and Methods,
Each data point represents the mean of three observations _+
SE of one representative experiment out of a series of
three.
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FIGURE 20
A549 growth curve in the presence of fibroblast conditioned 
medium.
A549 was treated with e ithe r M0G-LF113 conditioned medium 
or d ilu ted  M0G-LF113 conditioned medium and the e ffe c t on 
ce ll growth measured by d ire c t ce ll counts as described in 
the te x t.
Each data point represents the mean o f three observations hh 
SE o f one representative experiment out o f a series o f 
three.
Circles = control (serum free medium)
Squares = stero id treated fib ro b la s t conditioned medium
(undiluted)
Triangles = stero id treated fib ro b la s t conditioned medium 
(d ilu ted  1:1 with fresh serum free medium).
1 0 s
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20.
As can be deduced from the graphs, conditioned medium had no e ffe c t 
on the growth o f A549, e ithe r by d ire c t ce ll counting or using an 
adaptation o f the MTT assay. S im ila r ily , there was no e ffe c t on 
LF113, the ce ll lin e  from which the conditioned medium was derived. 
However, the medium was stimulatory to  Swiss 3T3 fib rob las ts  
(Figure 21), resu lting  in  a threefo ld increase in  optica l density 
when the ce lls  were treated with 100% conditioned medium.
4.7 HPLC ANALYSIS OF CONDITIONED MEDIUM
I t  was possible tha t dexamethasone s t i l l  remained in  the cu ltu re  
medium a fte r the 6 hour recovery period, due to  release o f bound 
stero id from receptors. Obviously, i f  traces o f s tero id  s t i l l  
remained, these could account fo r the increases in  pulmonary 
surfactant synthesis seen a fte r treatment with conditioned medium, 
since dexamethasone alone was found to  stimulate surfactant 
synthesis. To determine whether or not dexamethasone was s t i l l  
present, HPLC analysis o f both conditioned medium and in ta c t ce lls  
was performed, using a m odification o f the technique o f Derendorf 
e t al. (1986) -  see Materials and Methods.
Figure 22 shows the chromatographs obtained from the conditioned 
medium and confirms tha t dexamethasone levels fe l l  to  0.7nM 6 hours 
a fte r steroid removal. With the c e lls , there was no stero id  
detected a fte r the 6 hour recovery period (Table 6a,b). This
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FIGURE 21
Effect of M0G-LF113 conditioned medium on the growth of 
Swiss 3T3 fibroblasts.
Quiescent cultures o f Swiss 3T3 fib rob las ts  were treated 
with 0-100% fib ro b la s t conditioned medium and the e ffec t on 
ce ll growth measured by MTT reduction as outlined in the 
te x t.
Each data point represents the mean of three observations _+
SE of one representative experiment out of a series of
three.

FIGURE 22
HPLC chromatograph.
HPLC determination o f conditioned medium was performed as 
described in  the Materials and Methods.
DX = dexamethasone peak
6MPN = methylprednisol one internal standard fo r calculating 
dexamethasone recovery.
TABLE 6a: HPLC ANALYSIS OF STEROID TREATED FIBROBLAST EXTRACT,
TIME AFTER STEROID REMOVAL DEXAMETHASONE DETECTED 
(ug/106 ce lls )
0
1 minute
5 minutes 
10 minutes 
30 minutes
2 hours 
4 hours
6 hours
0.157
0.11
0.101
0.059
0.026
not detectable
TABLE 6b: HPLC ANALYSIS OF FIBROBLAST CONDITIONED MEDIUM.
TIME AFTER STEROID REMOVAL DEXAMETHASONE DETECTED
(ug/ml conditioned medium)
0
6 hours
10.51
0.289
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confirms tha t the e ffects seen using the conditioned medium must 
have been due to a constituent(s) in  the medium, since there was no 
s ig n ifica n t carryover o f dexamethasone.
4.8 ELECTRON HICROSCOPY
Electron microscopy was performed on A549 ce lls  treated with e ither 
fib ro b la s t conditioned medium or dexamethasone according to  the 
Materials and Methods to  see i f  there were any u ltras tru c tu ra l 
changes ind ica tive  of d iffe re n tia tio n , p a rt ic u la r ily  evidence o f 
m u lti1amel1ar body formation, a characte ris tic  feature o f type I I  
ce ll m aturity.
E.M. photographs o f both the treated and control ce lls  are shown in  
Plates 3 and 4, and there was a clear difference between control 
and treated cu ltures. Controls showed extensive surface m ic ro v il l i ,  
and the ce lls  appeared rounded. There was l i t t l e  evidence o f 
multi lamellar body formation. Conversely, the treated cultures 
were much f la t te r ,  with l i t t l e  sign o f surface m ic ro v il l i ,  and the 
treated ce lls  showed large numbers of multi lamellar bodies w ith in  
the ce ll cytoplasm.
PLATE 3: ELECTRON MICROGRAPH OF A549 CELLS GROWING ON A FILTER WELL.
P rin t magnification = 13 520X 
A = apical surface 
F = f i l t e r  well membrane 
Arrow = m ic ro v illi

PLATE 4: EFFECT OF FIBROBLAST CONDITIONED MEDIUM ON A549 MORPHOLOGY 
BY ELECTRON MICROSCOPY.
P rin t magnification = 34 100X
m = multi lam ellar body.
A = apical surface
F = f i l t e r  well membrane
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DISCUSSION
The main objective o f th is  Chapter was to  determine i f  fib rob las ts  
were important in  the response o f A549 ce lls  to  s te ro id , and to 
optimise the cu lture conditions permissive fo r d iffe re n tia tio n  in  
A549.
Induction of surfactant was maximised when A549 was cultured on a 
f i l t e r  membrane rather than on a conventional p la s tic  substrate. 
Other investigators have looked at the e ffects o f d iffe re n t cu lture  
systems on surfactant biosynthesis. Doucet e t a^, (1987), using 
foetal ra t lung, found th a t in  th e ir  system, growth in  semi-solid 
medium was preferred. They postulated tha t th is  may be due to  
better oxygenation o f the cultures or improved biophysical 
properties o f the substrate. I t  is  also possible tha t cu ltu re  in 
semi-sol id  media could improve ce ll shape or bring about the onset 
o f p o la r ity . E a rlie r, Douglas and Teel (1976), again using foetal 
ra t lung, found the ce ll could reorganise to  form a lve o la r- like  
structures when cultured on a 3-dimensional gelatin-sponge m atrix. 
This did not happen on p la s tic . Zimmermann, (1987), has described 
an organoid cu lture system whereby lung ce lls  were cultured a t high 
density at the a ir - l iq u id  in te rface . This permitted e p ith e lia l-  
mesenchymal ce ll so rting , the formation o f an a lve o la r- like  lumen 
and the formation o f a basal lamina, a ll features which point to  a 
more d iffe ren tia ted  phenotype.
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Relative to  control values, the addition o f fib rob las ts  to  A549 
ce lls  caused a stim ulation in  pulmonary surfactant secretion, a 
2 .5 -fo ld  increase in the presence o f s te ro id , and a 5 -fo ld  increase 
when steroid was absent. However, these observations were corrected 
fo r fibroblast-associated protein and were based on the assumption 
th a t fib rob lasts  cultured alone have the same growth 
characteris tics as fib rob las ts  cocultured with A549. Attempts were 
made to  t ry  to  separate the two ce ll populations using Percoll 
density gradient centrifugation , but i t  proved impossible to 
separate them cleanly (resu lts  not shown). Perhaps fo rtuna te ly , an 
even better stim ulation was observed when both ce ll types were 
cultured under t ra n s f i l te r  conditions, demonstrating tha t 
surfactant secretion in  A549 was not dependent on d ire c t c e ll-c e ll 
contacts, and suggesting the involvment of a d iffu s ib le  fa c to r.
Cultures o f foeta l mouse lung could produce pulmonary surfactant in  
response to dexamethasone in  agreement with e a rlie r  observations 
(de Lamos et al_, 1970; Kotas and Avery, 1971; Torday 1980). The 
resu lts  obtained were comparable with the pulmonary surfactant 
values achieved fo r LF113/A549 cocultures. As w ith A549, the actual 
levels o f surfactant were enhanced when the ce lls  were cultured on 
a f i l t e r  w e ll. However, on the f i l t e r ,  production of surfactant did 
not seem to  be much affected by the addition o f ste ro id , 
suggesting the importance of the correct cu lture environment fo r 
expression of d iffe ren tia ted  function. The effects o f cu lture  
conditions on the growth o f foeta l mouse lung cultures has been 
reported by H ilfe r  e t al_ (1988), who showed th a t ce lls  grown a t the
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a ir - l iq u id  in terface in  serum free medium ram ified, a characterstic 
consistent with normal lung development, and contained 
multi lamellar bodies, the in tra c e llu la r  storage s ites  fo r pulmonary 
surfactant. In submerged cultures, th is  did not occur, w ith a large 
central lumen forming instead o f a branched tree .
However, the foetal lung cultures contained mixed ce ll populations, 
with stroma already present. The cultures were derived from 19 day 
mouse embryos; in  the mouse, fu l l  term is  21 days, so i t  is  
possible tha t by 19 days, the fib rob las ts  were already "switched 
on" and pulmonary surfactant production was maximised. In th is  
respect, i t  would be useful to  look a t fib rob lasts  from d iffe re n t 
developmental ages to  see at which point they become switched on to  
induce pulmonary surfactant production in  lung epithelium.
Another p o s s ib ility  is  tha t d iffe re n tia tio n  o f foeta l mouse lung 
could be contro lled by autocrine and paracrine factors in t r in s ic  to 
the developmental program o f embryonic lung, and independent o f 
exogeneous hormonal contro ls. Such a proposal has also been put 
forward by Oaskoll e t a^ (1988), who noticed tha t long term 
cultures of embryonic lung primordial ce lls  cy tod iffe ren tia ted  and 
expressed pulmonary surfactant-associated proteins in  the absence 
o f exogeneous hormones or growth fac to rs .
In the lite ra tu re , two d iffe re n t schools o f thought appear to  have 
evolved regarding contact mediated epithelial-mesenchymal 
in te raction  versus d iffu s ib le  epithelial-mesenchymal in te rac tions ,
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and there appears to  be some disagreement as to  whether d ire c t 
c e ll-c e ll contacts are necessary fo r epithelial-mesenchymal 
in te ractions. These points, and how they are re lated to  the resu lts  
o f th is  study, w il l  be discussed below.
F irs t ly ,  contact mediated responses. Adamson and King (1986), have 
shown tha t ra ts born to  mothers in jected 2 days before b ir th  with 
stero id showed not only accelerated lung development, but also a 
greater frequency o f epithelial-mesenchymal ce ll contacts, 
supporting the concept tha t regulatory messages are passed d ire c tly  
from the foetal f ib ro b la s t to  spec ific  e p ith e lia l ce ll types, 
in it ia t in g  the onset o f pulmonary surfactant production. Moving 
away from lung, cultures o f human hepatocytes again maintained a 
more d iffe re n tia te d  phenotype when grown in  coculture w ith d ip lo id  
human fib ro b la s t feeder layers (Michaelopoulos e t £1, 1979). They 
suggested tha t the close proxim ity o f the fib rob las ts  may allow 
reciprocal exchange o f the products o f metabolism between the two 
ce ll types. Perhaps the most convincing piece o f evidence came from 
Kedinger e t af[ (1987), who showed tha t glucocorticoids could 
influence structura l d iffe re n tia tio n  o f in te s tin a l endodermal 
c e lls . This only happened under coculture conditions with 
fib rob la s ts , suggesting tha t there was a mesenchymal dependence on 
the hormonal response, and tha t th is  required d ire c t c e ll-c e ll 
contact.
In the same way, primary cultures o f adult hamster pancreatic 
ce lls  could be maintained on feeder layers o f irrad ia ted
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fib rob lasts  (Maiick et aj[, 1981). The pancreatic ce lls  retained 
many d iffe re n tia ted  properties, notably insu lin  production. The 
preponderance o f m ito tic  figures observed in  the pancreatic ce ll 
cultures indicated tha t e p ith e lia l- f ib ro b la s t in teractions were 
beneficia l fo r growth and p ro life ra tio n  o f the pancreatic c e lls , 
and retarded the process o f ded iffe ren tia tion  and resu ltan t loss of 
d iffe ren tia ted  functions.
S im ila r ily , mammary e p ith e lia l ce lls  cocultured w ith irrad ia ted  
Swiss 3T3 fib ro b la s t feeder layers showed tha t d ire c t e p ith e lia l-  
mesenchymal contacts permitted the mammary epithelium to  undergo 
hormone dependent d iffe re n tia tio n , with secretion o f casein in to  
the culture medium, a fte r a b r ie f period in  coculture (Levine and 
Stockdale, 1985).
Equally, there are examples in  which d iffe re n tia tio n  does not 
appear to  be mediated by d ire c t c e ll-c e ll contacts.. In 1953, 
Grobstein showed tha t isolated mouse mesenchyme could prevent the 
induction of morphogenesis, when both ce ll types were cultured on 
opposite sides o f a Mi H i pore f i l t e r .  S im ila r ily , Wolters and Van 
Mullen (1977), cultured epithelium and mesenchyme from 20-day old 
ra t embryo tooth germs on opposite sides o f a M illip o re  f i l t e r .  
Although the c e lls  did not touch, EM studies revealed th a t ce ll 
processes from both ce ll populations penetrated in to  the pores o f 
the f i l t e r ,  but fa ile d  to  make contact. Nevertheless, the 
e p ith e lia l ce lls  underwent d iffe re n tia tio n , implying th a t ce ll 
contact was unnecessary in  th is  system. More recently , Fusenig,
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(1986;1989) has demonstrated tha t f u l l  epidermal ke ra tin isa tion  of 
skin in  v itro  is  only possible when dermal and epidermal components 
are cultured together, not in  d ire c t contact, but separated by a 
layer o f collagen. This implies the intervention o f a d iffu s ib le  
"message".
Bohnert and colleagues (1986) carried out an elaborate series of 
experiments to  determine the e ffects o f both mesenchyme and 
substratum on epidermal ce ll d iffe re n tia tio n . Cells cultured on 
p la s tic  showed incomplete maturation w h ils t the same ce lls  cultured 
on a flo a tin g  collagen r a f t  displayed improved ce ll o rien ta tion  and 
tissue organisation. Why should th is  be so? When a collagen r a f t  is  
detached from the base of a cu lture  vessel, i t  shrinks, so i t  is  
possible tha t th is  permits the e p ith e lia l ce lls  to  change shape, 
thereby establishing the correct morphology fo r  the expression o f a 
d iffe ren tia ted  phenotype. The same group (Bohnert e t aT_, 1986), 
then looked at the consequences o f adding mesenchymal elements to  
the system. On flo a tin g  collagen plus mesenchyme, the ce lls  were 
very well d iffe re n tia te d , with an organised epithelium. S im ilar 
resu lts  were obtained when the ce lls  were cultured with a layer o f
i ; I
collagen interposed between the e p ith e lia l |and mesenchymali
elements. This implied tha t d ire c t ce ll contact was not necessary 
fo r the onset o f d iffe ren tia ted  functions.
In cancerous breast, Adams e t al  ^ (1988a,b), showed th a t conditioned 
medium from human breast fib rob lasts  affected the in  v it ro  growth 
and 17 beta-oestradiol dehydrogenase a c t iv ity  in  MCF-7 ce lls  in
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cu ltu re . Moreover, they showed tha t fib rob las ts  derived from normal 
breast tissue could secrete factors which could in h ib it  the growth 
of MCF-7, w h ils t fib rob las ts  from malignant breast tumours secreted 
factors which actua lly  stimulated growth. Therefore, breast stromal 
tissues have a strong paracrine e ffe c t on the surrounding 
e p ith e lia l c e lls , not only on growth but also on in tra c e llu la r
enzyme a c t iv it ie s  as w e ll. P u rifica tion  o f fib ro b la s t conditioned
medium has revaled a tryps in  sensitive polypeptide, which eluted 
from a Sephadex G-75 column with a molecular weight o f around 
50kDa. The observed paracrine a c t iv ity ,  a t least in  part, has been 
a ttribu ted  to  secretion o f th is  facto r (Adams e t al^, 1988b).
In the same way, Post e t al  ^ (1984), using ra t type I I  e p ith e lia l
ce lls  showed tha t the induction o f surfactant could be influenced
not only by hydrocortisone in  the presence o f lung fib ro b la s ts , but 
also by conditioned medium from stero id  treated lung fib ro b la s ts . 
Inh ib itio n  o f th is  induction was possible using a monoclonal 
antibody raised against a fac to r p u rified  from fib ro b la s t 
conditioned medium.
The observations made here showed tha t d ire c t c e ll-c e ll contact was 
unnecessary fo r the induction o f a more d iffe ren tia ted  phenotype in  
A549 ce lls  by glucocorticoid treated fib ro b la s ts . How does th is  f i t  
in  with regard to  the observations described above?
I t  could be argued from the resu lts  of Post e t al_ (1984), and 
Bohnert e t al (1986), c ited  above, th a t in  the lung, d ire c t c e ll-
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ce ll contact is  not required fo r the induction o f d iffe re n tia tio n . 
However, the resu lts  o f Adamson and King (1986), would appear to  
re fu te  th is  claim. One possible explanation may be a difference
between j_n v itro  and in  vivo response to  embryonic induction. In 
v i t r o , Adamson and King (1986), noted an increase in  e p ith e lia l-  
mesenchymal ce ll contacts fo llow ing stero id  administration to  
pregnant ra ts . In vivo, i t  would make good sense to  pass regulatory 
substances d ire c tly  from one ce ll type to  another. This would 
reduce the chances o f the substance being lo s t e.g. in  the 
bloodstream, or being degraded by e.g. macrophages. By having 
d ire c t c e ll-c e ll contacts, th is  would s ig n if ic a n tly  reduce the 
chances o f losing such information. In v it ro ,  one is  dealing with a 
contained environment, and any regulatory molecule which is  
produced cannot escape, so i t  has a greater like lihood  o f reaching 
the epithelium.
Another p o s s ib ility  is  the differences between normal and
transformed c e lls . However, a ll the lung examples c ited  dealt only 
with normal c e lls . In the breast system (Adams e t al^, 1988a,b), 
where a paracrine facto r was implicated, transformed c e lls  were
used, and th is  was also the case in  the present study. There
appears to  be no clearcut reason why some ce lls  need contact fo r 
the expression o f d iffe ren tia ted  function, w h ils t others do not, 
and i t  may be tha t d iffe re n t ce ll lineages have d iffe re n t 
requirements a t d iffe re n t times. Indeed, the p o s s ib ility  th a t both 
contact and d iffu s ib le  factors are necessary fo r optimum 
d iffe re n tia tio n  cannot be ruled out.
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Most of these examples, (with the notable exception o f breast), 
have been drawn from studies using normal lung epithelium not with 
a transformed lin e  such as A549, and i t  is  perhaps surpris ing tha t 
th is  ce ll l in e , which is  released from the normal constraints o f 
growth, can respond in  such a way.
One possible explanation maybe the re-establishment o f p o la r ity . 
This is  a normal condition in  vivo fo r many e p ith e lia l ce ll types. 
ID v ivo* concentration gradients o f nutrients and growth regulating 
factors are maintained across basement membranes and ce ll layers. 
Cells may attach to  the basement membrane on the basal surface and 
feed there, w h ils t showing more specialised d iffe re n tia te d  features 
at th e ir  apical surface. Many studies have shown the influence o f 
the substratum on the survival and growth o f e p ith e lia l ce ll types 
(Emerman and P ite lka , 1977; L i l l ie  e t a^, 1980 and Chambard e t aj_, 
1981). This can a ffe c t th e ir  response to  spec ific  growth factors 
and the concomitant expression o f d iffe ren tia te d  functions (Lee et 
al ,^ 1985). Indeed A549 ce lls  were able to  respond better when 
cultured on a f i l t e r  well membrane than when growing on a 
conventional p la s tic  substrate, therefore the p o s s ib ility  o f 
p o la rity  being important cannot be discounted. The development of 
p o la rity  may also be dependent on the degree o f d iffe re n tia tio n  of 
a c e l l .  A549 is  a reasonably well d iffe re n tia te d  tumour, so might 
be expected to  respond better when given the opportunity to  become 
polarised.
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Another in teresting  aspect o f the requirement fo r d ire c t c e ll-c e ll 
contacts is  the apparent sex-related differences in the fib ro b la s t 
response to  s tero id , and subsquent production o f pulmonary 
surfactant. Sex-related differences in  lung structure (Adamson and 
King, 1984a,b) and surfactant synthesis (Torday e t al^, 1981) have 
been id e n tif ie d  in  normal lung development, and i t  appears th a t the 
reason fo r the difference lie s  with the fib rob la s t (Torday, 1984). 
I t  has been shown tha t female fib rob lasts  have greater 
oxidoreductase a c t iv ity ,  which is  necessary fo r the conversion o f 
cortisone to  c o r tis o l.  Moreover, female fib rob lasts  secrete higher 
levels o f fib ro b la s t pneumonocyte fa c to r, especially in  response to  
co rtiso l (Torday, 1984). S im ila r ily , Adamson and King (1986), have 
shown there to  be greater numbers o f e p ith e lia l- in te rs t i t ia l ce ll 
contacts in  female fib rob la s ts , and more o f the e p ith e lia l ce lls  
contai ned 1amel1ar bodi es.
LF113 fib rob lasts  were derived from a foetus, the sex o f which, 
was unknown. I t  is  in te resting  to  speculate tha t the responses 
seen here may have been enhanced because the fib rob la s ts  were 
actua lly female derived.
Fibroblast conditioned medium was also found to  be stim ulatory to  
A549 c e lls , although i t  has to  be said, much less so than the 
presence o f fib rob la s ts . HPLC analysis o f the conditioned medium 
showed l i t t l e  evidence of stero id carryover, so i t  is  probable tha t 
the observations made were due e n tire ly  to  a fac to r(s) present in  
the conditioned medium. The reduction in  stim ulatory capacity
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re la tiv e  to  coculture and t ra n s f i l te r  resu lts  may be a ttribu ted  to 
3 possible explanations. (1) Although there was no d ire c t c e ll-c e ll 
contact when the ce lls  were cultured under t ra n s f i l te r  conditions, 
i t  is  possible th a t there may be reciprocal c e ll-c e ll 
communications, v ia , e.g. growth factors or d iffe re n tia tio n  
facto rs. Perhaps one or both ce ll types could respond to  a 
fac to r(s) produced by the other ce ll type, which in  turn may 
"switch on" surfactant synthesis in  A549. (2) Any fac to r(s ) being 
produced from the stero id treated fib rob las ts  may have a very short 
h a lf l i f e  in  cu ltu re , or i t  may even require to  be a lk a lif ie d  or 
ac id ifie d  before i t  becomes active, as is  the case with TGF-beta 
(Sporn e t aj[, 1987). (3) In the conditioned medium experiments, to 
avoid the p o s s ib ility  o f nu trien t exhaustion, the medium was 
d ilu ted  1:1 with fresh cu lture medium, so i f  the facto r 
concentration is  lim it in g , fu rthe r d ilu tio n  w il l  reduce the 
a c t iv ity .
Conditioned medium was neither stim ulatory nor in h ib ito ry  to  the 
growth o f A549 in  v i t r o , e ither by d ire c t ce ll counting or by the 
MTT assay. This suggests tha t the fac to r(s ) present in  the medium 
is  having a d ire c t e ffe c t on surfactant synthesis rather than on 
growth regulation. The medium had no e ffe c t on LF113 ce lls  e ith e r, 
so i t  can be assumed tha t the fac to r(s ) is  not an autocrine growth 
regulator fo r the ce lls  from which i t  was derived. In te re s tin g ly , 
the medium was stim ulatory to  Swiss 3T3 fib rob las ts  in  the MTT 
assay in  adose dependent manner, resu lting  in  a 3 -fo ld  increase in  
optical density (which is  proportional to  ce ll number), when the
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ce lls  were treated with 100% conditioned medium. Swiss 3T3 ce lls  
are known to respond to  a number o f exogeneous growth fac to rs , 
notably bombesin, which can induce DNA synthesis and ce ll d iv is ion  
in  these ce lls  (Woll and Rosengurtz, 1988). Indeed bombesin-like 
peptides are abundant in  foetal lung (Wharton e t a^, 1978; 
Yamaguchi e t al_, 1983) and the mRNA fo r bombesin is  maximally 
expressed at 16-30 weeks (Spindel e t al ,^ 1987). The LF113 ce ll lin e  
used here was derived from a f i r s t  trim ester foetus, corresponding 
to  a gestational time o f 12-24 weeks, so i t  is  ce rta in ly  possible 
tha t the stimulatory a c t iv ity  o f the medium could be a ttribu ted  to  
bombesin (although bombesin is  usually derived from e p ith e lia l 
c e lls , not fib ro b la s ts ). However, th is  is  e n tire ly  speculative at 
th is  stage, and arguments fo r and against bombesin w il l  be discussed 
in  a la te r  chapter.
As well as changes at the biochemical le ve l, there were a lte ra tions 
in  ce ll morphology both at the l ig h t  microscope and electron 
microscope le ve l. A549 c e lls , when cocultured with fib ro b la s ts , and 
examined under a l ig h t  microscope seemed to  form c ircu la r holes in  
the monolayer, with evidence o f chromophilic material in  the spaces 
so formed. From the surfactant re su lts , one could speculate tha t 
the chromophilic material could possibly be surfactant, secreted by 
the A549 ce lls  in to  putative "a lveolar" structures. A549 coplated 
on top o f the fib rob las ts  also showed a structura l reorganisation, 
although, because o f the density o f the two ce ll populations, no 
evidence o f chromophilic material could be seen.
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In the absence o f fib rob la s ts , A549 did not show any s tructura l 
reorganisation. These ce lls  were growing on non-tissue cu lture  
grade p la s tic , and would not re a lly  have been expected to  have 
grown at a l l .  Certain ly, the ce ll growth was patchy, but the ce lls  
themselves looked lik e  fa i r ly  typ ica l A549 cu ltures. The probable 
reason fo r the growth is  because the ce lls  are transformed, they 
are less dependent on the substratum.
E.M. studies showed untreated A549 c e lls  to  have widely dispersed 
endoplasmic reticulum throughout the ce ll cytoplasm. Tonofilament 
bundles were abundant, a feature typ ica l o f e p ith e lia l c e lls . In 
control cu ltures, m ic ro v illi were evident, suggesting metabolic 
a c t iv ity .  Cells treated with conditioned medium generally had a 
more elongated shape and the ce lls  tended to  form a layer which was 
only 1-2 ce lls  th ick  w h ils t the control cultures tended to p ile  up. 
In addition, there was no evidence o f m ic ro v il l i .  Large 
m ulti lamellar bodies were evident in  the cytoplasm o f most treated 
c e lls , suggesting surfactant synthesis and the potentia l fo r 
secretion. This concurs with the observation tha t conditioned 
medium actually stimulated surfactant production in  A549, and the 
morphological observations would seem to  point to  a better 
d iffe ren tia ted  c e ll.
Scanning electron micrographic observations o f a number o f ce ll 
lin e s , both tumour derived and ce lls  tranformed in  cu ltu re , have 
led several investigators to  suggest tha t neoplastic c e lls  show 
increased membrane a c t iv ity  in  the form of ru ff le s ,  blebs and
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m ic ro v illi (Pugh-Humphreys and S in c la ir, 1970; Borek and Fenoglio, 
1976; Gonda et aj[, 1976). I t  is  possible tha t the surface 
topography o f ce lls  is  correlated with levels of m ito tic  a c t iv ity .  
Studies by Gonda et al_ (1976), with A549 have shown tha t th is  ce ll 
lin e  does have extensive surface a c t iv ity  in  the form o f dense 
populations o f stubby m ic ro v il l i ,  agreeing with the observations 
made here with the control c e lls .
To summarise, the induction of pulmonary surfactant production in  
A549 was enhanced fo llow ing cu lture  on a f i l t e r  well compared to  a 
conventional p la s tic  substrate. The glucocorticoid response was 
enhanced by incorporating fib rob las ts  in to  the cu ltu re . No d ire c t 
c e ll-c e ll contact was necessary, suggesting the in tervention o f a 
d iffu s ib le  fa c to r(s ), as confirmed by the a c t iv ity  demonstrated in  
conditioned medium. I t  appears tha t a transformed ce ll such as A549 
can s t i l l  respond to signals from normal lung mesenchymal c e lls .
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CHAPTER FIVE
PARTIAL PURIFICATION OF FACTOR(S) FROM 
FIBROBLAST CONDITIONED MEDIUM
Conditioned medium was shown to  be active in  Chapter four, and i t  
seemed lik e ly  tha t a d iffu s ib le  facto r was responsible. This 
chapter w il l  describe a series o f p u rifica tio n  stages in  an attempt 
to  iso la te  and characterise the active component(s), and to  reduce 
the p o s s ib ility  o f stero id carryover.
Most o f the experiments described in  th is  Chapter were carried out 
at Glaxo Group Reseach, Greenford, Middx.
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INTRODUCTION
Proteins can be separated from each other and other types of 
molecules on the basis o f such characteris tics as s o lu b il ity ,  
charge, specific  a f f in i ty  to  chromatographic media, and s ize. These 
techniques were used e ithe r alone or in  combination in  an attempt 
to pu rify  a facto r or fac to r(s) from the conditioned medium shown 
to be active in  the previous chapter.
Cell cu lture medium represents a complex mixture, containing sa lts , 
vitamins, glucose and various essential and non-essential amino 
acids, and conditioned medium is  no exception, and is  perhaps even 
more complex in  tha t i t  contains metabolic cel 1 products. To 
attempt to  iso la te  the active component, i t  was necessary to  reduce 
the complexity o f the mixture, using a series o f well known protein 
p u rifica tio n  stages. The efficacy was evaluated a t each stage by 
assaying fo r the a b il i ty  to  stimulate pulmonary surfactant 
secretion. Also the to ta l amount o f protein harvested was measured 
so tha t the degree o f p u rific a tio n  a t each stage could be 
determined.
The f i r s t  stage selected was ammonium sulphate p re c ip ita tio n . This 
represents perhaps the simplest form o f protein p u rific a tio n  and 
permits loca lisa tion  of the active frac tio n  by d if fe re n tia l 
s o lu b il ity .  (NH2)4S04 read ily  precip ita tes proteins from so lu tion , 
an e ffe c t called "sa lting  ou t", and i t  is  believed to  do so by 
removing the water o f hydration from the protein molecules.
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Proteins precipita ted by sa lting  out generally re ta in  th e ir  native 
configuration, usually without denaturation. Moreover, (NH^SC^ is  
preferred fo r sa lting  out because i t  is  so soluble in  water tha t 
very high ion ic  strengths can be atta ined.
The iso e le c tric  point o f the active fra c tio n , was determined using 
iso e le c tric  focusing (IEF). IEF is  based on the fa c t tha t the pH at 
which a protein is  least soluble is  i t ' s  iso e le c tric  po int (p i) .  
This is  defined as the pH at which the molecule has no net charge, 
and at th is  pH, i t  fa i ls  to  move in  an e le c tr ic  f ie ld .  At pH values 
above or below the pi po in t, a ll protein molecules bear a net 
charge o f the same sign, causing them to  repel each other. Some 
proteins are v ir tu a l ly  insoluble at th e ir  iso e le c tric  pH, therefore 
th is  represents a good way o f separating them.
Having established the p i value, th is  allowed the correct choice o f 
an ion exchanger fo r the main p u rifica tio n  step. Ion exchange 
chromatography separates biomolecules on the basis o f th e ir  charge 
characte ris tics , and is  re lated to , but func tiona lly  d iffe re n t from 
IEF. Ion exchange can very easily be scaled up ( fo r  large scale 
industria l preparations), or down (to  p i lo t  scale FPLC), depending 
on the volume o f the mixture to  be separated. This step was 
followed by (NH^gSC^. The sequence o f p u rific a tio n  steps is  shown 
in Figure 23.
None of these techniques has considered the molecular s ize. 
Separations on the basis o f size can be achieved using gel
FIGURE 23: SEQUENCE OF PROTEIN PURIFICATION STEPS
STEROID TREATED FIBROBLAST CONDITIONED MEDIUM
(NH4 ) 2S04 PRECIPITATION IEF
ION EXCHANGE CHROMATOGRAPHY 
4
PRECIPITATION( nh4 ) 2so4
GEL FILTRATION
NO ACTIVITY ACTIVE FRACTION
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f i l t r a t io n  chromatography whereby proteins pass through an 
insoluble but highly hydrated carbohydrate polymer in  the form of 
beads. Small molecules can enter the beads w h ils t la rger ones 
cannot. Thus the movement o f small molecules through the gel bed is  
retarded. This technique was attempted in  the la t te r  stages o f the 
p u rifica tio n  process to  t ry  to  determine the molecular weight.
Another way o f determining molecular weights is  to  use 
polyacrylamide gel electrophoresis (SDS-PAGE). As well as being 
useful fo r molecular weight estimations, th is  technique proved 
invaluable at each stage o f the p u rific a tio n , since, a fte r 
s ta in ing , i t  permitted v isua lisa tion  o f individual bands, thereby 
determining the p u rity  o f the mixture a t each stage. Also, by using 
molecular weight markers, and constructing a standard curve, the 
approximate weights o f each band could be determined.
Having p u rified  the fa c to r(s ), i t  was useful to  know some o f i t ’ s 
physicochemical properties, e.g. was i t  stable to  heat, what was 
i t ' s  reaction to  proteases and how did i t  react a fte r treatment 
with acid or base; th is  can be correlated to  the IEF experiment. 
These points are important fo r characterisation and help in  
id e n tif ic a tio n .
F in a lly , an attempt was made to  id e n tify  the fac to r(s) using two 
approaches. F irs t ly ,  the a c t iv it ie s  o f the fac to r(s) were compared 
with those o f known growth factors and secondly, as the fac to r(s ) 
coul d be one o f the better known growth fac to rs , western b lo t t i  ng
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was carried out to  see i f  there was any recognition between the 
fac to r(s) and antibodies to  known growth fac to rs .
5.1 AMMONIUM SULPHATE PRECIPITATION
50ml aliquots o f conditioned medium at 4°C were precip ita ted  by 4 
d iffe re n t s a lt concentrations, 20,40,60 and 80% w/v, as described 
in  the Materials and Methods chapter. The precipitated samples were 
resuspended in  2ml o f PBS and dialysed extensively overnight. By 
reducing the volume to  2ml, the medium had been e ffe c tive ly  
concentrated 25-fo ld . The to ta l protein collected, as measured by 
the Bradford assay was 154ug, from a s ta rting  volume o f 50ml of 
conditioned medium.
10Oul aliquots o f each sample, and the fin a l supernatant were 
incubated with A549 ce lls  in  f i l t e r  wells fo r 48 hours, as th is  was 
the time required to  bring about maximum response with conditioned 
medium, and the ce lls  were then assayed fo r pulmonary surfactant 
production as described in  the Materials and Methods section.
Figure 24 shows tha t maximum stim ulation was achieved when the 
ce lls  were incubated with aliquots o f the 60% frac tion  (from now on 
referred to as M0G-FDF/I) resu lting  in  a 2 .6 -fo ld  stim ulation in  
surfactant secretion. The to ta l protein present in  the M0G-FDF/I 
was 52.0ug, so the actual concentration o f M0G-FDF/I added to  the 
ce lls  was 1.48ug/ml.
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FIGURE 24
E ffect o f (NH^)2S0  ^ precipitated conditioned medium on 
pulmonary surfactant production in A549.
A549 ce lls  growing on f i l t e r  wells were incubated with 
protein precip ita tes from conditioned medium and assayed fo r 
pulmonary surfactant production as described in  the te x t. S 
= f in a l supernatant remaining a fte r the p rec ip ita tion  steps.
* p < 0.02
Each data point represents the mean o f four separate 
experiments Hh SE
TABLE 7: EFFECT OF (NHA)2S04 PRECIPITATES ON PULMONARY SURFACTANT 
PRODUCTION IN A549.
% SATURATION (NH4)2S04 % STIMULATION (re la tive  to  contro l)
0 0
20 15
40 6
60 87
80 23
FINAL SUPERNATANT 19
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A summary o f a c tiv it ie s  re la tive  to  untreated controls is  shown in  
Table 7.
An SDS-PAGE gel o f the 4 fractions was performed under reducing 
conditions (see Materials and Methods chapter), and th is  is  shown 
in  Plate 5, The samples were by no means pure -  there was s t i l l  
quite a lo t  o f high molecular weight proteins remaining (>150kDa), 
which had barely entered the resolving gel, as well as evidence of 
BSA carryover, even although the samples were prepared from serum 
free medium. At th is  stage, i t  was impossible to  determine exactly 
where the a c t iv ity  la y , as there was no band unique to  MOG-FDF/I.
5.2 ISOELECTRIC FOCUSING OF CONDITIONED MEDIUM
Isoe lec tric  focusing was carried out on conditioned medium, 
dialysed overnight against Tris-HCl, pH 7.4, according to  the 
protocol described in  the Materials and Methods section. This 
yielded 20 separate fractions o f approximately 2ml. The pH o f each 
frac tion  was measured.
The to ta l protein harvested, using the Bradford assay, was 125ug 
from a s ta rting  volume of 50ml o f dialysed conditioned medium. Each 
frac tion  was tested fo r stimulatory a c t iv ity  in  the surfactant 
assay, as described in  section 5.1. The resu lts  are shown in  Figure 
25. Greatest stim ulation was seen in  fra c tion  12 (MOG-FDF/II), a t 
an approximate concentration o f 0.15ug/ml, which had a pi 
corresponding to  pH 8.77. As the graph shows, there was also a peak
PLATE 5: SDS-PAGE OF AMMONIUM SULPHATE PRECIPITATED SAMPLES.
Samples were run under reducing conditions as described in  the 
Materials and Methods, and the bands visualised by s ilv e r s ta in ing.
STD = molecular weight standards, with approximate molecular weights 
shown beside the fin a l lane.
1 = 20% (NH4)2S04 p rec ip ita te

FIGURE 25
Iso electric  focusing a c tiv ity  p ro file .
IEF was performed as described in  the Materials and Methods 
and the a c t iv ity  and pH o f each frac tion  determined.
Each data point represents the mean o f three observations + 
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of a c t iv ity  at fra c tio n  18, However, th is  peak corresponds to  a 
sharp pH change often observed towards the end o f a run, due to  
localised high s a lt concentrations created during the run, and is  
generally regarded as an a rte fac t o f the system, ra ther than 
ind icating a second pi value.
The active portion was contained in  the fractions with a basic pi 
po in t, therefore the the prote in(s) o f in te res t was l ik e ly  to  be
basic, with a p i value o f around 8.77, the value fo r MOG-FDF/II.
Aliquots o f each fra c tion  were separated on an SDS-PAGE gel (Plate 
6), but as with the previous p u rifica tio n  step, there was no unique 
band in  any one fra c tio n , making i t  d i f f ic u l t  to  determine exactly 
where the a c t iv ity  la y . Molecular weight determination o f a ll 20 
fractions harvested was carried out using a standard curve, and the 
molecular weights ranged from 16-220kDa, encompassing an extremely 
broad spectrum. The fra c tion  showing greatest a c t iv ity  in  the
assay, frac tion  12, showed only 2 bands on the ge l, with
approximate molecular weights o f 45 and 38kDa, but these were found 
throughout the 20 frac tio ns .
5.3 LARGE SCALE PURIFICATION OF CONDITIONED MEDIUM BY ION EXCHANGE 
CHROMATOGRAPHY
IEF analysis (section 5.2) o f the conditioned medium showed the 
active frac tion (s) to  have a basic iso e le c tric  po in t. For th is
PLATE 6: SDS-PAGE OF IEF SAMPLES.
Samples harvested from the IEF experiment were run on SDS-PAGE under 
reducing conditions as described in  the Materials and Methods.
Numbers 1-18 re fe r to  the individual samples harvested. Maximum 
a c t iv ity  was observed in  fra c tio n  12.
STD = molecular weight standards, with approximate molecular weights 
shown next to  the fin a l lane.
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reason, S-sepharose was chosen as the ion exchanger as i t  is  a 
cation exchanger.
Eight fractions were harvested from the S-sepharose column, each of 
approximately 10ml. The to ta l protein y ie ld  from these 8 fractions 
was 3.27mg. Each frac tion  was assayed fo r a c t iv ity  as in  section 
5.1. The a c t iv ity  p ro file  is  shown in  Figure 26. A c tiv ity  seemed to 
be contained in  the f i r s t  few frac tio n s , p a rt ic u la r ily  fra c tio n  2, 
(MOG-FDF/III; approximate concentration o f 1.64ug/ml , resu lting  in  
a maximum stim ulation o f 12-fold over the control values. This was 
the highest stim ulation seen to  date. However, th is  material from 
fra c tion  12 was s t i l l  heterogeneous on SDS-PAGE analysis (Plate 7).
In an attempt to  p u rify  the S-sepharose eluate, frac tions 1-8 were 
pooled, to  prevent loss o f any a c t iv ity ,  then precipated in  steps 
at 20,40,60 and 80% w/v (NH^SO^, and resuspended in  a small 
volume of PBS. Each frac tion  was assayed fo r a c t iv ity  and greatest 
a c t iv ity  was observed in  the 60% fra c tio n , M0G-FDF/IV, as 
previously observed with the unfractionated conditioned medium. A 
dose response to  M0G-FDF/IV is  shown in  Figure 27.
The gel p ro file  o f M0G-FDF/IV was much purer than previously, as 
shown in  Plate 8. Of the 12 bands present in  th is  fra c tio n , there 
was a unique band which had an estimated molecular weight o f 30kDa. 
This may correspond to the active fra c tio n , but th is  po int w il l  be 
discussed la te r .
To try  to  fu rthe r pu rify  the active fra c tio n , an attempt was made 
at gel f i l t r a t io n ,  by FPLC. The four ammonium sulphate precipated
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FIGURE 26
A ctiv ity  o f fractions eluted from S-sepharose ion exchange 
chromatography.
Conditioned medium was fractionated as described in  the te x t 
and each frac tio n  harvested assayed fo r stimulatory 
a c t iv ity .
Each data point represents the mean o f three observations hh 
SE o f one representative experiment out o f a series o f 
three.
PLATE 7: SDS-PAGE OF SAMPLES ISOLATED BY S-SEPHAROSE ION EXCHANGE 
CHROMATOGRAPHY.
Fractions isolated from the S-sepharose column were electrophoresed 
under reducing conditions as described in  the Methods.
Numbers 1-15 re fe r to  ind ividual samples harvested.
STD = molecular weight standards, with approximate molecular weights 
shown beside the fin a l lane.
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FIGURE 27
A549 dose response to  MOG-FDF/IV.
A549 ce lls  growing in  f i l t e r  wells were treated with various 
concentrations o f MOG-FDF/IV and assayed fo r pulmonary 
surfactant production as indicated in  the te x t.
Each data point represents the mean o f three separate 
experiments + SE
PLATE 8: SDS-PAGE OF MOG-FDF/IV.
(NH4)2S04 Precipitated S-sepharose samples were electrophoresed 
under reducing conditions as described in  the Methods.
1 = 20% frac tion
2 = 40% frac tion
3 = 60% fra c tio n  (MOG-FDF/IV)
4 = 80% frac tion
STD refers to  the molecular weight standards, with approximate 
molecular weights shown next to  the f in a l lane.
4 3 2 1 std
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samples, including MOG-FDF/IV, were loaded onto a Superose 12 
column (Pharmacia) linked to  the FPLC system. Superose 12 consists 
o f cross linked agarose beads with a p a rtic le  size o f 30um, and is  
capable o f frac tiona ting  samples with a molecular weight range o f 
1.0-300kDa. Before loading the sample, protein standards (k ind ly 
provided by Dr Roberto S o lari, Glaxo Group Research, Greenford, 
Middx.) were loaded f i r s t .  200ul a liquots o f each sample were 
in jected onto the column and the fractions collected every 2 
minutes in PBS. The trace obtained can be seen in  Figure 28a. A 
ca lib ra tion  curve was constructed using the protein standards, and 
from th is  the approximate molecular weights o f the samples could be 
determined (Table 8 ).
TABLE 8 Molecular weight estimation a fte r gel f iltra t io n  using a 
Superose 12 column
FRACTION NOS. ELUTION DISTANCE (cm) MOLECULAR WEIGHT (kDa)
(on chart paper
10-13 3.2-4.1 >290
14-15 4.1-4.8 290-170
16-18 5.1 135
19-20 6.8 36
21-23 7.7-8.6 18-12.5
24-26 9.0-9.7 <10
However, on assaying the frac tions , no a c t iv ity  cou ld  be detected
FIGURE 28a
Superose 12 FPLC trace.
Chromatographic trace obtained a fte r FPLC o f MOG-FDF/IV
FIGURE 28b
Superose 12 a c tiv ity  p ro file
Fractions collected from the FPLC run above were assayed fo r 
stim ulation of pulmonary surfactant production in  A549 
c e lls .
Each data point represents the mean o f three observations hh 
SE o f one representative experiment out o f a series of 
three.
E L U T IO N  P R O F IL E
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(Figure 28b). This could be because the loading capacity o f the 
column was only 200ul, and the concentration o f the protein 
solution was 97ug/ml, so each frac tion  collected contained 
extremely low amounts o f a c t iv ity ,  not s u ff ic ie n t to  induce 
surfactant synthesis.
Although MOG-FDF/IV was s t i l l  c lea rly  heterogeneous, i t  was decided 
to  proceed with fu rthe r physicochemical and physiological 
characterisation, as the time available fo r fu rthe r p u rifica tio n  
was lim ited , and determination o f the phenotypic e ffects  o f MOG- 
FDF/IV was the prime objective. For th is  reason, MOG-FDF/IV was 
freeze dried and reconstituted in  PBS and used fo r a ll subsequent 
assays. An outline  o f the p u rifica tio n  stages used to  iso la te  MOG- 
FDF/IV is  shown in  Figure 29.
The main p u rifica tio n  stages, y ie ld  and enrichments are summarised 
in  Figure 30 and Table 9.
5.4 PHYSICOCHEMICAL PROPERTIES
Aliquots o f freeze dried MOG-FDF/IV, reconstituted in  PBS were 
subjected to  a varie ty  o f treatments and then assayed fo r  th e ir  
a b il i ty  to  stimulate pulmonary surfactant production.
FIGURE 29: OUTLINE OF THE MAIN PURIFICATION STAGES REQUIRED TO ISOLATE 
MOG-FDF/IV.
STEROID TREATED FIBROBLAST CONDITIONED MEDIUM
ION EXCHANGE CHROMATOGRAPHY
MOG-FDF/III 
AMMONIUM SULPHATE PRECIPITATION
I
MOG-FDF/IV
/  \
GEL FILTRATION FREEZE DRIED
I I
NO ACTIVITY CHARACTERISED
USED IN ALL REMAINING EXPERIMENTS
FIGURE 30: SUMMARY OF PURIFICATION STEPS.
AMMONIUM SULPHATE PRECIPITATION (MOG-FDF/I)
Starting volume = 50ml
Total protein harvested (a fte r d ia lys is ) = 153ug 
Total protein in  60% fra c tion  = 52ug 
% recovery o f protein in  60% frac tion  = 34%
ISOELECTRIC FOCUSING (MOG-FDF/II)
Starting volume = 50ml o f dialysed conditoned medium 
Total protein harvested = 125ug 
Total protein in  fra c tion  12 (most active) = 5ug 
% recovery o f protein in  fra c tio n  12 = 4.2%
ION EXCHANGE CHROMATOGRAPHY (MOG-FDF/III)
Starting volume = 20 l i t r e s  (d ilu ted  1:4 with 50mM MES buffer) 
Total protein harvested = 411ug 
Total protein in  fra c tio n  2 (most active) = 57ug 
% recovery o f protein in  frac tion  2 = 14%
AMMONIUM SULPHATE PRECIPITATION OF POOLED ION EXCHANGE FRACTIONS 
(MOG-FDF/IV)
Starting volume = 100ml
Total protein harvested = 343ug
Total protein in  60% frac tion  (most active) = 97ug
% recovery o f protein in  60% frac tion  = 28%
TABLE 9: SUMMARY OF CONDITIONED MEDIUM PURIFICATION STEPS
PURIFICATION STEP PS/mg PROTEIN X-FOLD
ENRICHMENT3
CONTROL 2050 1.0
MOG-FDF/I
(60% ammonium sulphate) 4550 2.0
MOG-FDF/II 
(IEF frac tion  12) 11235 5.0
MOG-FDF/III
(ion exchange frac tio n  2) 22172 10.0
MOG-FDF/IV
(60% ammonium sulphate 
ppt o f pooled ion
34939 17.0
3m-PS = pulmonary surfactant, expressed as incorporation o f °H 
choline/mg ce ll p rote in .
aRelated to  serum free conditions
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5.4.1 Heat treatment
Aliquots were e ither heated to  100°C in  a bo iling  water bath fo r 15 
minutes then cooled rap id ly  on ice, or maintained a t 56°C fo r 30 
minutes, then cooled on ice .
MOG-FDF/IV was stable to  both regimes o f heat treatment (Table 10).
5 .4 .2  Effects o f proteases
Samples were incubated with e ithe r tryps in  (1OOug/ml; Worthington) 
fo r 2 hours at 37°C or with pronase (Streptomyces griseus; Sigma) 
at 1OOug/ml under the same conditions. The action o f tryps in  was 
stopped by the addition o f soybean tryps in  in h ib ito r  (1OOug/ml; 
Sigma). Pronase a c t iv ity  was terminated by bo iling  fo r 5 minutes to  
denature the enzyme.
The a c tiv ity  o f MOG-FDF/IV was reduced by approximately 50% 
fo llow ing protease digestion (Table 10).
5 .4 .3  S ta b ility  to  ac id /a lka li
To te s t fo r acid s ta b il i ty ,  a liquots were ac id ifie d  w ith an equal 
volume o f 1.0M acetic acid at 4°C fo r 1 hour, followed by 
neutra lisa tion with 1.0M NaOH. To measure s ta b il i ty  to  a lk a li,  
aliquots were a lk a lif ie d  to  pH 9.0 with 0.5M Tris-HCl fo r  1 hour at 
4^C, and then returned to pH 7.4 with 1.0M HC1.
MOG-FDF/IV was a lk a li stable but acid la b ile  (Table 10).
TABLE 10: EFFECT OF PHYSICAL AND CHEMICAL TREATMENTS ON THE ABILITY 
OF MOG-FDF/IV TO STIMULATE PULMONARY SURFACTANT 
PRODUCTION.
TREATMENT ACTIVITY (% UNTREATED CONTROL)
CONTROL 100
TRYPSIN (lOOug/ml), 2hr 37°Ca 50
TRYPSIN (1OOug/ml) *  soybean 
in h ib ito r , 2hr 37UC 90
PRONASE (1OOug/ml) ,  2hr 37°Cb 56
HEAT 56°C, 30 minutes 77
HEAT 100°C, 5 minutes 81
ACID, 1M acetic0 50
BASE, pH 9.0d 95
a The treatment was terminated by the addition o f soybean tryps in  
in h ib ito r , (100ug/ml).
b Pronase was obtained from Streptomyces griseus. Treatment was 
terminated by bo iling  fo r 3 minutes.
c The samples were a c id ifie d  with 1M acetic acid fo r 1 hour a t 4°C,
followed by neutra lisa tion  with 1M NaOH.
d The samples were a lk a lif ie d  to  pH 9.0 with 0.5M Tris-HCl fo r  1
hour at 4UC and then returned to  pH 7.4 with 1M HC1.
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MOG-FDF/IV appeared to  be heat and a lk a li stable but acid la b ile  
and p a r t ia lly  protease la b ile .
5.5 EFFECT OF KNOWN GROWTH FACTORS ON PULMONARY SURFACTANT 
SECRETION
Induction o f pulmonary surfactant production by the a c t iv ity  o f 
MOG-FDF/IV was compared with the a c t iv ity  o f known growth factors 
to  look fo r clues as to  i t s  possible id e n tity . A ll the growth 
factors (k ind ly supplied by various people in  the Dept. C ellu lar 
Sciences, Glaxo Group Research, Greenford, Middx.) were d ilu ted  
w ith serum free medium to  various predetermined concentrations (as 
used in  assays currently in  use at Glaxo). The resu lts  o f the 
experiment were expressed as % o f untreated control and are shown 
in  Table 11 along with the concentrations o f growth factors used.
Of the 8 growth factors assayed, 3 were capable o f stim ulating 
surfactant release, namely, PDGF, bFGF and IGF-1. Although in su lin  
was apparently stim ulatory, th is  was not s ta t is t ic a lly  s ig n if ic a n t. 
However, none gave as large a stim ulation as MOG-FDF/IV. The 
im plications o f these observations w il l  be discussed la te r .
TABLE 11: EFFECTS OF KNOWN GROWTH FACTORS ON PULMONARY SURFACTANT 
PRODUCTION IN A549
GROWTH FACTOR CONCENTRATION % STIMULATION MOLECULAR WEIGHT (kDa)
CONTROL — 100 —
TGF-alpha 0.1uM 125 5.6
TGF-beta 1.0ng/ml 104 25
PDGF 3.0 units/ml 311* 32
bFGF 10.0ng/ml 183** 14-18
IGF—1 10.0ng/ml 175** 7
INSULIN 1.Oug/ml 238 5.7
EGF 0.1uM 131 6
BOMBESIN 0.1uM 115 1.6
MOG-FDF/IV 1 .Oug/ml 1278***
*  p < 0.01
* *  p < 0.02
* * *  p < 0.002
[NOTE: PDGF spec ific  a c t iv ity  -  3.0 un1ts/ml, 70 OOOU/mg]
Each observation represents the mean o f three separate experiments. 
S ta tis tic a l analysis was carried out using the Student's t - te s t  
(paired sample te s t) .
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5.6 WESTERN BLOTTING
In a fu rthe r attempt to id e n tify  MOG-FDF/IV, a series o f western 
b lots were performed using 3 growth fac to r antibodies. These were 
selected on the basis o f th e ir  b io log ica l properties and also on 
the resu lts  o f section 5.5
5.6.1 TGF-beta b lo tting
Proteins were transferred onto n itroce llu lose  paper exactly as 
described in  the Materials and Methods. To id e n tify  TGF-beta, a 
polyclonal anti-TGF-beta k i t  was used (B ritish  Biotechnology). 
The protocol used was identica l to  the manufacturers instructions 
but with the fo llow ing exceptions:
1. The antibody (stock 2ug/ml in  t r i s  buffered saline (TBS) + 0.25% 
EIA grade ge la tin ) was d ilu ted  1:500 with TBS + 1% EIA grade 
ge la tin  (BioRad).
2. The b lo t was incubated with the second antibody, b io t in -  
conjugated a n ti-ra b b it IgG, fo r 1 hour a t room temperature, and 
then overnight a t 4°C.
Detection was by the s trep ta v id in -b io tin  method, according to  the 
manufacturers ins truc tions .
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5.6 .2  bFGF and PDGF blotting
Anti-bFGF (AMS Biotechnology) stock 10ing/ml in  TBS + 0.25% EIA
grade gelatin  was d ilu ted 1:500, and anti-PDGF (B ritish
Biotechnology) stock 10mg/ml in  the same buffer was d ilu ted  1:1000 
in  TBS + 1% EIA grade ge la tin , and incubated with the b lo ts fo r 1 
hour at room temperature. This was followed by 3x10 minutes washes 
in  TBS containing 1% Tween 20 (BioRad), incubation w ith the second 
antibody (goat a n ti-ra b b it IgG; BioRad) at a d ilu tio n  o f 1:3000 fo r 
1 hour a t room temperature, then overnight a t 4°C. The b lo ts were 
then washed extensively in  TBS + 1% Tween 20.
Detection was by the diami nobenzidine (DAB) method. 10mg o f DAB and 
14ul o f 30% hydrogen peroxide were added to  a fresh ly  prepared 
solution o f 50mM Tris-HCl (pH 7.6) containing 100mM imidazole (a ll 
from Sigma). Once a s u ffic ie n t level o f stain ing had been atta ined,
th is  solution was poured o f f  and the b lo ts stored in  d is t i l le d
water.
Photographs o f representative b lo ts are shown in  Plates 9a,b,c.
I t  can be concluded from the b lots th a t anti-TGF-beta does not seem 
to react with the fa c to r. S im ila r ily , p u rified  TGF-beta when 
incubated with A549 ce lls  did not seem to  stimulate pulmonary 
surfactant secretion, so the p o s s ib ility  o f the fac to r being TGF- 
beta can be e ffe c tive ly  ruled out. The PDGF and bFGF b lo ts  showed
PLATE 9: REPRESENTATIVE WESTERN BLOTS.
Plate 9a: TGF-beta b lo t.
Arrow refers to  the position o f TGF-beta.
1 = MOG-FDF/IV
2 = TGF-bets standard
Plate 9b: bFGF b lo t.
1 = MOG-FDF/IV
2 = FGF standard
Plate 9c: PDGF b lo t.
1 = MOG-FDF/IV
2 = PDGF standard
Approximate molecular weights were derived from a separate gel run under 
identica l conditions.
am.w
1 2 2 1
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high levels o f nonspecific sta in ing , making i t  d i f f ic u l t  to 
ascertain, in  the time available, i f  there was any spec ific  binding 
between the factor and the antibodies. These points w il l  be 
discussed la te r .
DISCUSSION
From the resu lts  presented in  th is  Chapter, i t  was possible to
p u rify  p a r t ia lly  and characterise a fa c to r, or possibly a mixture
£
of factors, from steroid treated fib ro b la s t conditioned medium, 
using a number o f d iffe re n t p u rifica tio n  p ro c e d u re s . This 
fa c to r(s ), called MOG-FDF/IV, derived from fractions 1-8 from S- 
sepharose ion exchange, and then "salted out" by 60% (NH^SO ^ 
was capable o f stim ulating pulmonary surfactant production, 12-fold 
over control values, the highest level o f stim ulation o f a ll the 
material tested.
Attempts were made to  characterise MOG-FDF/IV using 3 methods; 
physicochemical properties, comparison o f a c t iv it ie s  w ith other 
growth factors and western b lo ttin g  using growth facto r antibodies. 
The physicochemical properties w il l  be discussed f i r s t .
Three d iffe re n t measurements were recorded, namely, the e ffec ts  o f 
proteases, heat and changing the pH. Incubation o f MOG-FDF/IV with 
the p ro teo ly tic  enzymes tryps in  and pronase could only reduce the 
a c t iv ity  by one h a lf.  This find ing was reasonable as fa r  as tryps in
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went, since i t  is  a highly specific  protease, cleaving polypeptides 
only on the carboxyl side o f lysine and arginine residues. However, 
a fte r treatment with pronase, which is  a p a r t ic u la r ily  agressive 
protease, since i t  is  rather non spec ific , one might have expected 
the a c t iv ity  to be abolished completely. As i t  was not, th is  raised 
doubts as to  whether a ll the stim ulatory a c t iv ity  observed with 
regard to  pulmonary surfactant synthesis was actua lly  protein 
induced. Certainly there was a component o f the stim ulation which 
was protein induced, but i t  may well be tha t there was a non­
protein component as well e.g. perhaps a carbohydrate or a 
g lyco lip id  bound to  a prote in .
The p o s s ib ility  o f stero id carryover cannot be ruled out, but i t  is  
un like ly , however, tha t stero id carryover was responsible. F irs t ly ,  
HPLC analysis o f conditioned medium (see Chapter 4) showed th a t < 
0.7nM free stero id was detectable in  the medium 6 hours a fte r 
dexamethasone removal, the time at which the medium was co llected, 
and from the dexamethasone dose response curves, > 0.1nM
dexamethasone is  required to  stimulate pulmonary surfactant 
production. Secondly, treatment o f the ce lls  with dexamethasone 
alone gave an approximately 10-fold smaller stim ulation than MOG- 
FDF/IV. The amount o f pulmonary surfactant produced a fte r treatment 
with dexamethasone was 3.27x103 cpm 3H-choline incorporation/mg 
prote in, and 3.79x104 cpm/mg protein a fte r treatment w ith MOG- 
FDF/IV. Protease res is tan t a c t iv ity  was s t i l l  5 -fo ld  higher than 
the maximum obtained with dexamethasone a t 10"7M, and in f in i te ly
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higher than any stim ulation with 10~10M, the probable maximum 
concentration in  conditioned medium.
MOG-FDF/IV was also found to  be acid la b ile , but, as w ith the 
protease experiments, the a c t iv ity  could not be reduced by more 
than 50%. Perhaps the simple addition o f MOG-FDF/IV, w ith some 
residual a c t iv ity  remaining a fte r treatment, may s t i l l  be enough to  
stimulate pulmonary surfactant, with the cleaved peptide s t i l l  
active but with reduced a c t iv ity .  Or, the treated fac to r(s ) may 
s t i l l  have shown a degree o f recognition at the receptor s ite  
(maybe a reduced a f f in i t y ) ,  enough perhaps to  tr ig g e r surfactant 
secretion.
Treatment with base had no e ffe c t on MOG-FDF/IV1s a b i l i t y  to 
stimulate surfactant secretion in  A549. This is  reasonable, since 
the IEF experiments determined tha t the active fra c tio n  eluted with 
a basic p i po in t. This being the case, i t  is  not surpris ing tha t 
acid treatment reduces the a c t iv ity .
The molecular weight o f MOG-FDF/IV was d i f f ic u l t  to  determine 
accurately, since gel f i l t r a t io n  by FPLC fa ile d  to  iso la te  an 
active fra c tio n . However, in  the 60% (NH4)2S0^ precipated MOG- 
FDF/IV fra c tio n , there was a unique band on SDS-PAGE, w ith an 
estimated molecular weight o f 30kDa. I t  is  possible th a t th is  band 
might correspond to  the a c t iv ity ,  but i t  may be tha t the a c t iv ity  
could be a ttribu ted  to  a band undetectable, even with s ilv e r  sta in  
which supposedly can detect nanogram quantities o f p ro te in . Another
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p o s s ib ility  is  tha t MOG-FDF/IV may be glycosylated and th is  would 
give a fa lse estimation o f the molecular weight. Attempts were 
made to  elute spec ific  bands using native PAGE run under non­
reducing conditions (data not shown), but i t  proved impossible to  
demonstrate any a c t iv ity .
The effects o f other growth factors on pulmonary surfactant 
secretion were also determined. Growth factors are defined as 
polypeptides which stimulate ce ll p ro life ra tio n  through binding to  
spec ific  high a f f in i ty  ce ll membrane receptors. They are thought 
not to  act in  an endocrine fashion, but rather to  d iffuse  over a 
short range through in tra c e llu la r  spaces and act lo c a lly  ( in  a 
paracrine manner). As well as being found in  many adult and 
embryonic tissues, they are known to  be released by a va rie ty  of 
ce lls  in  cu lture (Shields, 1978).
Of the 8 growth factors assayed, 3 showed some s ig n ific a n t 
stimulatory a c t iv ity ,  namely PDGF, bFGF and IGF-1. PDGF showed the 
greatest stim ulation, although not as great as MOG-FDF/IV. Although 
insu lin  showed stim ulation as w e ll, i t  was not s ta t is t ic a l ly  
s ig n ifica n t.
PDGF is  a major mitogen in  serum and was o r ig in a lly  iso la ted from 
expired human p la te le ts  where i t  is  stored as a component o f the 
alpha-granules (Ross and Vogel, 1978). On SDS polyacrylamide gels, 
two bands have been reported, in  the molecular weight range 30- 
32kDa (Goustin e t al., 1986). Each o f the 2 bands are apparently
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composed o f dimers o f 2 polypeptide chains designated A and B, and 
the d iffe re n t molecular weights o f the 2 bands are thought to  be 
the re su lt o f d iffe re n tia l processing or degradation o f the A chain 
ends as well as d iffe re n t degrees o f glycosylation (Goustin e t a l ,
1986).
Expression o f PDGF or a PDGF-like molecule has been shown in  a 
broad spectrum o f c e lls , both transformed and untransformed (Bowen- 
Pope e t al., 1984; Nimian e t al., 1984) and w h ils t PDGF receptors 
have been found on a varie ty  o f mesenchymal ce lls  (Heldin e t al., 
1981; Bowen-Pope et al., 1984), other than trophoblast c e lls , most 
e p ith e lia l ce lls  tend to  lack PDGF receptors (Heldin e t al., 1981). 
A549, although transformed, is  s t i l l  an e p ith e lia l ce ll and could 
respond to PDGF, in  apparent contradiction to  the observations o f 
Heldin et al., 1981. Fibroblasts do produce PDGF, in  an autocrine 
stim ulation loop in  wound repa ir, so MOG-FDF/IV may be re lated to 
PDGF.
IGF—1 showed a s lig h t stim ulation in  pulmonary surfactant 
secretion. Formerly known as somatomedin C, IGF-1 is  the best known 
member o f a fam ily o f in s u lin - lik e  peptides, ancestra lly re la ted to  
proinsulin  (Blundell and Humbel, 1980). Produced in  response to 
c ircu la tin g  growth hormone, IGF-1 is  one o f the important growth 
factors found in  serum and plasma (Svoboda e t a lj. 1980), active in  
stim ulating a number of cultured ce lls  (Van Wyk e t al., 1981). 
Moreover, IGF-1 appears to  c ircu la te  in  the plasma noncovalently 
bound to a specific  ca rrie r protein (Furlanetto, 198Q). The
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molecular weight o f IGF-1 is  7kDa. However, nothing smaller than 
30kDa was observed on SDS-PAGE gels, although i t  has already been 
proposed tha t there may be smaller molecules present, in  such small 
quantities tha t they fa ile d  to  show up a fte r s ilv e r  s ta in ing . Also, 
a fte r (NH^SC^ p re c ip ita tio n , there was a d ia lys is  step. The 
molecular weight c u t-o ff o f the the d ia lys is  tubing was 10kDa, so 
unless IGF-1 was bound to  a ca rrie r protein (and th is  is  not an 
unreasonable supposition, since i t  c ircu la tes in  the plasma in  such 
a way), i t  was presumably lo s t in  the d ia lys is  stage. I f  bound and 
retained, IGF-1 may yet be a possible candidate.
bFGF also showed some stimulatory a c t iv ity .  FGF’ s are members o f a 
fam ily o f polypeptide growth factors which show potent mitogenic 
a c t iv ity  fo r a varie ty o f ce lls  o f mesodermal o r ig in , including 
p rim arily  fib ro b la s ts , but also vascular and corneal endothelial 
c e lls , chondrocytes, osteoblasts, myeloblasts, smooth muscle and 
g lia l ce lls  (Thomas and Gimenez-Gallego, 1985). Two forms o f FGF 
e x is t, acid ic and basic FGF. aFGF has a p i o f 5.7 w ith a 
corresponding molecular weight o f 14kDa. bFGF is  a la rger molecule 
with a molecular weight o f 18kDa. The acid ic form shares a 55% 
sequence homology with the basic form (Thomas and Gimenez-Gallego, 
1985). However, there have been reports tha t pure preparations o f 
both acidic and basic FGF can actua lly repress terminal 
d iffe re n tia tio n  in  mouse myeloblasts (Clegg e t al ,^ 1987); in  the 
A549 system, ce lls  became more d iffe re n tia te d  when treated with 
MOG-FDF/IV, (although i t  cannot be discounted th a t the a c t iv it ie s  
o f FGF may be d iffe re n t on d iffe re n t lineages o f ta rge t c e lls ) .
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Also, FGF's tend to  be associated with healing responses, where 
they serve a stim ulatory function. Furthermore, bFGF has been shown 
to  cause a profound increase in  PA levels in  bovine ca p illa ry  
endothelial ce lls  (Saksela e t al ,^ 1987), which was ce rta in ly  not 
the case with A549 (see la te r ) .
TGF-beta showed no apparent stim ulation o f pulmonary surfactant 
production in  A549. TGF-beta has been p u rifie d  to  homogeneity from 
4 sources, namely, bovine kidney (Roberts e t al,, 1983), human 
placenta (F ro lik  et al,, 1983), expired human p la te le ts  (Assoian et 
a l , 1983) and fe lin e  sarcoma virus-transformed ra t ce lls  (Massague,
1984). The molecular weight o f TGF-beta is  25kDa, consisting o f 2 
identica l subunits linked together by disulphide bonds. TGF-beta 
has been found to  be responsible fo r inducing normal human 
bronchial epithelium to undergo squamous d iffe re n tia tio n  jm v itro  
(Massui e t al,, 1986), characterised by an increase in  ce ll surface 
area, the formation o f cross linked envelopes and the cessation of 
ce ll d iv is ion . I t 's  d iffe ren tia tion -induc ing  ca pab ilities  have also 
been reported by McMahon and colleagues (1986), who noticed both 
structura l and functional changes in  a ra t l iv e r  e p ith e lia l ce ll 
lin e  fo llow ing treatment with TGF-beta. A549 has abundant TGF-beta 
receptors and indeed secretes la te n t TGF-beta (Wakefield e t al,,
1987), but lik e  many cultured c e lls , cannot repsond to  i t ' s  own 
la te n t TGF-beta. I t  appears to  have lo s t the a b il i ty  to  activa te  
la te n t TGF-beta and hence continues to  p ro life ra te  in  the presence 
o f high concentrations o f la te n t autocrine TGF-beta (Sporn e t al,, 
1987; Wakefi el d e t al,, 1987).
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Anti-TGF-beta did not react with MOG-FDF/IV, as demonstrated in  the 
western b lo ts . S im ila r ily , there was no stim ulation o f pulmonary 
surfactant when the ce lls  were incubated with pure TGF-beta 
suggesting tha t TGF-beta does not have any d iffe re n tia tin g  e ffects 
on th is  p a rticu la r ce ll l in e . Indeed, TGF-beta has recently  been 
shown to actua lly in h ib it  surfactant apoprotein synthesis in  
pulmonary type I I  e p ith e lia l ce lls  (W hitsett e t a^, 1987), which is  
in  d ire c t contrast to the action of MOG-FDF/IV. Therefore i t  is  
probably true to  say tha t TGF-beta was not the factor iso lated from 
stero id treated fib ro b la s t conditioned medium.
Western b lots o f PDGF and bFGF proved d i f f ic u l t  to  in te rp re t, due 
to  high levels o f non-specific background sta in ing . This may be 
a ttribu ted  to  the fa c t tha t a to ta l IgG frac tion  was used, so tha t 
complete monospecificity could not be guaranteed. Another 
p o s s ib ility  is  tha t MOG-FDF/IV could share some sequence homology 
with one or both o f the growth fac to r antibodies. However, the 
b lo ts were fa r from convincing, making i t  impossible, in  the time 
available, to  draw too many conclusions from them.
In Chapter 4, i t  was speculated th a t bombesin might be the fac to r 
iso lated from conditioned medium, since bombesin-like peptides are 
abundant in  foetal lung (Wharton e t al ,^ 1978; Yamaguchi e t al ,^ 
1983), although a fte r b ir th  levels decline, such tha t in  adults, 
these peptides are found only sparsely in  bronchial neuroendocrine 
c e lls . Also, there has been speculation tha t bombesin may be 
involved in  surfactant production, since bombesin is  not expressed
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in  the immature lungs o f in fants with respira tory d istress syndrome 
(Ghatei e t al_, 1983), As previously mentioned, respira tory d istress 
syndrome is  associated with a malfunction in  pulmonary surfactant 
synthesis, so i t  may be tha t bombesin may have a ro le  in  th is .  
Moreover, a s tru c tu ra lly  re lated form, gastrin releasing peptide 
(GRP) is  found in  the gut where i t  induces the secretion o f gastrin 
(Lezoche e t al^, 1981). There is  l i t t l e  doubt tha t the isolated 
facto r has secretory properties regarding A549, so in  th is  respect, 
and the fa c t tha t bombesin can stimulate lung m aturity, i t  could be 
re lated to  bombesin. However, cultures o f A549 when treated with 
p u rified  bombesin showed no stim u la tion . Also, the size o f bombesin 
fa l ls  fa r short o f the smallest band observed on SDS-PAGE, being a 
tetradecapeptide o f molecular weight 1.6kDa, and would have been 
excluded by d ia lys is . For these reasons, bombesin is  an un like ly  
candidate.
I t  was possible tha t the MOG-FDF/IV was a mixture o f fac to r(s ) 
rather than one spec ific  factor (indeed the gel p ro file  showed more 
than one band). In th is  respect, an in te resting  avenue to  pursue 
would be to  use d iffe re n t combinations o f growth factors and see i f  
there was an additive or synergistic e ffe c t. For example, bombesin 
had no e ffec t on pulmonary surfactant production, but i t  may well 
be tha t could have an e ffe c t when combined with other growth 
fac to rs . The growth factors which gave highest stim ulation in  th is  
work were PDGF (3 fo ld  stim u la tion), bFGF (1.8 fo ld  stim ula tion) 
and IGF-1 (2 fo ld  stim u la tion). However, combining the to ta l 
a c tiv it ie s  o f these growth factors a rithm e tica lly , gave only a
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potential stim ulation o f less than h a lf o f the the value attained 
fo r the pu rified  fa c to r(s ). E ither other growth factors are 
involved, or the in te raction  would need to  be synerg istic .
The ra tiona le  behind th is  work was based on observations by Smith 
(1979), who were able to  p a r t ia lly  p u rify  a facto r from co rtiso l 
treated fib ro b la s t conditioned medium. The facto r could accelerate 
lung maturation in  foetal ra ts . Smith's fac to r, which he christened 
fib ro b la s t pneumocyte facto r (FPF) was prepared by acid hydrolysis 
o f size fractionated conditioned media. However, MOG-FDF/IV 
appeared to  be acid la b ile , which would suggest tha t MOG-FDF/IV is  
d iffe re n t from Smith's FPF.
Like Smith's, MOG-FDF/IV isolated here was by no means pure. 
Indeed, Smith reported 4 bands on SDS-PAGE gels, 2 major bands o f 
molecular weights 3.14kDa and 8.9kDa, plus 2 intermediate bands 
(molecular weights not specified). Later, in  1983, Smith and Sabry 
again pu rified  FPF, ca llin g  i t  FPF-II. Again there were 4 bands, 
th is  time of s lig h t ly  higher molecular weights, 12, 10, 8 and 5kDa, 
but these could be a ttribu ted  to  d iffe re n t degrees of 
glycosylation.
C learly, there were major differences between the molecular weights 
o f FPF/FPF-II and MOG-FDF/IV, fu rthe r suggesting the involvement o f 
a d iffe re n t (and possibly unique?) fa c to r.
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CHAPTER SIX
EFFECT OF MOG-FDF/IV ON OTHER PHENOTYPIC MARKERS
AND CHEMOSENSITIVITY 1H VITRO
This chapter w il l  be divided in to - 2 parts. The f i r s t  part w il l 
concentrate on the e ffects o f MOG-FDF/IV on other phenotypic 
markers e.g. plasminogen activa tor a c t iv ity ,  clonogenicity in  so ft 
agar, DNA and GAG synthesis. The second part w il l  deal y/ith some 
e ffects on the chemosensitivity o f A549 ce lls  pretreated with MOG- 
FDF/IV.
The implications o f the resu lts  o f both sections w il l  be brought 
together in  a general discussion at the end.
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PART ONE: PHENOTYPIC ALTERATIONS
Up u n til th is  po in t, the only phenotypic modulation to  be studied 
has been the a b il i ty  o f the MOG-FDF/IV to  stimulate pulmonary
surfactant secretion in A549. I t  is  possible tha t the e ffe c t o f
MOG-FDF/IV was to act so le ly on the induction on surfactant
synthesis, rather than having a more general d iffe re n tia tin g
e ffe c t, so i t  was necessary to  Took at other parameters to  see 
whether or not th is  was the case.
Three markers were selected, namely, glycosaminog!yean (GAG) 
synthesis (a marker associated with d iffe re n tia tio n ; Shirasuna et 
al^, 1988), plasminogen activa tor a c t iv ity  (a marker associated with 
malignant ce lls ; Duffy and O' Grady, 1984) and the e ffe c t on
cloning in  suspension (a fu rthe r malignancy-associated marker; 
Freedman and Shin, 1974) re la tive  to  monolayer cloning.
Before considering these parameters, i t  is  f i r s t  necessary to  
define exactly what is  meant by d iffe re n tia tio n  markers and 
malignancy-associated markers. The term "d iffe re n tia tio n  marker" 
w il l  be used to define the expression o f the spec ific  
characteristics which are expressed in  a functiona lly  mature c e ll,  
and which are generally lacking in  undifferentia ted or transformed 
c e lls . Malignancy, as such, cannot be demonstrated in v i t r o , but jm 
vivo a tumour is  c la ss ifie d  as being malignant once i t  has crossed 
the basement membrane and invaded normal tissues. I t  has been 
reported by Barsky et al_ (1983), by immunofluorescence and
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immunoperoxidase techniques, tha t invasive tumours lack the 
basement membrane components laminin and type IV collagen, w h ils t 
th e ir  benign counterparts showed in ta c t basement membranes with 
linea r staining o f laminin and type IV collagen. Malignancy- 
associated properties are by r\p means unique to  malignant c e lls , 
since many normal ce lls  express them as w e ll, p a rt ic u la r ily  during 
development and wound repa ir.
The three phenotypic markers chosen often show a co rre la tion , since 
i t  is  frequently observed tha t with increased progression o f a 
tumour, the histology usually indicates a much poorer degree of 
d iffe re n tia tio n , coupled to  an increased invasive capacity and 
hence an increased malignancy. On the basis o f these observations, 
i t  is  often assumed tha t there is  an inverse re la tionsh ip  between 
the expression o f d iffe re n tia tio n  and malignancy-associated 
properties, such tha t the induction o f d iffe re n tia tio n  has been 
proposed as a potential mode o f therapy (Spremulli and Dexter, 
1984; Freshney, 1985). I f  a ce ll population becomes more 
d iffe re n tia te d , th is  w il l  presumably change the status o f the 
tumour, causing a reduction in  the p ro life ra tiv e  pool, w h ils t 
increasing the pool o f d iffe ren tia ted  c e lls .
Changes in GAG synthesis have been correlated with discrete stages 
o f development in embryonic systems (Toole, 1981) and the 
commitment to  a p a rticu la r pathway o f c e llu la r  d iffe re n tia tio n  may 
be mediated by, or in tr in s ic a lly  associated w ith, changes in  the 
ce ll surface molecules (Lyman et al_, 1976; Fukada et al_, 1980).
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Normal maturation o f granulocytes and monocytes also appears to  be 
accompanied by spec ific  changes in  the GAG p ro files  (Kolsted et a l , 
1983), GAGS have been shown to be important as structu ra l and 
functional elements in  tissues (Hascall and Hascall, 1981) and as 
potent regulators of blood coagulation (Bjork and Lindahl, 1981; 
Marcum and Rosenberg, 1985). For these reasons, GAGS represent a 
useful way o f measuring an a lte ra tion  in  the d iffe re n tia tio n  of 
c e lls .
GAGS are polyanionic carbohydrates o f the ce ll surface, composed o f 
line a r high molecular weight polysaccharide chains, most often 
covalently bound to a core protein in  the matrix or on the ce ll 
surface. They form repeating disaccharide units which bear a strong 
negative charge, due largely to  varying degrees of sulphation and 
carboxylation. Common GAGS include hyaluronic acid, chondroitin 4- 
and 6-sulphate, keratan sulphate, dermatan sulphate, heparin and 
heparan sulphate. The b io logical function o f GAGS is  p a rtly  re lated 
to  th e ir  physicochemical properties, but they also play an 
important ro le  in  c e ll-c e ll and ce ll-substra te  in teractions 
(Rollins and Culp, 1979).
GAGS therefore have a wide varie ty o f specialised functions, but 
the most in te resting  with respect to  th is  study is  th e ir  a b i l i t y  to 
a lte r  when a ce ll becomes committed to a pa rticu la r pathway o f 
c e llu la r d iffe re n tia tio n . By measuring GAG synthesis, th is  should 
provide fu rthe r evidence as to  whether treatment with MOG-FDF/IV 
re a lly  does a lte r the phenotype of the c e lls .
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Plasminogen activa tors (PA's) are serine p ro teo ly tic  enzymes which 
catalyse the conversion o f b io lo g ica lly  inactive plasminogen to  
plasmin, the enzyme responsible fo r  dissolving f ib r in  (Dano e t al., 
1985). In addition to  i t s  ro le  in  f ib r in o ly s is , increased PA 
a c tiv ity  has been linked to  the expression o f the malignant 
phenotype, including tumorigenesis (Laung et al., 1975; Duffy and 
O'Grady, 1984), and an increased metastatic potential (Dano e t a l , 
1985). This corre la tion  is  fu rthe r supported by observations with 
fresh lung biopsies and lung ce ll lin e s , tha t most (although not 
a l l)  transformed ce lls  show an increased secretion o f PA a c t iv ity  
when compared with th e ir  corresponding non-transformed counterparts 
(Markus e t al_, 1980). The increased release of PA occurs whether 
the transformation is  accomplished by chemicals, oncogenic DNA or 
RNA viruses (Duffy and O'Grady, 1984; Camiolo and Greco, 1986), and 
Ossowski and Reich (1983) showed tha t an antibody raised against a 
PA from a human epidermoid carcinoma, HEp3, w h ils t unable to  
in h ib it  tumour growth at the s ite  o f the primary inocu la tion, could 
nevertheless prevent or strongly in h ib it ,  metastasis to  the 
embryonic lung. However, PA a c t iv ity  is  by no means unique to 
transformed c e lls , since i t  is  found in  nearly a ll animal tissues, 
p a rt ic u la r ily  where wound repa ir is  going on, and in  many body 
f 1ui ds.
I have shown in  an e a rlie r chapter tha t MOG-FDF/IV is  capable o f 
stim ulating pulmonary surfactant production in  A549 c e lls , so i f  
d iffe re n tia tio n  and malignancy are in te rre la te d , i t  may be capable 
o f reducing PA leve ls . Indeed, some o f the classica l
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d iffe re n tia tin g  agents have been shown to reduce PA a c t iv ity  e.g. 
sodium butyrate has been reported to  reduce PA a c tiv ity  in  glioma 
ce ll lines (Gross et al_, 1988), DMSO has s im ila r e ffects on the PA 
levels in human epidermoid carcinoma ce lls  (Ossowski and Bel in ,
1985) and dexamethasone and g lia l maturation fac to r, which enhance 
d iffe re n tia tio n  in glioma, repress PA (McLean et al^, 1986). 
Hence,if the ce lls  are becoming more d iffe re n tia te d , and therefore 
possibly less malignant, we might expect to  see a reduction in  PA 
leve ls .
A reduction in  suspension cloning is ,  l ik e  PA, a fu rthe r ind ica tion  
o f a reduction in  malignancy-associated properties. Transformed 
ce lls  read ily  form colonies in  suspension (MacPherson and 
Montaigner, 1964), unlike th e ir  normal counterparts. Hence, i f  a 
ce ll is  becoming more d iffe re n tia te d , and presumably less 
malignant, one might expect to  see a reduction in  clonogenicity in 
so ft agar.
Another parameter to  be considered is  the e ffe c t o f MOG-FDF/IV on 
ce ll growth. In Chapter 4, the e ffe c t o f conditioned medium on A549 
ce ll growth was examined, and although th e ir  was no apparent e ffe c t 
on ce ll growth, i t  is  important to  study the e ffe c t o f p u rifie d  
MOG-FDF/IV, since i t  has already been shown tha t i t  has a 
di ffe re n ti a ti ng e ffe c t.
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6.1 EFFECTS OF MOG-FDF/IV ON A549 CELL GROWTH
6.1.1 Effect on terminal cell density
Mid-log phase cultures of A549 growing in Nunclon 25cm  ^ flasks were 
exposed to various concentrations o f MOG-FDF/IV in  serum free 
medium fo r 3 days. At the end o f the incubation period, the ce lls  
were trypsinised and counted e le c tro n ica lly . As can be seen in 
Figure 31, treatment o f A549 with MOG-FDF/IV during log phase had 
no e ffec t on terminal ce ll density.
6.1 .2  Effects on 3H-thymid1ne Incorporation
A549 ce lls  were plated out at a concentration o f 105 ce lls/m l in  24 
well p lates. A fte r overnight incubation, the medium was removed and 
replaced with fresh medium containing MOG-FDF/IV (1.Ong-1Oug/ml) . 
DNA synthesis was assayed 24 hours la te r  with a pulse o f 3H- 
thymidine (0.5uCi/ml, 2uCi/mmol; Amersham) fo r 2 hours at 37°C. The 
ce lls  were then rinsed twice with ice cold PBS and lysed with 1N 
NaOH. The lysate was neutralised with 4N HC1 and the acid insoluble 
materials precip ita ted with 10% TCA (BDH).on ice . The p rec ip ita te  
was collected on a Mi H i pore f i l t e r  (0.45uM) and the ra d io a c tiv ity  
determined in  a liq u id  s c in t i l la t io n  counter (Packard). The 
resu lts , expressed as percentage o f untreated con tro l, are shown in  
Table 12 and although there was an apparent difference between DNA
FIGURE 31
Effect of MOG-FDF/IV on the terminal cell density of A549 in 
monolayer culture.
Log phase cultures o f A549 growing in 24 well plates were 
incubated with various concentrations MOG-FDF/IV as 
indicated in the te x t.
Each data point represents the mean of three separate 
experiments + SE.
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TABLE 12: EFFECT OF MOG-FDF/IV ON 3H-THYMIDINE INCORPORATION.
AMOUNT ADDED (ug/ml) cpm + SE (x10~4) % UNTREATED CONTROL
0 2.32 0.31 100
0.001 2.07 0.19 89
0.01 1.87 0.09 80
0.1 1.68 0.26 72
1.0 1.96 0.29 84
10 1.82 0.35 78
Each observation represents the mean o f four separate experiments 
SE.
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synthesis in treated and untreated ce lls , th is  was not 
s ta t is t ic a lly  s ig n ific a n t.
6.2 EFFECTS OF MOG-FDF/IV ON GAG SYNTHESIS
GAG synthesis was measured as fo llow s. A549 ce lls  were seeded at a 
concentration of 105 ce ll/m l in to  Nunclon 24 well plates and 
allowed to  plate down overnight. Cells were then incubated with 
various concentrations o f factor (0.001ug/ml-1Oug/ml), made up in  
serum free medium, fo r 48 hours. At the end o f the incubation 
period, the medium was aspirated and replaced with fresh cu lture  
medium containing 5uCi/ml, (1OOmCi/mmol) 3H-acetate (NEN) and 
incubated fo r a fu rthe r 24 hours. The medium and ce ll lysate were 
digested together with pronase E (Streptomyces griseus; Sigma) made 
up in  0.2M Tris-HCl, pH 7.8 (Sigma) at 55°C overnight containing 
12.5ug/ml o f hyaluronic acid and chondroitin sulphate (both Sigma) 
as cold ca rrie rs . The to ta l digest was precipated w ith 2% 
cetylpyridinium  chloride (CPC;Sigma) fo r 1 hour at 37°C and the 
resultan t GAGS collected on a membrane f i l t e r  (Mi H i pore; 0.45um) 
under vacuum. The f i l t e r s  were transferred to  s c in t i l la t io n  v ia ls  
fo r counting (Packard Liquid S c in t il la tio n  counter) and GAG 
synthesis expressed as percentage o f the untreated con tro l. The 
results  are shown in  Table 13 and there was an increase in  to ta l 
ce llu la r and secreted GAGS a fte r treatment with MOG-FDF/IV.
TABLE 13s EFFECT OF MOG-FDF/IV ON PRODUCTION OF GAGS IN A549.
AMOUNT ADDED (ug/ml) TOTAL GAGS (cpm + SE x 10-5 ) % UNTREATED
CONTROL
0 1.47 0.11 100
0.001 2.03* 0.07 137
0.01 2.04** 0.08 139
0.1 1.99* 0.13 135
1.0 1.60 0.15 108
10 1.45 0.12 98
* p < 0.05
**  p < 0.02
Each measurement represents the mean o f four observations + the SE.
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Data from sections 6,1,2 and 6.2 were p lotted on the same graphs to 
allow d ire c t comparison between DNA and GAG synthesis to  be made. 
This is  shown in Figure 32. I t  appears tha t GAG synthesis but not 
DNA synthesis can be altered by pretreatment o f the ce lls  with 
fa c to r, causing a r is e  in GAG synthesis with a non-s ign ificant 
reduction in  DNA synthesis. An increase in  GAG synthesis may be 
re lated to  c e llu la r  d iffe re n tia tio n .
i
6.3 EFFECT OF MOG-FDF/IV ON PLASMINOGEN ACTIVATOR ACTIVITY IN A549 
AND WIL
PA was measured according to  a modification o f the chromogenic 
assay developed by Whur e t al  ^ (1980). The assay is  a two step 
process resu lting  in  an ami d o -ly tic  reaction which releases para- 
n itro a n ilin e  from the synthetic chromogenic substrate, S-2251 (H-D- 
va ly l-L -leucy l-L -lys ine -pa ra -n itroan iline ) employed in  the assay. 
This is  cleaved by plasmin and PA is  measured as the plasminogen- 
dependent release o f pa ra -n itroan iline . A schematic representation 
of th is  is  shown in  Figure 33.
Cells were seeded at a density o f 5x104 cells/m l in to  Costar 6.5mm 
f i l t e r  wells and exposed to  1ug/ml o f MOG-FDF/IV in  serum free 
medium fo r 48 hours. The medium was then changed to  serum free , 
phenol red free (see section 6.3.1) overnight (the assay is  
co lo rim etric , so phenol red present in  normal cu ltu re  medium may 
in te rfe re ). This was aspirated, the ce ll monolayers were
FIGURE 32
Combined effect of MOG-FDF/IV on 3H-thymidine incorporation 
and GAG synthesis in A549 expressed as percentage of 
untreated control.
DNA synthesis was measured by 3H-thymidine incorporation and 
to ta l GAGS by 3H-acetate incorporation in to  CPC precipitates 
o f ce ll digests and medium and both observations converted 
to  percentage untreated control as described in  the te x t.
Each data point represents the mean of 4 separate 
experiments + SE
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washed twice with HBSS (phenol red fre e ), and then incubated with
0.5ml aliquots o f reaction mixture (see 6.3.1) fo r 2 hours at 37°C. 
The reaction was terminated by the addition o f 0.5ml o f 5% acetic 
acid (BDH), and the absorbance at 405nm was measured on a G ilfo rd  
spectrophotometer. PA in  plough units/ml was determined by means 
o f a standard curve, using urokinase as the standard,. Protein 
determination o f the ce ll monolayers was carried out using the 
Bradford protein assay (see Materials and Methods), and the fin a l 
resu lts  expressed as plough units/mg o f p rote in .
The resu lts  o f the PA assay are tabulated in  Table 14, and c lea rly  
show tha t treatment o f both A549 and WIL caused a s ig n ific a n t 
reduction on PA a c t iv ity  in  both these ce ll lin e s .
6.3.1 Appendix to  PA assay
( i )  phenol red free medium
HBSS (phenol red free; Flow) 95ml
Vitamins (Gibco) 1.0ml
MEM essential amino acids (Gibco) 2.0ml
Non-essential amino acids (Gibco) 1.0ml
Glutamine, 200mM (Gibco) 1.0ml
10% glucose (BDH) in HBSS 1.0ml
Sodium bicarbonate (Gibco) 1.1ml
1N NaOH -  enough to bring the pH to 7.4
TABLE 14: PLASMINOGEN ACTIVATOR ACTIVITY OF A549 AND WIL AFTER 
PRETREATMENT WITH MOG-FDF/IV.
CELL LINE PA ACTIVITY (PU/mg PROTEIN) % REDUCTION BY
MOG-FDF/IV
CONTROL + SE TREATED + SE
A549 4.73 0.49 1.53* 0.13 32
WIL 13.16 0.09 3.83** 0.21 29
* p < 0.02
**  p < 0.002
PU = Plough un its .
Each observation represents the mean o f three separate experiments 
+ SE.
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The solution was f i l t e r  s te r ilis e d  using a 0.22um R ill ex GV f i l t e r  
(low protein binding)
( i i )  reaction mixture (per 16mm w ell)
Plasminogen (5cu/ml in  HBSS; KabiVitrum) 100ul
6.4 EFFECT OF MOG-FDF/IV ON CLONING OF A549 CELLS
The clonogenicity of A549 both in  monolayer and in  so ft agar was 
compared. In h ib itio n  o f cloning in  monolayer would suggest a 
cytotoxic or a cy tos ta tic  e ffe c t (or both). While agar cloning 
would also measure th is , i t  is  supposedly transformation-dependent. 
Hence a disproportionate reduction in  agar cloning compared to  
monolayer cloning would imply reduced transformation.
6.4.1 Cloning in  monolayer
A549 ce lls  were pretreated with various concentrations o f ROG- 
FDF/IV (0.1ng-10ug/ml) fo r 48 hours and then cloned according to  
the protocol in  the Raterials and Rethods section.
The results are shown in Table 15 and i t  can be seen tha t there was
S-2251 (5mR in  HBSS; KabiVitrum) 
Poly-D-lysine (1.5mg/ml; Sigma) 
HBSS (phenol red free; Flow)
10Oul
250ul
50ul
TABLE 15: EFFECT OF MOG-FDF/IV ON CLONING IN MONOLAYER.
[FACTOR] (ug/ml) COLONY NUMBER + SE PLATING EFFICIENCY {%)
0.01 188.83 1.90 37.37
0.1 196.67 1.96 39.33
1.0 202.72 2.48 40.54
10.0 204.72 3.06 40.94
0 207.33 2.22 41.47
Each observation represents the mean o f three separate experiments 
+ SE.
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no s ig n ifica n t e ffe c t o f the factor on the clonongenic potentia l in 
monolayer, with an average p la ting  e ffic iency  o f 40% and a typ ica l 
colony number o f approximately 200 co lonies/petri dish in  both 
control and treated c e lls .
6.4.2 Cloning in  s o ft agar
Clonogenicity in  so ft agar was performed on A459 ce lls  which had 
been pretreated with e ither MOG-FDF/IV (1ug/ml), f ib ro b la s t 
conditioned medium or stero id treated fib ro b la s t conditioned medium 
fo r 48 hours. The resu lts  are shown in  Table 16 and a photograph of 
some typ ica l MTT stained clones is  shown in  Plate 10. A549 was able 
to  grow well in  semi sol id  agar, with a p la ting  e ffic iency  o f around 
33%, as measured by the number o f colonies containing more than 10 
c e lls . Treatment with conditioned medium (both with or without 
steroid pretreatment) had no e ffe c t on clonogenicity. However, 
pretreatment with MOG-FDF/IV caused a s ig n ifica n t reduction in  
colony number by some 30%.
TABLE 16: EFFECT OF MOG-FDF/IV ON SUSPENSION CLONING IN SOFT AGAR.
COLONY NUMBER PLATING EFFICIENCY
(Mean ^  SE) (%)
CONTROL 333 26 33
CONDITIONED MEDIUM 294 18 29
DX TREATED CM 313 16 31
MOG-FDF/IV {1ug/ml) 221* 16 22
*  p < 0.02
Abbreviations: DX dexamethasone
CM conditioned medium
Each value represents the mean o f three separate experiments + SE.
PLATE 10: TYPICAL SOFT AGAR CLONE AFTER STAINING WITH HTT.
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PART TWO: ASPECTS OF CHEMOSENSITIVITY
Tumour ce ll resistance to  cytotoxic drugs is  considered to  be one 
o f the major causes o f fa ilu re  o f c lin ic a l chemotherapy. This 
emergence o f resistance is  considered to  be the major cause of 
death in  lung, breast and ovarian cancers. C learly, strategies to 
circumvent resistance have to be developed. I t  has recently been 
proposed by Lotan and Nicholson (1988), th a t anti cancer therapy may 
be improved by the sequential use o f cytotoxic and d iffe re n tia tin g  
agents in  an e f fo r t  to  suppress tumour ce ll d ive rs ifica tio n .
In the f i r s t  part o f th is  Chapter, i t  was shown tha t pretreatment 
with MOG-FDF/IV could induce d iffe re n tia tio n  and suppress 
malignancy-associated properties in  A549. I t  was therefore o f 
in te res t to  see i f  pretreatment o f the ce lls  with MOG-FDF/IV could 
in  any way a lte r  the s e n s it iv ity  o f A549 to a commonly used 
cytotoxic drug, Adriamycin, since the combination of 
d iffe re n tia tio n  inducing agents and low doses of conventional 
cytoxic agents represents a p o s s ib ility  fo r  c lin ic a l application of 
d iffe re n tia tio n  therapy. The e fficacy o f th is  has been demonstrated 
by Kasukabe et a^ (1987), who showed tha t continuous treatment of 
myeloid leukaemia ce lls  with both d iffe re n tia tio n  inducers such as 
1 alpha, 25-dihydroxyvitamin D3 and anti-leukaemic drugs such as 1- 
beta-D-arabinofuranosylcytosine was more e ffec tive  therapeutica lly  
than treatment with a d iffe re n tia tio n  inducer alone both vn v it ro  
and i_n v ivo . The advantages o f such combinations may be maximal 
induction o f te rm ina lly d iffe ren tia ted  ce lls  and suppression o f
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drug res is tan t populations w h ils t lim it in g  the development of 
acquired resistance.
Adriamycin belongs to  the anthracycline group o f compounds and is  
an a n tib io tic  iso lated from cultures o f the fungus, Streptomyces 
peucetius. Adriamycin is  believed to in te rca la te  w ith DNA, 
inserting  i t s e l f  between the double he lica l strands o f the DNA 
molecule, where i t  e ffects DNA damage through in te raction  with type 
I I  DNA topoisomerases, inducing double strand breakages. However, 
there is  evidence to suggest tha t the drug can also be active ly  
cytotoxic without entering the c e lls , by in teraction  at the ce ll 
surface (T ritton  and Yee, 1982). The cytotoxic e ffects  o f 
Adriamycin are maximal during S phase o f the ce ll cycle, but there 
is  some a c t iv ity  during other phases o f the cycle as well.
Treatment o f A549 with M06-FDF/IV has been shown to  a lte r  the 
phenotype and repress malignancy-asociated properties in  th is  ce ll 
l in e . A more d iffe re n tia ted  ce ll may show greater s e n s it iv ity  to  
cytotoxic drugs. Experiments were devised to  examine a lte ra tions in  
chemosensitivity associated with phenotypic change.
6.5 EFFECTS OF PRETREATMENT WITH MOG-FDF/IV ON CHEMOSENSITIVITY OF 
A549 TO ADRIAMYCIN.
The chemosensitivity assay was performed using an adaptatation o f 
the MTT assay (Mossman, 1983), as modified by Plumb e t al  ^ (1989).
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Cells were seeded Into 96 well m ic ro titre  plates (Flow 
Laboratories) at a concentration o f 5x108 cells/m l and le f t  in  a 
378C incubator fo r 48 hours. The medium was removed and the ce lls  
treated with 1ug/ml of MOG-FDF/IV in  serum free medium fo r 24
hours. Parallel cultures as controls were set up and they received
serum free medium only. Following exposure to MOG-FDF/IV, the ce lls  
were refed with fresh cu lture medium containing 10% FCS and 
Adriamycin (10“ ^M-10"^M) fo r a fu rthe r 24 hours. For the next 3 
days the ce lls  were fed da ily  with fresh, drug free , medium and on 
the fourth day a fte r drug treatment, the MTT assay was performed. 
Cells were refed with 200ul o f cu lture  medium containing 10mM HEPES 
buffer (Gibco). 50ul o f a stock solution o f MTT (5mg/ml; Sigma) was 
added to each w e ll, and the plates incubated in  the dark a t 37°C
fo r 4 hours. The medium was then removed from the wells and the
water insoluble purple formazan crysta ls  dissolved in  200ul o f DMSO 
(BDH) per w e ll. 25ul o f Sorenson's glycine buffer (see mitogenesis 
assay) was added to  each well and the plates read in  an ELISA plate 
reader (BioRad, model 2550) at an absorbance o f 570nm.
A graph of the resu lts  is  shown in  Figure 34a,b, and shows tha t 
pretreatment o f the ce lls  with MOG-FDF/IV had no e ffe c t on the ID^q 
o f A549 to Adriamycin. Control cultures had an ID50 o f 1.0 x 10"8M 
and pretreated ce lls  had the same ID^q.
FIGURE 34a
Chemosensitivity o f A549 to  Adriamycin in  v i t r o .
The chemosensitivity o f A549 to  Adriamycin was determined 
using the MTT assay as outlined in  the te x t.
n = 3 + SE 
FIGURE 34b
E ffect o f p re-trea ting  A549 w ith MOG-FDF/IV on the 
chemosensitivity o f A549 to  Adriamycin in  v i t r o .
A549 ce lls  growing in  96-well plates were pre-treated with 
MOG-FDF/IV and th e ir  chemosensitivity to  Adriamycin measured 
using the MTT assay as described in  the te x t.
n = 3 + SE
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6.6 CHEMOSENSITIVITY OF A549 CELLS AFTER CULTURE UNDER MAXIMUM 
INDUCING CONDITIONS
The optimal conditions fo r cu lture o f A549 ce lls  fo r induction o f 
pulmonary surfactant synthesis has been shown to  be a f i l t e r  w e ll, 
where increased synthesis o f pulmonary surfactant was observed when 
the ce lls  were treated with a soluble mediator(s) p u rifie d  from 
dexamethasone-treated fibroblast-conditioned medium. I f  phenotypic 
change is  re lated to  chemosensitivity, then the optimal conditions
fo r d iffe re n tia tio n , may cause an a lte ra tion  in  the
chemosensitivity o f the ce lls  to  Adriamycin. Under these optimal 
conditions, the chemosensitivity o f A549 was investigated.
A549 ce lls  were grown to  log phase in  Costar 24.5mm f i l t e r  wells
(see Materials and Methods) in  the presence or absence o f a
confluent monolayer o f fib rob lasts  growing on the bottom o f the 
dish which housed the f i l t e r  w e ll. The ce lls  were e ithe r exposed to  
adriamycin (doxorubicin; 0.01-10uM) fo r 24 hours, or 0.25uM 
dexamethasone fo r 48 hours, or a combination o f both, with 
adriamycin added in  the second 24 hour period. A fte r Adriamycin 
exposure, the ce lls  were trypsinised and cloned in  monolayer a t a 
concentration o f 100 ce lls /m l, according to  the protocol described 
in  the Materials and Methods section. The results  are shown in  
Tables 17a,b and Figure 35.
The e ffe c t o f Adriamycin, with and without dexamethasone, on the 
clonogenicity of A549 exposed in  f i l t e r  wells was measured as a
TABLE 17a: EFFECT OF TREATMENT WITH ADRIAMYCIN + DEXAMETHASONE IN 
FILTER WELLS ON THE CLONOGENICITY OF A549 IN MONOLAYER.
[ADR] (uM) COLONY NUMBER + SE PLATING EFFICIENCY
+DX -DX +DX -DX
0 208 2 250 3 41 50
0.001 278 4 283 1 55 56
0.01 291 4 273 3 58 54
0.1 316 3 245 1 63 49
1.0 147 6 160 2 29 32
10 0 0 0 0 0 0
TABLE 17b: EFFECT OF TREATMENT WITH ADRIAMYCIN + DEXAMETHSONE IN 
FILTER WELLS IN THE PRESENCE OF LF IfJ  ON THE 
CLONOGENICITY OF A549 IN MONOLAYER.
[ADR] (uM) COLONY NUMBER + SE PLATING EFFICIENCY
+DX -DX +DX -DX
0 333 3 298 1 66 59
0.001 316 3 252 1 63 50
0.01 325 2 284 2 65 57
0.1 344 4 242 4 68 48
1.0 123 7 169 6 24 34
10 2 0.5 0 0 0.004 0
Each observation represents the mean o f three separate experiments 
+ SE •
FIGURE 35: A549 SURVIVING FRACTION AFTER EXPOSURE TO 
DEXAMETHASONE AND ADRIAMYCIN.
Figure 35a: Control surviving frac tion
Figure 35b: Surviving fra c tio n  a fte r drug exposure in  the 
presence o f fib rob las ts
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simple assay fo r c y to to x ic ity . Low concentrations o f Adriamycin 
(<0.1uM) caused an increase in  the p la ting e ffic iency  o f A549, 
while concentrations exceeding 0.1uM were cy to tox ic . In the 
presence o f dexamethasone, the e ffe c t was s im ila r, although the 
overall stim ulation in  p la ting  e ffic iency  was even greater.
The ID5o!s were sh ifted  s lig h t ly ;  in  the absence o f s te ro id , the 
ID5q was 1.55uM, while in  the presence o f s tero id , i t  was 1.75uM. 
On the addition o f fib rob las ts , the mitogenic e ffe c t o f Adriamycin 
was abolished, both in  the presence and absence o f s tero id , 
although ove ra ll, the p la ting  e ffic ienc ies  were higher, 
p a r t ic u la r ily  a fte r stero id treatment. This was re flected  in  a 
corresponding s h if t  in  ID5q from 1.35uM to  1.0uM with the drug 
combinations. These resu lts  are summarised in  Table 18.
TABLE 18 SUMMARY OF ID50'S AFTER DIFFERENT DRUG TREATMENTS
CULTURE CONDITIONS ID50 (uM) ADRIAMYCIN
DEXAMETHASONE(uM) 0 0.25
A549 ALONE 1.55 1.75
A549 + FIBROBLASTS 1.35 1.0
In the presence o f fib rob la s ts , the ID50 value was reduced a fte r
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each treatment regime, although th is  was not s ta t is t ic a lly  
s ig n ifica n t.
DISCUSSION
The main aim o f th is  Chapter was to  examine the e ffects o f M0G- 
FDF/IV on other phenotypic markers, namely, DNA and GAG synthesis, 
PA a c t iv ity  and clonogenicity in  suspension. As well as the 
phenotypic markers, the chemosensitivity o f A549 to  a cytotoxic 
drug, Adriamycin, was investigated, to  see i f  there was any 
a lte ra tion  in  the chemosensitivity asociated with phenotypic 
change.
I t  was o f in te re s t tha t MOG-FDF/IV increased the to ta l GAG 
synthesis in  A549 c e lls . This observation concurs with the findings 
of Shirasuna e t al^  (1988), who showed tha t incubation o f a sa livary 
adenocarcinoma ce ll lin e  with fib ro b la s t conditioned medium could 
increase GAG synthesis. Moreover, they presented evidence which 
suggested tha t a soluble factor from the conditioned medium was 
responsible. However, lik e  Shirasuna1s data (1988), the experiments 
here looked at gross changes in  to ta l GAGS synthesis, and without 
knowing exactly which GAGS were involved, the GAGS data are 
d i f f ic u l t  to  in te rp re t.
Although there was an apparent reduction in  3H-thymidine 
incorporation a fte r incubation with MOG-FDF/IV, th is  observation
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was not s ta t is t ic a l ly  s ig n ifica n t. Shirasuna e t (1988) have 
reported an inverse corre la tion between DNA and GAG synthesis 
fo llow ing treatment o f a human sa livary adenocarcinoma ce ll lin e  
with fib ro b la s t conditioned medium, with a reduction in  DNA 
synthesis and an increase in  GAG synthesis. With certa in  
reservations, the data presented here could agree with tha t o f 
Shirasuna et aK However, by d ire c t ce ll counting, the terminal 
ce ll density o f A549 was unaffected by treatment with MOG-FDF/IV 
suggesting there was no e ffe c t on ce ll growth.
Treatment o f A549 and a lung adenocarcinoma, WIL, with MOG-FDF/IV 
resulted in  a s ig n ifica n t reduction in  PA levels in  both ce ll 
lin e s . This suggests tha t the MOG-FDF/IV was capable o f reducing PA 
a c t iv ity  in  both these ce ll lines and agrees with observations made 
by several groups tha t hormones or hormone-like substances can 
a lte r  the secretion of PA's (Mira-y-Lopez e t al_, 1983; Ossowski and 
Bel in , 1985; Gross et al_, 1988). Increased PA levels have been 
correlated with the malignant phenotype in  a number o f experimental 
systems, although the expression o f PA is  by no means unique to  
tumour ce lls  (Duffy and 0*Grady. 1984; Camiolo and Greco, 1985). I t
is  in teresting  to speculate tha t there may be an inverse
re la tionsh ip  between maliganancy-associated properties i . e .  PA 
expression and the induction o f a more d iffe ren tia ted  phenotype, 
since treatment of A549 ce lls  with MOG-FDF/IV not only reduced
absolute PA leve ls , but also increased the synthesis o f pulmonary
surfactant and to ta l GAGS. The p o s s ib ility  o f such a re la tionsh ip  
agrees with the findings of Frame e t <i\m (1984), who showed th a t in
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a panel o f early passage glioma ce ll lin es , less well 
d iffe ren tia ted  ce ll lines expressed high PA leve ls , with a 
decrease in PA expression in  ce ll lines displaying a more 
d iffe ren tia ted  phenotype.
Of the three members o f the PA group o f enzymes (c ircu la tin g  PA 
found in the blood, tissue PA (tPA) and urokinase-like PA (uPA), 
the PA most commonly associated with tumour ce lls  is  uPA. This has 
been proven using studies with monoclonal antibodies. 90% o f the PA 
expressed in  human lung tumours is  uPA, compared to  only 50% in
normal tissues (Markus e t al ,^ 1980). The same is  true o f breast,
although the difference is  less, where 80% o f the PA is  uPA in 
tumours, and only 62% in  normal breast (Evers e t al^, 1982). In 
retrospect, measurement o f uPA may have given a better ind ica tion  
o f exactly which PA was involved.
Clonogenicity in  so ft agar was reduced by about 30% without any 
effects in  monolayer, suggesting a spec ific  growth in h ib it io n  in  
suspension. This is  in  lin e  with the observations of Shirasuna e t 
al_ (1988), who noticed a marked reduction, not only in  colony
number, but also in  colony size when a sa livary adenocarcinoma ce ll 
lin e  was treated with WI-38 conditioned medium.
These phenotypic measurements imply th a t the e ffe c t o f MOG-FDF/IV 
was not solely on pulmonary surfactant synthesis, but tha t a 
coordinated phenotypic e ffe c t was occurring. As surfactant
synthesis is  a s ig n ifica n t marker o f d iffe re n tia tio n  in  th is  ce ll
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l in e , and GAG synthesis a fu rthe r d iffe re n tia tio n  marker and 
reduced suspension cloning, coupled with a concomitant reduction in 
PA are ind ica tive  o f a reduction in  malignancy associated 
properties, i t  would appear tha t MOG-FDF/IV may be a lte rin g  the 
phenotype o f A549 to  a less malignant and more d iffe re n tia ted  form 
(See also Chapter 7).
In addition to  the phenotypic markers ju s t described, the e ffects 
o f MOG-FDF/IV on A549 chemosensitivity were also examined. There 
was no s ig n ifica n t difference between the ID50 o f A549 to 
Adriamycin, as measured by MTT reduction, with or without 
pretreatment with MOG-FDF/IV. As is  the case fo r most non-small 
ce ll lung carcinomas, A549 is  fa ir ly  res is tan t to  cytotoxic drugs, 
so i t  may not have been the best ce ll lin e  to  have chosen i f  an 
increase in  resistance was expected. I t  should, however, have shown 
any increased s e n s it iv ity . The s lig h t increase shown in  the 
presence o f fib rob las ts  and dexamethasone, though not s ig n ific a n t, 
is  in  agreement with previous unpublished data from th is  
laboratory, lin k in g  increased pulmonary surfactant synthesis with 
Adriamycin s e n s it iv ity  (McCormick and Freshney, unpublished 
observations).
The e ffe c t o f combined treatment with Adriamycin and dexamethasone 
on the clonogenicity o f A549 pre-exposed to  the drugs on f i l t e r  
w ells, was also studied, since cu lture  o f A549 on f i l t e r  wells 
appeared to  cause maximal stim ulation o f the ce lls  to  produce 
pulmonary surfactant. With Adriamycin alone, there was an increase
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In p la ting e ffic iency  and a growth stim ulation (a la rger colony 
size) at subtoxic drug concentrations (> 0.1uM). The a b il i ty  o f 
adriamycin to  stimulate growth o f a varie ty o f ce ll types a t low 
t i t r e s  is  not an uncommon event, and has been reported sporadically 
in  the lite ra tu re  over the years, most recently by Vi chi and 
T ritto n  (1989).
Relative to  control values, dexamethasone alone reduced the 
surviving frac tion  by some 20%, with a corresponding reduction in 
p la ting  e ffic ie ncy . This observation is  not surpris ing, bearing in  
mind tha t in  a previous chapter o f th is  thesis, dexamethasone was 
shown to  have a cy tos ta tic  e ffe c t on A549.
When dexamethasone was combined with various concentrations of 
Adriamycin, overall there was an enhanced clonal growth at subtoxic 
concentrations (>0.1uM), suggesting tha t differences in
chemosensitivity were not due to  altered ce ll p ro life ra tio n . This 
is  in  agreement with observations by McCormick and Freshney (1987), 
who showed tha t A549 cloned in  the presence and absence o f 
dexamethasone showed increased s e n s it iv ity  to  Adriamycin a t high 
steroid concentrations, but greater resistance a t high low stero id  
concentrations. Both concentrations could, however, enhance clonal 
growth.
On the addition o f fib rob lasts  t ra n s f i l te r ,  low concentrations o f 
Adriamycin again had a growth stim ulatory e ffe c t, and in  general 
the stim ulation was of a s im ila r order o f magnitude as observed
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with A549 cultured under the same conditions but in  the absence of 
fib rob la s ts . Dexamethasone, however, was stim ulatory, increasing 
the surviving frac tion  by about 10% in  the presence o f LF113. 
S im ila r ily , Adriamycin plus dexamethasone increased the surviving 
frac tion  by 20-30%, in  the subtoxic range. In previous Chapters, 
dexamethasone was shown to be stim ulatory fo r the growth o f LF113 
c e lls , as well as causing the production o f M06-FDF/IV. So, while 
MOG-FDF/IV had a d iffe re n tia tin g  function on A549, i t  appears to  be 
making the ce lls  more res is tan t by increasing the clonal ce ll 
growth. However, without knowing exactly what e ffe c t the Adriamycin 
was having on the fib rob las ts , the resu lts  o f the coculture 
experiments are d i f f ic u l t  to  in te rp re t. I t  appears, though, tha t 
Adriamycin chemosensitivity was not altered s ig n if ic a n tly , e ither 
by the presence of MOG-FDF/IV or by a lte ring  the cu lture  
conditions.
From the results  presented here, i t  appears tha t MOG-FDF/IV can 
a lte r phenotypic markers other than pulmonary surfactant, 
confirming tha t the ce lls  were becoming more d iffe re n tia te d  and 
less malignant. However, there did not appear to  be any major 
a lte ra tion  in  A549 chemosensitivity to  Adriamycin.
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CHAPTER SEVEN 
STUDIES IN VIVO
I f  MOG-FDF/IV was causing a coordinated s h if t  from malignancy to 
d iffe re n tia tio n , a decrease in  tumour growth vn vivo might be 
expected. This Chapter w il l  describe experiments on tumours 
generated as xenografts in  nude mice to  examine th is  question.
The design of a ll the experiments in  th is  Chapter and the analysis 
o f resu lts  were carried out by myself. HoWever due to my a lle rg ic  
response to  the animals, the experimental techniques were carried 
out by Mr Tom Hamilton and Dr Dim Cassidy. Processing and sta in ing 
o f xenograft sections was carried out by Mr Tony Savage, Glaxo 
Group Research, Greenford, Middx.
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INTRODUCTION
Another aspect concerning the b io log ica l e ffects o f MOG-FDF/IV was 
i t s  e ffects rn v ivo. I t  has already been shown tha t i t  could act 
as a d iffe re n tia tin g  inducer fo r A549 ini v i t r o . Does i t  f u l f i l  a 
si mi 1ar ro le  vn vivo?
With few exceptions, most animal tumours only grow in  the 
syngeneic host. Heterotransplantation only works in a priv ileged 
s ite  or in  an immune-deficient host. Human tumours can be grown in 
vivo using immunodeficient "nude mice". These mice are genetica lly 
athymic and lack T lymphocytes although B lymphocytes are s t i l l  
present. Because they are T ce ll de fic ie n t, nude mice are usually 
maintained under s te r ile  conditions to  minimise the r is k  of 
in fection  from external sources.
One of the problems associated with growing tumours in  a non- 
syngeneic host is  knowing whether or not the xenograft s t i l l  
reta ins the characteris tics o f the tumour from which i t  was 
derived. This has been investigated by Shorthouse et al (1980) who 
showed tha t histology and chromosome analysis o f the xenografts 
indicated tha t the characteristics o f the o rig ina l tumour were 
maintained in  the xenografts. A fu rthe r problem is  co rre la ting  the 
in  vivo and i_n v it ro  response, and th is  is  p a rt ic u la r ily  important 
when dealing with chemotherapeutic compounds. In many cases, the 
chemotherapeutic response of xenografts shows a pos itive
148
corre la tion with the response o f the patient (Shorthouse et al_ 
1980).
A corre la tion between in  vivo and J_n v itro  responses has been 
shown with a number o f putative d iffe re n tia tin g  agents. Steroid 
hormones, which have been demonstrated to  have a n tip ro life ra tiv e  
e ffects against several d iffe re n t tumour ce ll lines in  v i t r o , have 
s im ila r such e ffects in  v ivo . Dexamethasone was cy tos ta tic  towards 
a human NSCLC ce ll lin e  in  v i t r o , and when grown as a xenograft, 
treatment o f the hosts with the stero id caused to ta l cessation of 
xenograft growth (McLean e t al_, 1986). Polar solvents such as NMF 
and DMF can a lte r  the growth characterstics o f human colon cancer 
ce ll lines i j i  v i t r o , with an increase in  population doubling 
times, a decrease in  saturation density, and a loss of 
clonogenicity in  so ft agar (Dexter e t al ,^ 1979). This correlates 
well with the vn vivo response where both DMF and i t s  metabolite,
NMF inh ib ited  the growth o f two colon carcinomas xenografted in
nude mice (Dexter e t al_, 1982).
In v i t r o , treatment of A549 ce lls  with MOG-FDF/IV has been shown
to  cause a s h if t  to  a more d iffe re n tia te d  phenotype, and a 
resultan t loss o f malignancy-associated properties. This Chapter 
w il l  examine whether or not th is  applies in  v ivo .
Another parameter investigated was ta rge t ce ll s p e c if ic ity , since 
most of the previous experiments had dealt almost exclusively w ith
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A549. To determine whether MOG-FDF/IV was spec ific  to  A549, three 
other xenografts, o f lung and non-lung o rig in  were also examined.
7.1 EFFECT ON A549
A549 xenografts were prepared as described in  the Materials and 
Methods section. Four groups o f mice were used, and each contained 
at least f iv e  animals. Group one (controls) received da ily  
in traperitoneal ( i.p )  in jections o f 5ul/g body weight o f PBS. 
Group two received i .p .  in jections of dexamethasone (100ng/g), 
since i t  has been shown previously tha t dexamethasone could 
induce, d ire c tly , pulmonary surfactant production in  A549. Group 
three received MOG-FDF/IV (50ng/g) i . p . ,  and group four received
i.p .  in jections o f both dexamethasone and MOG-FDF/IV. Each group 
were treated da ily  fo r 12 out o f 14 days (excluding the weekend). 
Tumour volumes were estimated using double ca liper measurements 
three times weekly and converted in to  mm3 (on the assumption tha t 
the tumour was e l l ip t ic a l in section) using the follow ing formula 
(Fergusson e t al ,^ 1986):
TUMOUR VOLUME (mm3) =D d2 p i/6
Where D = larger diameter 
d = smaller diameter
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At the end o f the experiment, the tumours were excised and 
processed fo r l ig h t  microscopy as described in  the Materials and 
Methods.
There was a s tr ik in g  difference in  both the re la tive  sizes (i_n 
vivo and fresh ly excised), and the overall appearance o f the 
fresh ly excised tumours (Plates 11-12), with the controls showing 
evidence of vascularisation, while the MOG-FDF/IV treated 
xenografts had a whitish appearance with no evidence o f surface 
blood vessels.
H is to log ica lly , the control group contained many viable tumour 
c e lls , with l i t t l e  evidence o f s tructure . There were some stromal 
elements, and signs o f vascularisation (Plate 13a). The 
dexamethasone treated group showed areas o f necrosis. (Plate 13b). 
The most in te resting  observation was seen in  group three which 
received MOG-FDF/IV (Plate 13c). There was a s tr ik in g  difference 
in  the tumour histo logy, with evidence of extensive s tructura l 
reorganisation, with stromal in f i l t r a t io n  and signs o f glandular- 
l ik e  or duct-like  formation, and the appearance o f columnar 
epithelium. This is  shown in  greater de ta il in  Plate 13e. There 
were very few ( i f  any) blood vessels and small pockets o f 
necrosis. In group 4 (both MOG-FDF/IV and dexamethasone), the 
histology was intermediate to  groups two and three (Plate 13d).
While the control xenografts continued to  increase in  volume 
throughout the course o f the experiment, the tumour volumes o f a ll
PLATE 11: NUDE MICE BEARING A549 XENOGRAFTS.
Arrow represents s ite  o f implantation.
Plate 11a: Control mouse approximately one month a fte r f i r s t  implantation.
Plate 11b: Mouse pretreated with MOG-FDF/IV.
One month post im plantation, 12 in jec tions o f MOG-FDF/IV during
1cm
I 1
^
PLATE 12: GROSS MORPHOLOGICAL APPEARANCE OF EXCISED A549 XENOGRAFTS.
C = control 
D = dexamethasone 
B = dexamethasone and MOG-FDF/IV 
F = MOG-FDF/IV
1cm
PLATE 13: HISTOLOGICAL APPEARANCE OF A549 XENOGRAFTS
H & E stain
Plate 13a Control xenograft, one month a fte r f i r s t  implantation.
Plate 13b Dexamethasone treated xenograft, one month post-implantation,
12 days out o f the la s t 14 with 100ng/g MOG-FDF/IV i .p .
Plate 13c MOG-FDF/IV treated xenograft, one month post-implantation, 
12 days out o f the la s t 14 with 50ng/g MOG-FDF/IV.
mm,
Plate 13d: H istological appearance o f dexamethasone and MOG-FDF/IV 
treated A549 xenografts (treatment as 13b and c 
combined).
Plate 13e: Higher power photomicrograph o f 13c showing columnar 
epithelium surrounding a "duc t-like " structure .
l a  v t ^ v ^ v *  :••
FIGURE 36
Effect of I .p .  administration of dexamethasone on the growth 
of A549 xenografts In nude mice.
Mice were treated with dexamethasone, i .p .  three times 
weekly and the tumour volumes estimated as described in  the 
Materials and Methods. Tumour status as Plate 13.
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FIGURE 37
Effect of i .p .  administration of MOG-FDF/IV on the growth of
A549 xenografts in nude mice.
Mice received i .p .  in jec tions o f MOG-FDF/IV three times 
weekly and the tumour volumes were determined using double 
ca liper measurements, as outlined in  the te x t. The tumour 
status was as described in  Plate 13.
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FIGURE 38
Effect of simultaneous i .p .  administration of MOG-FDF/IV and
dexamethasone on the in vivo growth of A549 xenografts.
Nude mice bearing A549 xenografts (status as Plate 13) 
received i .p .  in jections o f both MOG-FDF/IV and 
dexamethasone 3 times weekly as described in  the te x t. 
Tumour volumes were measured by double ca liper measurements.
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three treated groups indicated s ig n ifica n t in h ib itio n  o f growth. 
This is  shown in  Figures 36-38.
7.2 EFFECT ON LT-34
LT-34 is  an early passage NSCLC derived from a lymph node 
metastasis grown as a xenograft in  nude mice and then cultured i j i  
v i t r o . Xenografts were established as previously described in  the 
Materials and Methods, but only two experimental groups were used 
and they received e ithe r PBS or M06-FDF/IV (dosage and treatment 
regimes as 7 .1 ). No h isto log ica l examination was carried out.
As can be seen in  Figure 39, treatment with MOG-FDF/IV appeared to  
reduce the tumour volume during the course o f the experiment, 
although th is  reduction was not s ta t is t ic a lly  s ig n ifica n t.
7.3 EFFECT ON A2780 OVARIAN CARCINOMA
Xenografts were established as previously described, but since the 
tumour was o f ovarian o rig in , female BALB/c mice were used. There 
were two experimental groups, a control group and a group which 
received MOG-FDF/IV (dosage and treatment regimes as 7 .1 ). At the 
end of the experiment, both sets o f tumours were excised and 
processed fo r l ig h t  microscopy.
FIGURE 39
Effect of i .p .  administration o f MOG-FDF/IV on the growth of
LT-34 xenografts in nude mice.
Nude mice bearing LT-34 xenografts (approximately three 
weeks post-im plantation), were treated with MOG-FDF/IV fo r 
12 out o f 14 days and the tumour vol umes determi ned by 
double ca liper measurements.
n = 2 + SE
(3-
ot 
x 
e
uiui) 
a
w
m
o
A
 
u
n
o
w
n
x
4
3
2
1
0
20 8 104 6
DAYS
o CONTROL 
• + MOG-FDF/IV
152
As can be seen from Figure 40, MOG-FDF/IV had no e ffe c t on the 
growth o f A2780 xenografts. S im ila r ily , there was no evidence o f 
s tructura l reorganisation at the h is to log ica l level (Plate 15),
with both controls and treated tumours containing densely packed 
ce lls  with evidence o f blood vessels and granulocytes.
7.4 EFFECT ON H69V
H69V is  a SCLC which grows as a monolayer, and was derived in  th is  
laboratory from the parental l in e , NCI-H69, which is  a classic 
SCLC. Xenografts were established as described in  the Materials 
and Methods, and the two experimental groups (control and MOG-
FDF/IV) received the same dose and treatment regimes as 7.1. The 
xenografts were examined h is to lo g ica lly  a t the end o f the
treatment.
MOG-FDF/IV appeared to  in h ib it  growth in  H69V xenografts, but
sample number was low, and variance too high to  make the 
differences s ta t is t ic a l ly  s ig n ifica n t (Figure 41). There was some 
evidence o f stromal in f i l t r a t io n  in  the treated group (Plate 16), 
and some structura l reorganisation, although much less than tha t 
observed in  the A549 xenografts treated with MOG-FDF/IV.
FIGURE 40
Effect of i .p .  administration of MOG-FDF/IV on the growth of
A2780 xenografts.
Female BALB/c nude mice bearing A2780 xenografts (status as 
Plate 13) were treated with MOG-FDF/IV as described in  the 
Materials and Methods fo r 12 out o f 14 days, and the tumour 
volumes estimated by double ca liper measurements.
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PLATE 14: HISTOLOGICAL APPEARANCE OF CONTROL AND TREATED A2780 
XENOGRAFTS.
H & E s ta in .
Plate 14a: Control xenograft, one month post-im plantation.
Plate 14b: MOG-FDF/IV treated xenograft (treatment as Plate 13).

FIGURE 41
Effect of MOG-FDF/IV on the growth of H69V as xenografts.
Mice received a da ily  i . p .  in je c tio n  of MOG-FDF/IV, and 
tumour volume was estimated every 2 days as described in  the 
te x t.
Each data point represents the mean o f two observations + 
SE.
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PLATE 15: HISTOLOGICAL APPEARANCE OF H69V XENOGRAFTS.
H & E s ta in .
Plate 15a: Control xenografts, one month post-im plantation.
Plate 15b: MOG-FDF/IV treated xenografts (treatment as Plate
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DISCUSSION
This Chapter set out to  examine the e ffects o f M06-FDF/IV on the 
in  vivo response o f A549, to  see i f  there was any corre la tion  with 
the reponses j_n v i t r o . To assess ta rge t ce ll s p e c if ic ity , three 
other xenografts were examined in  p a ra lle l.
A fte r treatment with MOG-FDF/IV, fresh ly  excised A549 xenografts 
had quite d iffe re n t gross morphology from the PBS contro ls . The 
control group displayed evidence of extensive vascularisation 
w h ils t the xenografts treated with MOG-FDF/IV had a d is t in c t ly  
whitish appearance with no surface evidence o f vascularisation. 
The dexamethasone treated group and the group receiving both MOG- 
FDF/IV and dexamethasone, although having a reduced size compared 
to  contro ls, s t i l l  showed surface c a p illa r ie s . This is  somewhat 
surpris ing, since i t  is  believed tha t one jm vivo action of 
dexamethasone is  to  a ffe c t vascular functions in  diseased tissues 
and Braunschweiger and Schiffer (1986), have shown th is  to  be 
precisely the case with xenografts of RIF-1 tumours growing in 
nude mice. However, the gross difference observed here was in 
surface vasculature, which is  systemic rather than tumour. The 
data showed tha t tumour growth was severely cu rta iled  and necrosis 
was evident, in  agreement with vascular collapse reported by 
Braunschweiger and Sch iffer (1986). From these observations, i t  is  
possible tha t MOG-FDF/IV is  acting on the tumour vasculature, 
and, given tha t the complete id e n tity  o f MOG-FDF/IV is  not yet
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known, then i t  could be acting on the vascular endothelial ce lls , 
perhaps by making the tumour less angiogenic.
MOG-FDF/IV could in h ib it  the growth o f A549 xenografts. This was 
s ig n ifica n t with a p value o f < 0.01. MOG-FDF/IV was administered 
as an i .p .  in je c tio n , so to  reach the xenograft, where, presumably 
i t  was having i ts  e ffe c t, i t  would have to  get in to  the host 
c ircu la tio n . In a previous Chapter, an attempt was made to 
id e n tify  MOG-FDF/IV, and although i t  was c lea rly  heterogeneous, 
from SDS-PAGE analysis, i t  appeared tha t the molecular weight was 
probably not smaller than 10kDa, because o f d ia ly s is . I f  th is  is  
the case, is  d i f f ic u l t  to  imagine how such large molecules could 
pass through the peritoneal cavity and in to  the bloodstream. 
Certainly there is  a lo t  o f p ro teo ly tic  a c t iv ity  associated with 
the peritoneal cav ity , so i t  is  possible tha t MOG-FDF/IV is  being 
degraded in to  a smaller and more manageable form by the peritoneal 
enzymes w h ils t s t i l l  re ta in ing  b io log ica l a c t iv ity .  In a smaller 
form, i t  may be able to  pass in to  the bloodstream more read ily , 
thus becoming more accesible to  the tumour. Previous experiments 
showed tha t MOG-FDF/IV was only 50% protease la b ile ; the remaining 
a c t iv ity  may be small enough to enter the vascular system. In th is  
respect, an important experiment to  carry out would be to  tre a t 
the mice with i . v .  rather than i .p .  in jections o f MOG-FDF/IV. This 
should prove whether or not peritoneal enzymatic a c t iv ity  was 
necessary to  allow MOG-FDF/IV to  reach the correct s ite .
1 5 5
As well as reducing xenograft growth, treatment with MOG-FDF/IV 
resulted in  extensive structura l reorganisation w ith in  the 
xenograft i t s e l f ,  with evidence o f stromal in f i l t r a t io n .  I t  has 
been reported tha t untreated NSCLC tumours contain prominent 
fibrous stroma when grown as xenografts in  nude mice (Bergh, 
1988). However, the apparent lack o f stromal elements in  both the 
control and the dexamethasone treated xenografts implied th a t MOG- 
FDF/IV was responsible fo r stromal in f i l t r a t io n .  Given th a t MOG- 
FDF/IV orig inates from stromal c e lls , i t  is  in te res ting  to 
speculate tha t i t  may be re c ru itin g  host stromal ce lls  in to  the 
xenograft, perhaps in  an attempt to  iso la te  the xenograft and 
prevent i t  from undergoing metastasis. In a human basal ce ll 
carcinoma, a fte r growing as xenografts in  nude mice fo r  between 
two and five  months, 15/17 contained d iffe ren tia ted  epithelium 
with morphologically recognisable stroma (Stamp et al., 1988).
The formation of g landu lar-like  structures and the appearance of 
ductal epithelium in the MOG-FDF/IV treated xenografts would seem 
to  point to  a more d iffe ren tia ted  phenotype. Such a claim has been 
reported recently by Hatekeyama and colleagues (1988), who looked 
at the e ffec t o f subcutaneous administration o f dexamethasone four 
times weekly fo r e ight weeks, to  nude mice bearing xenografts o f a 
sa livary gland adenocarcinoma. This regime completely inh ib ited  
tumour growth and enhanced an apparent luminal structure in  the 
xenograft sections. They claimed th a t the stero id was inducing 
c e llu la r d iffe re n tia tio n  by acting through g lucocortico id 
receptors. In th is  study, dexamethasone, w h ils t reducing the
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volume of the xenografts, induced no such structura l 
reorganisation. Moreover, in  the study by Hatekeyama e t Q  (1988), 
the mice were treated with the stero id  fo r eight weeks, so i t  is  
highly l ik e ly  tha t they would experience some sort o f to x ic  e ffec t 
a fte r such long term stero id treatment. In one series of 
experiments in  th is  study (resu lts not shown), the dexamethasone 
treatment was carried on fo r a fu rthe r week, and by the middle of 
the th ird  week o f treatment, almost h a lf o f the mice had died, 
presumably from stero id to x ic ity .
From the A549 histo logy, i t  could be th a t MOG-FDF/IV is  inducing 
d iffe re n tia tio n . The consequences o f th is  may have important 
im plications; by inducing the ce lls  to  d iffe re n tia te , the ce lls  
are presumbably becoming more normal, leading to  a benign rather 
than a malignant tumour. The release o f angiogenesis factors may 
be reduced, and the invasive capacity lim ite d . The d iffe re n tia ite d  
component o f the tumour is  also l ik e ly  to  be less p ro life ra tiv e .
To determine whether MOG-FDF/IV was spec ific  to  A549, i t s  e ffec t 
on three other xenografts was examined. MOG-FDF/IV had no e ffe c t 
on the i_n vivo growth of A2780 (ovarian carcinoma). With H69V 
(derived from SCLC but which shows both NSCLC and SCLC phenotype), 
and LT-34 (another NSCLC), there was an apparent reduction in  
tumour growth, but on s ta t is t ic a l analysis, th is  was not 
s ig n ifica n t. A possible reason fo r th is  may be tha t fewer mice 
were used than with the A549 experiments, due to  a shortage of
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MOG-FDF/IV. In th is  respect, i t  would be worthwhile to  repeat 
these experiments using larger numbers o f animals.
In the H69V group, there was some evidence o f stromal in f i l t r a t io n  
in both the control and the treated groups. As mentioned above, 
observations by Bergh (1988), have shown tha t in  general 
xenografts o f NSCLC contain stromal elements, although in  the case 
o f A549, th is  was only true in  the group treated with MOG-FDF/IV. 
However, H69V is  not s t r ic t ly  speaking, a NSCLC. Although derived 
from a classic SCLC, NCI-H69, work in  th is  laboratory has shown 
tha t i t  displays both NSCLC and SCLC features (Zareen Khan, 
personal communication).
In a previous chapter (Chapter s ix ) ,  levels o f PA were measured in  
A549 and in  another NSCLC, WIL, fo llow ing treatment w ith MOG- 
FDF/IV, and there was a s ig n ifica n t reduction in PA in  both 
treated ce ll lin e s . This suggested tha t perhaps MOG-FDF/IV was 
non-specific. To fo llow  up these observations, attempts were made 
to  grow the ce ll lin e  WIL as a xenograft. This ce ll lin e  normally 
grows very well as a xenograft, but a fte r try ing  fo r several 
weeks, i t  became apparent tha t the ce ll l in e , fo r some reason had 
lo s t the capacity to form xenografts. On the basis o f th is  
observation, and the results  with LT-34 and H69V, i t  is  d i f f ic u l t  
to say whether or not MOG-FDF/IV is  spec ific  to A549, or to  lung, 
but i t  ce rta in ly  has a more s ig n ifica n t e ffe c t on A549 both i_n 
vivo and in  v it ro .
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In v itro  tissue cu ltu re  experiments, w h ils t useful in  determining 
the efficacy o f potential anti cancer agents often have certa in 
shortcomings, most importantly in  corre la ting  the i_n v itro  
response with the predicted response in  v ivo . One o f the questions 
posed in  the Introduction to  th is  Chapter was to  ask i f  there was 
such a corre la tion with the response o f A549 to  MOG-FDF/IV. From 
the results presented in  th is  Chapter, there does appear to  be an 
i_n v it ro  and jn  vivo co rre la tion . Therefore MOG-FDF/IV is  
e ffec tive  jm vivo apparently re ta in ing  i t s  d iffe re n tia tin g  
properties observed in  v i t r o .
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CHAPTER EIGHT
GENERAL DISCUSSION AND CONCLUSIONS
This Chapter w il l  discuss the main findings o f th is  thesis and 
th e ir  im plications, with suggestions fo r fu ture  work.
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8.1 PREAMBLE
The main aim of th is  thesis was to examine the e ffe c t o f 
glucocorticoids on the ro le  o f human foetal lung fib ro b la s ts , MOG- 
LF113 in  the i_n v it ro  and jm vivo d iffe re n tia tio n  o f a human 
alveolar lung carcinoma, A549.
In the general in troduction (Chapter One), the developmental 
fa ilu res  in  neoplasia were outlined and the concept o f re-inducing 
d iffe re n tia tio n  in  these tissues was introduced. I t  was shown tha t 
normal embryonic d iffe re n tia tio n  requires the support o f the 
mesenchyme fo r organogenesis and the correct expression o f the 
mature, d iffe ren tia ted  phenotype. This raised the p o s s ib ility  tha t 
such a system could be applied to  human e p ith e lia l tumours. A fter 
a l l ,  tumours often adopt a quasi-embryonic phenotype and may be 
more responsive to embryonic-like induction.
8.2 STROMAL-EPITHELIAL INTERACTIONS IN NEOPLASIA
As well as being necessary in  normal e p ithe lia l development, the 
influence o f the stroma was shown to  be important fo r the 
glucocorticoid induced expression o f d iffe ren tia ted  functions in  
A549. This was measured by increased production o f pulmonary 
surfactant, a marker of d iffe re n tia tio n  in  A549 c e lls . D irect 
f ib ro b la s t-e p ith e lia l ce ll contact was not important, since
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conditioned medium collected from stero id treated fib rob las ts  was 
e ffec tive , and the ro le  o f a d iffusable facto r was implicated.
I f  such an induction is  possible, why is  the host stroma 
ine ffec tive  under normal circumstances? Probably the main reason 
is  tha t the fib rob las ts  used in  th is  study were derived from 
foetal lung. Foetal fib rob lasts  have important inductive 
properties during embryogenesis, and since most tumours often 
adopt an embryonic phenotype, they may respond more read ily  to  
foetal induction. Also, in  a tumour, the host stroma is  very often 
damaged by factors produced by the tumour, in  such a way tha t i t  
can no longer give the correct inductive signals, so the normal 
d iffe re n tia tio n  pathway is  perturbed.
8.3 IDENTITY OF MOG-FDF/IV
I t  was possible to  p a r t ia lly  p u rify  a heterogeneous mixture o f 
proteins from fib ro b la s t conditioned medium using several protein 
p u rifica tio n  techniques. This mixture was designated MOG-FDF/IV. 
I t  was shown to  be heat and a lka li stable, but acid la b ile  and 
p a r t ia lly  (50%) protease la b ile . From the resu lts  presented here, 
i t  is  d i f f ic u l t  to  say, and probably unwise to  speculate about the 
possible id e n tity  o f id e n tity  o f MOG-FGF/IV.
The main problem was the uncertainty about the molecular weight. 
On SDS-PAGE gels, there was nothing smaller than 30kDa v is ib le
1 6 2
a fte r s ilv e r s ta in ing , although the p o s s ib ility  tha t the a c t iv ity  
may have been a ttribu ted  to  a frac tio n  present in  such small 
quantities tha t i t  i t  fa ile d  to  show up, even a fte r s ilv e r
sta in ing, has been previously discussed.
However, with the knowledge tha t is  available, i t  is  possible to 
look at where MOG-FDF/IV f i t s  in  with respect to  known growth 
facto rs. This is  shown in Table 19.
The actions o f MOG-FDF/IV are, not su rp ris ing ly , closest to  those 
o f Smith's FPF, since i t  was on the consequences o f these 
observations tha t th is  study was based. However, as discussed 
previously, Smith's facto r was prepared by acid hydrolysis of 
conditioned medium, and MOG-FDF/IV was acid la b ile . In one o f
Smith's reports (Post e t aj_, 1984), the group was able to  produce 
a monoclonal to  FPF. An attempt was made to  obtain some o f th is ,  
but th is  proved unsuccessful. This was unfortunate, since i t  would 
have been useful to  help fu rthe r id e n tify  MOG-FDF/IV.
The actions of MOG-FDF/IV are quite d iffe re n t from the other 
three growth factors in  the Table. A549 was (with the exception o f 
the animal studies), re a lly  the only ce ll lin e  studied in  any 
great d e ta il, where the principal action of MOG-FDF/IV was to
induce pulmonary surfactant production. This occurred with the
native form of MOG-FDF/IV, i .e .  without p rio r a c id if ic a tio n  or 
a lka lisa tio n . Nevertheless, by examining the e ffects o f MOG-
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FDF/IV on other ce ll lin e s , i t  may turn out to  have d iffe re n t 
e ffects on d iffe re n t lineages of ta rget c e lls .
8.4 ACTIONS OF MOG-FDF/IV
Another question to  be considered is  the possible mode o f action 
o f MOG-FDF/IV. As already discussed, the principal ro le  o f MOG- 
FDF/IV jm v itro  was to  induce pulmonary surfactant production in 
A549 c e lls . However, dexamethasone was also capable o f stim ulating 
pulmonary surfactant production in A549 c e lls . Since two 
apparently d iffe re n t compounds can bring about the same end 
product, i t  must be asked i f  they act in  the same way i .e .  do they 
share a fin a l common pathway or do they act through d iffe re n t 
pathways?
From the resu lts  presented here, there are probably two possible 
scenarios. F irs t ly ,  dexamethasone could have a d irec t e ffe c t via 
glucocorticoid receptors. Indeed, A549 ce lls  have been shown in  
the past to  possess glucocorticoid receptors (McLean, 1986), so i t  
is  not surprising tha t these ce lls  can respond to  th is  s te ro id .
The other p o s s ib ility  is  tha t dexamethasone, acting via stero id  
receptors in  A549, stimulates the production o f MOG-FDF/IV by A549 
and the ce lls  respond to  th is  in  an autocrine manner, in fluencing 
gene expression and resu lting  in  pulmonary surfactant production. 
In a human breast carcinoma ce ll l in e , ZR-75, a lpha-interferon
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induces production of TGF-beta, regulating th e ir  growth in  an 
autocrine fashion (Kerr e t al^, 1988).
In view o f the ce ll growth data, i t  is  l ik e ly  tha t dexamethasone 
and MOG-FDF/IV act via d iffe re n t routes, but have the same end 
re s u lt. Whilst dexamethasone was cy tos ta tic  to A549 a t both log 
and plateau phases o f the ce ll growth cycle, MOG-FDF/IV did not 
appear to  have any s ig n ifica n t e ffe c t on the growth o f A549 c e lls .
8.5 ROLE OF FDFs IN DEVELOPMENT
FPF has been id e n tif ie d  in  normal lung. In the l iv e r ,  f ib ro b la s t 
hepatocyte fac to r (FHF), which is  an tigen ica lly  d iffe re n t to  FPF, 
has also been p a r t ia lly  p u r if ie d . (Dow e t al_, 1984), and th is  is  
important fo r hepatic development. Such regulatory peptides may be 
commonplace in  embryonic stim ulation, with each major organ 
having i ts  own spec ific  FDF. In neoplasia, the same s itua tion  may 
also arise, whereby mutual in teractions between the stroma and the 
epithelium is  a ltered, and the d iffe re n tia tio n  inducing, or 
maintaining e ffe c t o f the stroma is  lo s t.
8.6 INTER-RELATIONSHIP BETWEEN MALIGNANCY AND DIFFERENTIATION
I t  has often been proposed tha t there is  an in te r-re la tio n sh ip  
between d iffe re n tia tio n  and malignancy-associated properties,
165
whereby an increase in  d iffe re n tia tio n  would be correlated with a 
decrease in  malignancy-associated properties. Marker properties 
representing the mature d iffe ren tia ted  and malignancy-associated 
phenotype were id e n tif ie d  and biochemical and b io log ica l assays 
used to  quantify them. Looking a t the resu lts  as a whole, i t  
appears tha t such a re la tionsh ip  now applies to  A549 c e lls . MOG- 
FDF/IV was found to  induce d iffe re n tia tio n , measured by an 
increase in  pulmonary surfactant production, an increase in  the 
to ta l ce llu la r and secreted GAGS, and the induction o f a more 
d iffe ren tia ted  phenotype in  xenografts, as well as repressing 
malignancy-associated properties (a reduction in  PA and 
clonogenicity in  so ft agar). There appears to  be an inverse 
corre la tion between between d iffe re n tia tio n  and malignancy.
8.7 CORRELATION BETWEEN IN VITRO AND .IN VIVO RESULTS
There did appear to  be a corre la tion between the i_n vivo and vn 
v itro  resu lts , with d iffe re n tia tio n  rn v it ro  accompanied by an 
apparent d iffe re n tia tio n  i_n v ivo . Such a re la tionsh ip  raises the 
p o s s ib ility  tha t restoration o f normal d iffe re n tia tio n  by 
paracrine factors may represent a novel way o f trea ting  e p ith e lia l 
tumours.
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8.8 FUTURE PROSPECTS
The results  o f th is  study have raised a number of in te resting  
points which would m erit fu ture examination.
Greatest pulmonary surfactant production was observed when the 
A549 ce lls  were cultured on a f i l t e r  w e ll. As discussed 
previously, th is  could be due to  one o f two p o s s ib ilit ie s . Since 
the o rig in  o f A549 is  reputed to  be from an alveolar carcinoma, 
the in v it ro  conditions on the f i l t e r  well may mimic more closely 
the _in vivo environment. Whether th is  only applies to  alveolar 
e p ith e lia l ce lls  is  not known, but i t  would be benefic ia l to  
cu lture other lung e p ithe lia l ce lls  from d iffe re n t areas o f the 
lung under such conditions to  see i f  there was an increase in  the 
expression o f d iffe ren tia ted  functions.
Perhaps the most important point is  the id e n tity  and fu rthe r 
characterisation o f MOG-FDF/IV. As was evident from the resu lts  o f 
Chapter 5, MOG-FDF/IV was by no means pu rified  to  homogeneity. 
Obviously fo r fu ture studies i t  was be a great advantage to know 
i f  MOG-FDF/IV was a unique facto r or one o f the bette r known 
growth or d iffe re n tia tio n  facto rs. Having a p u rified  fac to r would 
not only make some o f the experiments much easier, since there 
may be the p o s s ib ility  o f ra is ing  a monoclonal antibody to  i t ,  
but also raise the p o s s ib ility  o f having the facto r sequenced and 
cloned. Also, i t  would be much easier to  radio-label something o f
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specific  id e n tity , rather than an impure mixture. This would be 
important e.g. fo r receptor competition assays.
Another point is  the re la tionsh ip  between MOG-FDF/IV and other 
growth factors, to  see i f  there are any add itive , synerg istic or 
antagonistic e ffec ts . The resu lts  presented here have indicated 
tha t PDGF, bFGF and IGF-1 a ll have s ig n ifica n t e ffects  in 
stim ulating pulmonary surfactant production. I t  may well be tha t 
MOG-FDF/IV is  actua lly a mixture o f growth factors which are
working in  combination. I f  th is  is  so, i t  would be benefic ia l to
unveil th e ir  in te rac tive  e ffe c ts . Such experiments are currently  
underway in  th is  laboratory.
MOG-FDF/IV can induce d iffe re n tia tio n  and repress malignancy-
associated properties in  A549, but i t  is  not known i f  th is  
represents terminal d iffe re n tia tio n  or not, since d iffe re n tia tio n  
pathways in  so lid  tumours are not very well characterised. This 
would be an important aspect to  be considered at some stage.
Connected to  th is ,  is  the potential e ffe c t o f MOG-FDF/IV on the 
invasive properties o f A549, and there are several ways o f 
measuring th is  e.g invasion of embryonic chick heart (Mareel e t 
a !, 1979).
Other important aspects to  consider are s p e c if ic ity  fo r the both 
the target epithelium, the fib rob las ts  from which the fac to r may 
be derived, and, to  a lesser extent, the phenotypic inducer. The 
s p e c ific ity  o f mesodermal induction may be dependent on the source
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of the epithelium. I t  is  possible tha t the e ffe c t o f MOG-FDF/IV is  
specific  to alveolar or lung epithelium, but an inductive e ffec t 
on other e p ith e lia l tissues may be found i f  the correct markers 
were examined. The s p e c if ic ity  o f MOG-FDF/IV was carried out to  a 
lim ited  extent here, and i t  was shown tha t perhaps i t  was 
spec ific , a t least to NSCLC. However these resu lts  need fu rthe r 
examination using a greater range o f tumour models.
In th is  study, only foetal lung fib rob las ts  were used. Adult 
fib rob la s ts , although they have probably lo s t th e ir  inductive 
properties, would nevertheless be worthwhile try in g . Foetal 
fib rob lasts  from a source other than lung would also be a good 
option, since th is  would determine stromal s p e c if ic ity . I t  would 
also be in te resting  to  examine the prolonged e ffe c t o f A549 on 
M0G-LF113, to  see i f  fib rob lasts  exposed to  tumour c e lls  could 
s t i l l  respond in  the same way to  g lucocorticoid and release active 
fac to r.
I t  was shown tha t dexamethasone could act d ire c tly  on A549 c e lls , 
where, as well as inducing pulmonary surfactant, i t  had a 
cy tosta tic  e ffe c t. From the observations in  th is  study, i t  has 
already been discussed tha t there are two possible modes o f action 
(see above). I t  would be o f value at some stage to  pu rify  
dexamethasone treated A549 conditioned medium to see i f  such an 
e ffe c t was found. Of less importance would be to  t ry  other 
stero ids, e ithe r dexamethasone analogues or d iffe re n t ste ro ids. I t  
would also be o f value to  look a t other phenotypic inducers such
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as sodium butyrate, both d ire c tly  on the A549 ce lls  and in d ire c tly  
through the fib rob lasts  to  see i f  production o f MOG-FDF/IV could 
be stimulated by substances other than stero ids.
Many studies have implied tha t the correct substratum is  important 
fo r the expression o f d iffe ren tia ted  properties in  e p ith e lia l 
c e lls . In th is  respect, i t  may be of use to  cu lture the ce lls  on 
basement membrane coated dishes or f i l t e r  wells and monitor the 
e ffe c ts .
In conclusion, i t  appears tha t strom al-epithe lia l in teractions are 
important fo r the induction o f d iffe re n tia tio n  and the reduction 
of malignancy-associated properties in  human alveolar lung 
carcinoma c e lls . This is  regulated by a fac to r, possibly unique, 
which is  released from glucocorticoid stimulated foeta l lung 
fib rob las ts . The resu lts  o f th is  study suggest tha t neoplastic 
ce lls  s t i l l  re ta in  the capacity to  respond to  paracrine phenotypic 
inducers. Although s t i l l  in  an early stage, i t  is  possible tha t 
such inducers may have a ro le  in  cancer therapy in  the fu tu re .
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